Association	O
of	O
TRAF1	B-protein
,	O
TRAF2	B-protein
,	O
and	O
TRAF3	B-protein
with	O
an	O
Epstein-Barr	B-DNA
virus	I-DNA
LMP1	I-DNA
domain	I-DNA
important	O
for	O
B-lymphocyte	B-cell_type
transformation	O
:	O
role	O
in	O
NF-kappaB	B-protein
activation	O
.	O

The	O
Epstein-Barr	B-protein
virus	I-protein
(	I-protein
EBV	I-protein
)	I-protein
transforming	I-protein
protein	I-protein
LMP1	I-protein
appears	O
to	O
be	O
a	O
constitutively	B-protein
activated	I-protein
tumor	I-protein
necrosis	I-protein
factor	I-protein
receptor	I-protein
(	O
TNFR	B-protein
)	O
on	O
the	O
basis	O
of	O
an	O
intrinsic	O
ability	O
to	O
aggregate	O
in	O
the	O
plasma	O
membrane	O
and	O
an	O
association	O
of	O
its	O
cytoplasmic	B-protein
carboxyl	I-protein
terminus	I-protein
(	O
CT	B-protein
)	O
with	O
TNFR-associated	B-protein
factors	I-protein
(	O
TRAFs	B-protein
)	O
.	O

We	O
now	O
show	O
that	O
in	O
EBV-transformed	B-cell_line
B	I-cell_line
lymphocytes	I-cell_line
most	O
of	O
TRAF1	B-protein
or	O
TRAF3	B-protein
and	O
5	O
%	O
of	O
TRAF2	B-protein
are	O
associated	O
with	O
LMP1	B-protein
and	O
that	O
most	O
of	O
LMP1	B-protein
is	O
associated	O
with	O
TRAF1	B-protein
or	O
TRAF3	B-protein
.	O

TRAF1	B-protein
,	O
TRAF2	B-protein
,	O
and	O
TRAF3	B-protein
bind	O
to	O
a	O
single	O
site	O
in	O
the	O
LMP1	B-protein
CT	I-protein
corresponding	O
to	O
amino	O
acids	O
(	O
aa	O
)	O
199	O
to	O
214	O
,	O
within	O
a	O
domain	O
which	O
is	O
important	O
for	O
B-lymphocyte	O
growth	O
transformation	O
(	O
aa	O
187	O
to	O
231	O
)	O
.	O

Further	O
deletional	O
and	O
alanine	O
mutagenesis	O
analyses	O
and	O
comparison	O
with	O
TRAF	B-DNA
binding	I-DNA
sequences	I-DNA
in	O
CD40	O
,	O
in	O
CD30	O
,	O
and	O
in	O
the	O
LMP1	B-protein
of	O
other	O
lymphycryptoviruses	O
provide	O
the	O
first	O
evidence	O
that	O
PXQXT/S	B-DNA
is	O
a	O
core	O
TRAF	B-DNA
binding	I-DNA
motif	I-DNA
.	O

The	O
negative	O
effects	O
of	O
point	O
mutations	O
in	O
the	O
LMP1	B-DNA
(	I-DNA
1-231	I-DNA
)	I-DNA
core	I-DNA
TRAF	I-DNA
binding	I-DNA
motif	I-DNA
on	O
TRAF	O
binding	O
and	O
NF-kappaB	B-protein
activation	O
genetically	O
link	O
the	O
TRAFs	B-protein
to	O
LMP1	B-protein
(	O
1-231	O
)	O
-mediated	O
NF-kappaB	B-protein
activation	O
.	O

NF-kappaB	B-protein
activation	O
by	O
LMP1	B-protein
(	O
1-231	O
)	O
is	O
likely	O
to	O
be	O
mediated	O
by	O
TRAF1	B-protein
/TRAF2	B-protein
heteroaggregates	O
since	O
TRAF1	B-protein
is	O
unique	O
among	O
the	O
TRAFs	B-protein
in	O
coactivating	O
NF-kappaB	B-protein
with	O
LMP1	B-protein
(	O
1-231	O
)	O
,	O
a	O
TRAF2	B-protein
dominant-negative	O
mutant	O
can	O
block	O
LMP1	B-protein
(	O
1-231	O
)	O
-mediated	O
NF-kappaB	B-protein
activation	O
as	O
well	O
as	O
TRAF1	B-protein
coactivation	O
,	O
and	O
30	O
%	O
of	O
TRAF2	B-protein
is	O
associated	O
with	O
TRAF1	B-protein
in	O
EBV-transformed	O
B	O
cells	O
.	O

TRAF3	B-protein
is	O
a	O
negative	O
modulator	O
of	O
LMP1	B-protein
(	O
1-231	O
)	O
-mediated	O
NF-kappaB	B-protein
activation	O
.	O

Surprisingly	O
,	O
TRAF1	B-protein
,	I-protein
-2	I-protein
,	I-protein
or	I-protein
-3	I-protein
does	O
not	O
interact	O
with	O
the	O
terminal	B-protein
LMP1	I-protein
CT	I-protein
aa	O
333	O
to	O
386	O
which	O
can	O
independently	O
mediate	O
NF-kappaB	B-protein
activation	O
.	O

The	O
constitutive	O
association	O
of	O
TRAFs	B-protein
with	O
LMP1	B-protein
through	O
the	O
aa	B-protein
187	I-protein
to	I-protein
231	I-protein
domain	I-protein
which	O
is	O
important	O
in	O
NF-kappaB	B-protein
activation	O
and	O
primary	O
B-lymphocyte	B-cell_type
growth	O
transformation	O
implicates	O
TRAF	B-protein
aggregation	O
in	O
LMP1	B-protein
signaling	O
.	O

MOLECULAR	NULL
AND	NULL
CELLULAR	NULL
BIOLOGY	NULL
,	NULL
Dec.	NULL
1996	NULL
,	NULL
p.	NULL
7098-7108	NULL
0270-7306/96/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
©	NULL
1996	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

16	NULL
,	NULL
No	NULL
.	NULL

12	NULL
Association	NULL
of	NULL
TRAF1	NULL
,	NULL
TRAF2	NULL
,	NULL
and	NULL
TRAF3	NULL
with	NULL
an	NULL
Epstein-Barr	NULL
Virus	NULL
LMP1	NULL
Domain	NULL
Important	NULL
for	NULL
B-Lymphocyte	NULL
Transformation	NULL
:	NULL
Role	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
Activation	NULL
ODILE	NULL
DEVERGNE	NULL
,	NULL
EUDOXIA	NULL
HATZIVASSILIOU	NULL
,	NULL
KENNETH	NULL
M.	NULL
IZUMI	NULL
,	NULL
KENNETH	NULL
M.	NULL
KAYE	NULL
,	NULL
MAURITS	NULL
F.	NULL
KLEIJNEN	NULL
,	NULL
ELLIOTT	NULL
KIEFF	NULL
,	NULL
*	NULL
anp	NULL
GEORGE	NULL
MOSIALOS	NULL
Departments	NULL
of	NULL
Microbiology	NULL
and	NULL
Molecular	NULL
Genetics	NULL
and	NULL
Medicine	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
and	NULL
Brigham	NULL
and	NULL
Women	NULL
's	NULL
Hospital	NULL
,	NULL
Boston	NULL
,	NULL
Massachusetts	NULL
02115	NULL
Received	NULL
5	NULL
July	NULL
1996/Returned	NULL
for	NULL
modification	NULL
27	NULL
August	NULL
1996/Accepted	NULL
10	NULL
September	NULL
1996	NULL
The	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
transforming	NULL
protein	NULL
LMP1	NULL
appears	NULL
to	NULL
be	NULL
a	NULL
constitutively	NULL
activated	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor	NULL
(	NULL
TNFR	NULL
)	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
an	NULL
intrinsic	NULL
ability	NULL
to	NULL
aggregate	NULL
in	NULL
the	NULL
plasma	NULL
membrane	NULL
and	NULL
an	NULL
association	NULL
of	NULL
its	NULL
cytoplasmic	NULL
carboxyl	NULL
terminus	NULL
(	NULL
CT	NULL
)	NULL
with	NULL
TNFR-associated	NULL
factors	NULL
(	NULL
TRAFs	NULL
)	NULL
.	NULL

We	NULL
now	NULL
show	NULL
that	NULL
in	NULL
EBV-transformed	NULL
B	NULL
lymphocytes	NULL
most	NULL
of	NULL
TRAF1	NULL
or	NULL
TRAF3	NULL
and	NULL
5	NULL
%	NULL
of	NULL
TRAF2	NULL
are	NULL
associated	NULL
with	NULL
LMP1	NULL
and	NULL
that	NULL
most	NULL
of	NULL
LMP1	NULL
is	NULL
associated	NULL
with	NULL
TRAF	NULL
]	NULL
or	NULL
TRAF3	NULL
.	NULL

TRAF1	NULL
,	NULL
TRAF2	NULL
,	NULL
and	NULL
TRAF3	NULL
bind	NULL
to	NULL
a	NULL
single	NULL
site	NULL
in	NULL
the	NULL
LMP1	NULL
CT	NULL
corresponding	NULL
to	NULL
amino	NULL
acids	NULL
(	NULL
aa	NULL
)	NULL
199	NULL
to	NULL
214	NULL
,	NULL
within	NULL
a	NULL
domain	NULL
which	NULL
is	NULL
important	NULL
for	NULL
B-lymphocyte	NULL
growth	NULL
transformation	NULL
(	NULL
aa	NULL
187	NULL
to	NULL
231	NULL
)	NULL
.	NULL

Further	NULL
deletional	NULL
and	NULL
alanine	NULL
mutagenesis	NULL
analyses	NULL
and	NULL
comparison	NULL
with	NULL
TRAF	NULL
binding	NULL
sequences	NULL
in	NULL
CD40	NULL
,	NULL
in	NULL
CD30	NULL
,	NULL
and	NULL
in	NULL
the	NULL
LMP1	NULL
of	NULL
other	NULL
lymphycryptoviruses	NULL
provide	NULL
the	NULL
first	NULL
evidence	NULL
that	NULL
PXQXT/S	NULL
is	NULL
a	NULL
core	NULL
TRAF	NULL
binding	NULL
motif	NULL
.	NULL

The	NULL
negative	NULL
effects	NULL
of	NULL
point	NULL
mutations	NULL
in	NULL
the	NULL
LMP1	NULL
(	NULL
1-231	NULL
)	NULL
core	NULL
TRAF	NULL
binding	NULL
motif	NULL
on	NULL
TRAF	NULL
binding	NULL
and	NULL
NF-KB	NULL
activation	NULL
genetically	NULL
link	NULL
the	NULL
TRAFs	NULL
to	NULL
LMP1	NULL
(	NULL
1-231	NULL
)	NULL
-mediated	NULL
NF-KB	NULL
activation	NULL
.	NULL

NF-KB	NULL
activation	NULL
by	NULL
LMP1	NULL
(	NULL
1-231	NULL
)	NULL
is	NULL
likely	NULL
to	NULL
be	NULL
mediated	NULL
by	NULL
TRAFI/TRAF2	NULL
heteroaggregates	NULL
since	NULL
TRAF1l	NULL
is	NULL
unique	NULL
among	NULL
the	NULL
TRAFs	NULL
in	NULL
coactivating	NULL
NF-KB	NULL
with	NULL
LMP1	NULL
(	NULL
1-231	NULL
)	NULL
,	NULL
a	NULL
TRAF2	NULL
dominant-negative	NULL
mutant	NULL
can	NULL
block	NULL
LMP1	NULL
(	NULL
1-231	NULL
)	NULL
-mediated	NULL
NF-KB	NULL
activation	NULL
as	NULL
well	NULL
as	NULL
TRAF1	NULL
coactivation	NULL
,	NULL
and	NULL
30	NULL
%	NULL
of	NULL
TRAF2	NULL
is	NULL
associated	NULL
with	NULL
TRAF1	NULL
in	NULL
EBV-transformed	NULL
B	NULL
cells	NULL
.	NULL

TRAF3	NULL
is	NULL
a	NULL
negative	NULL
modulator	NULL
of	NULL
LMP1	NULL
(	NULL
1-231	NULL
)	NULL
-mediated	NULL
NF-KB	NULL
activation	NULL
.	NULL

Surprisingly	NULL
,	NULL
TRAF1	NULL
,	NULL
-2	NULL
,	NULL
or	NULL
-3	NULL
does	NULL
not	NULL
interact	NULL
with	NULL
the	NULL
terminal	NULL
LMP1	NULL
CT	NULL
aa	NULL
333	NULL
to	NULL
386	NULL
which	NULL
can	NULL
independently	NULL
mediate	NULL
NF-KB	NULL
activation	NULL
.	NULL

The	NULL
constitutive	NULL
association	NULL
of	NULL
TRAFs	NULL
with	NULL
LMP1	NULL
through	NULL
the	NULL
aa	NULL
187	NULL
to	NULL
231	NULL
domain	NULL
which	NULL
is	NULL
important	NULL
in	NULL
NF-KB	NULL
activation	NULL
and	NULL
primary	NULL
B-lymphocyte	NULL
growth	NULL
transformation	NULL
implicates	NULL
TRAF	NULL
aggregation	NULL
in	NULL
LMP1	NULL
signaling	NULL
.	NULL

Latent-infection	NULL
membrane	NULL
protein	NULL
1	NULL
(	NULL
LMP1	NULL
)	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
ability	NULL
of	NULL
EBV	NULL
to	NULL
induce	NULL
continuous	NULL
proliferation	NULL
of	NULL
primary	NULL
human	NULL
B	NULL
lymphocytes	NULL
(	NULL
20	NULL
)	NULL
.	NULL

LMP1	NULL
comprises	NULL
an	NULL
N-terminal	NULL
cytoplasmic	NULL
domain	NULL
(	NULL
amino	NULL
acids	NULL
[	NULL
aa	NULL
]	NULL
1	NULL
to	NULL
24	NULL
)	NULL
,	NULL
six	NULL
markedly	NULL
hydrophobic	NULL
transmembrane	NULL
domains	NULL
separated	NULL
by	NULL
short	NULL
reverse	NULL
turns	NULL
(	NULL
aa	NULL
25	NULL
to	NULL
186	NULL
)	NULL
,	NULL
and	NULL
a	NULL
long	NULL
cytoplasmic	NULL
carboxyl	NULL
terminus	NULL
(	NULL
CT	NULL
)	NULL
(	NULL
aa	NULL
187	NULL
to	NULL
386	NULL
)	NULL
(	NULL
6	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Recombinant	NULL
EBV	NULL
genetic	NULL
analyses	NULL
indicate	NULL
that	NULL
the	NULL
six	NULL
transmembrane	NULL
domains	NULL
and	NULL
the	NULL
CT	NULL
first	NULL
45	NULL
aa	NULL
are	NULL
sufficient	NULL
for	NULL
primary	NULL
B-lymphocyte	NULL
growth	NULL
transformation	NULL
in	NULL
the	NULL
context	NULL
of	NULL
a	NULL
specifically	NULL
mutated	NULL
EBV	NULL
recombinant	NULL
(	NULL
18	NULL
,	NULL
20	NULL
,	NULL
21	NULL
,	NULL
23	NULL
)	NULL
.	NULL

Sevzzral	NULL
lines	NULL
of	NULL
evidence	NULL
indicate	NULL
that	NULL
LMP1	NULL
is	NULL
a	NULL
constitutively	NULL
activated	NULL
tumor	NULL
necrosis	NULL
factor	NULL
family	NULL
receptor	NULL
(	NULL
TNFR	NULL
)	NULL
similar	NULL
to	NULL
activated	NULL
CD40	NULL
.	NULL

First	NULL
,	NULL
expression	NULL
of	NULL
LMP1	NULL
in	NULL
B	NULL
lymphoblasts	NULL
or	NULL
in	NULL
primary	NULL
B	NULL
lymphocytes	NULL
results	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
and	NULL
expression	NULL
of	NULL
Bel-2	NULL
,	NULL
activation	NULL
markers	NULL
,	NULL
adhesion	NULL
molecules	NULL
,	NULL
and	NULL
autocrine	NULL
growth	NULL
factors	NULL
,	NULL
all	NULL
of	NULL
which	NULL
are	NULL
induced	NULL
in	NULL
normal	NULL
B	NULL
lymphocytes	NULL
after	NULL
stimulation	NULL
by	NULL
CD40	NULL
ligand	NULL
and	NULL
interleukin-4	NULL
or	NULL
-10	NULL
(	NULL
1	NULL
,	NULL
11	NULL
,	NULL
16	NULL
,	NULL
24	NULL
,	NULL
26	NULL
,	NULL
30	NULL
,	NULL
33	NULL
,	NULL
41	NULL
,	NULL
42	NULL
)	NULL
.	NULL

Second	NULL
,	NULL
a	NULL
significant	NULL
fraction	NULL
of	NULL
LMP1	NULL
constitutively	NULL
aggregates	NULL
in	NULL
a	NULL
patch	NULL
in	NULL
the	NULL
plasma	NULL
membrane	NULL
of	NULL
lymphoblastoid	NULL
cell	NULL
lines	NULL
(	NULL
LCLs	NULL
)	NULL
(	NULL
12	NULL
,	NULL
26	NULL
,	NULL
27	NULL
,	NULL
29	NULL
)	NULL
.	NULL

The	NULL
aggregation	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
six	NULL
hydrophobic	NULL
transmembrane	NULL
domains	NULL
and	NULL
is	NULL
essen	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Departments	NULL
of	NULL
Microbiology	NULL
and	NULL
Molecular	NULL
Genetics	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
and	NULL
Brigham	NULL
and	NULL
Women	NULL
's	NULL
Hospital	NULL
,	NULL
75	NULL
Francis	NULL
St.	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02115	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
617	NULL
)	NULL
525-4252	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
617	NULL
)	NULL
525-4257	NULL
.	NULL

Electronic	NULL
mail	NULL
address	NULL
:	NULL
ekieff	NULL
@	NULL
bustoff.bwh.harvard.edu	NULL
.	NULL

7098	NULL
tial	NULL
for	NULL
transformation	NULL
.	NULL

Thus	NULL
,	NULL
LMP1	NULL
comprising	NULL
only	NULL
the	NULL
last	NULL
five	NULL
transmembrane	NULL
domains	NULL
and	NULL
the	NULL
entire	NULL
CT	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
LMP1	NULL
aa	NULL
44	NULL
to	NULL
386	NULL
,	NULL
diffusely	NULL
distributes	NULL
in	NULL
the	NULL
plasma	NULL
membrane	NULL
and	NULL
is	NULL
nontransforming	NULL
(	NULL
20	NULL
,	NULL
26	NULL
)	NULL
,	NULL
whereas	NULL
LMP1	NULL
comprising	NULL
the	NULL
last	NULL
two	NULL
transmembrane	NULL
domains	NULL
and	NULL
the	NULL
CT	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
LMP1	NULL
aa	NULL
129	NULL
to	NULL
386	NULL
,	NULL
diffusely	NULL
distributes	NULL
in	NULL
all	NULL
cytoplasmic	NULL
membranes	NULL
and	NULL
has	NULL
no	NULL
effect	NULL
on	NULL
lymphoblasts	NULL
(	NULL
16	NULL
,	NULL
26	NULL
,	NULL
41	NULL
)	NULL
.	NULL

Third	NULL
,	NULL
the	NULL
LMP1	NULL
CT	NULL
aa	NULL
187	NULL
to	NULL
231	NULL
,	NULL
which	NULL
are	NULL
sufficient	NULL
for	NULL
transformation	NULL
when	NULL
linked	NULL
to	NULL
the	NULL
six	NULL
transmembrane	NULL
domains	NULL
[	NULL
LMP1	NULL
(	NULL
1-231	NULL
)	NULL
]	NULL
(	NULL
23	NULL
)	NULL
,	NULL
interact	NULL
with	NULL
a	NULL
protein	NULL
that	NULL
also	NULL
interacts	NULL
with	NULL
the	NULL
CD40	NULL
cytoplasmic	NULL
domain	NULL
(	NULL
3	NULL
,	NULL
15	NULL
,	NULL
31	NULL
,	NULL
39	NULL
)	NULL
;	NULL
a	NULL
CD40	NULL
cytoplasmic	NULL
domain	NULL
nonsignal-ing	NULL
mutant	NULL
fails	NULL
to	NULL
interact	NULL
with	NULL
this	NULL
protein	NULL
(	NULL
15	NULL
)	NULL
.	NULL

This	NULL
protein	NULL
(	NULL
previously	NULL
called	NULL
LAP1	NULL
,	NULL
CD4O0bp	NULL
,	NULL
CRAF1	NULL
,	NULL
or	NULL
CAP1	NULL
)	NULL
is	NULL
now	NULL
designated	NULL
TRAF3	NULL
because	NULL
of	NULL
its	NULL
extensive	NULL
C-terminal	NULL
``	NULL
TRAF	NULL
domain	NULL
``	NULL
homology	NULL
to	NULL
TNFR-associated	NULL
factor	NULL
2	NULL
(	NULL
TRAF2	NULL
)	NULL
and	NULL
TRAF1	NULL
(	NULL
also	NULL
called	NULL
EBI6	NULL
)	NULL
(	NULL
36	NULL
,	NULL
37	NULL
)	NULL
.	NULL

The	NULL
LMP1	NULL
CT	NULL
can	NULL
also	NULL
bind	NULL
to	NULL
TRAF2	NULL
in	NULL
vitro	NULL
and	NULL
associates	NULL
with	NULL
TRAF1	NULL
,	NULL
TRAF2	NULL
,	NULL
and	NULL
TRAF3	NULL
in	NULL
the	NULL
plasma	NULL
membrane	NULL
of	NULL
transiently	NULL
transfected	NULL
cells	NULL
(	NULL
22	NULL
,	NULL
31	NULL
)	NULL
.	NULL

TRAF2	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
CD40-	NULL
,	NULL
p80	NULL
TNFR-	NULL
,	NULL
and	NULL
p60	NULL
TNFR-mediated	NULL
NF-KB	NULL
activation	NULL
(	NULL
14	NULL
,	NULL
36	NULL
)	NULL
.	NULL

The	NULL
LMP1	NULL
CT	NULL
has	NULL
two	NULL
domains	NULL
(	NULL
aa	NULL
187	NULL
to	NULL
231	NULL
and	NULL
aa	NULL
332	NULL
to	NULL
386	NULL
)	NULL
that	NULL
can	NULL
transmit	NULL
NF-	NULL
«	NULL
B-activating	NULL
signals	NULL
.	NULL

LMP1	NULL
aa	NULL
1	NULL
to	NULL
386	NULL
with	NULL
aa	NULL
188	NULL
to	NULL
331	NULL
deleted	NULL
(	NULL
LMPA188-331	NULL
)	NULL
activates	NULL
NF-	NULL
«	NULL
B	NULL
better	NULL
than	NULL
LMP1	NULL
(	NULL
1-231	NULL
)	NULL
(	NULL
16	NULL
,	NULL
30	NULL
)	NULL
.	NULL

LMP1	NULL
(	NULL
1-231	NULL
)	NULL
-mediated	NULL
NF-KB	NULL
activation	NULL
can	NULL
be	NULL
inhibited	NULL
by	NULL
a	NULL
dominant-negative	NULL
TRAF2	NULL
mutant	NULL
,	NULL
implicating	NULL
TRAF2	NULL
in	NULL
NF-kB	NULL
activation	NULL
by	NULL
LMP1	NULL
(	NULL
1-231	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
LMPA188-331-mediated	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
was	NULL
largely	NULL
unaffected	NULL
by	NULL
dominant-negative	NULL
TRAF2	NULL
overexpression	NULL
(	NULL
22	NULL
)	NULL
.	NULL

The	NULL
experiments	NULL
reported	NULL
here	NULL
were	NULL
designed	NULL
to	NULL
investigate	NULL
Vou	NULL
.	NULL

16	NULL
,	NULL
1996	NULL
LMP1	NULL
A	NULL
4457	NULL
plagma	NULL
membrane	NULL
.	NULL

187	NULL
1	NULL
129	NULL
cytop	NULL
asmN	NULL
j	NULL
-	NULL
>	NULL
NF-	NULL
«	NULL
B	NULL
1	NULL
*th	NULL
B	NULL
cell	NULL
transformation	NULL
A	NULL
arl	NULL
os	NULL
aco	NULL
332	NULL
+	NULL
386	NULL
NF-KB	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Schematic	NULL
representation	NULL
of	NULL
LMP1	NULL
.	NULL

LMP1	NULL
consists	NULL
of	NULL
a	NULL
25-aa	NULL
N-terminal	NULL
cytoplasmic	NULL
domain	NULL
,	NULL
six	NULL
hydrophobic	NULL
transmembrane	NULL
domains	NULL
separated	NULL
by	NULL
short	NULL
reverse	NULL
turns	NULL
,	NULL
and	NULL
a	NULL
200-aa	NULL
C-terminal	NULL
cytoplasmic	NULL
domain	NULL
.	NULL

The	NULL
LMP1	NULL
N-terminal	NULL
cytoplasmic	NULL
domain	NULL
is	NULL
not	NULL
essential	NULL
for	NULL
growth	NULL
transformation	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Codon	NULL
44-initiated	NULL
LMP1	NULL
,	NULL
expressed	NULL
from	NULL
the	NULL
EBV	NULL
genome	NULL
,	NULL
is	NULL
unable	NULL
to	NULL
transform	NULL
B	NULL
lymphocytes	NULL
and	NULL
is	NULL
diffusely	NULL
distributed	NULL
in	NULL
the	NULL
plasma	NULL
membrane	NULL
,	NULL
illustrating	NULL
the	NULL
importance	NULL
of	NULL
plasma	NULL
membrane	NULL
patching	NULL
in	NULL
LMP1	NULL
effects	NULL
on	NULL
cell	NULL
growth	NULL
(	NULL
20	NULL
)	NULL
.	NULL

LMP1	NULL
aa	NULL
1	NULL
to	NULL
231	NULL
[	NULL
LMP1	NULL
(	NULL
1-231	NULL
)	NULL
]	NULL
are	NULL
sufficient	NULL
for	NULL
primary	NULL
B-lymphocyte	NULL
growth	NULL
transformation	NULL
(	NULL
21	NULL
,	NULL
23	NULL
)	NULL
and	NULL
can	NULL
activate	NULL
NF-	NULL
«	NULL
B	NULL
with	NULL
25	NULL
%	NULL
of	NULL
the	NULL
efficiency	NULL
of	NULL
wild-type	NULL
LMP1	NULL
(	NULL
16	NULL
,	NULL
30	NULL
)	NULL
.	NULL

LMP1	NULL
aa	NULL
1	NULL
to	NULL
386	NULL
with	NULL
a	NULL
deletion	NULL
of	NULL
aa	NULL
188	NULL
to	NULL
331	NULL
(	NULL
LMPA188-331	NULL
)	NULL
can	NULL
activate	NULL
NF-	NULL
«	NULL
B	NULL
with	NULL
about	NULL
75	NULL
%	NULL
of	NULL
the	NULL
efficiency	NULL
of	NULL
wild-type	NULL
LMP1	NULL
(	NULL
16	NULL
,	NULL
30	NULL
)	NULL
.	NULL

the	NULL
interaction	NULL
of	NULL
TRAF1	NULL
,	NULL
-2	NULL
,	NULL
and	NULL
-3	NULL
with	NULL
LMP1	NULL
in	NULL
LCLs	NULL
,	NULL
identify	NULL
key	NULL
residues	NULL
in	NULL
the	NULL
LMP1	NULL
CT	NULL
that	NULL
interact	NULL
with	NULL
TRAF1	NULL
,	NULL
-2	NULL
,	NULL
and	NULL
-3	NULL
,	NULL
and	NULL
evaluate	NULL
the	NULL
relative	NULL
roles	NULL
of	NULL
TRAF1	NULL
,	NULL
-2	NULL
,	NULL
and	NULL
-3	NULL
in	NULL
NF-kB	NULL
activation	NULL
by	NULL
LMP1	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
lines	NULL
.	NULL

1B4	NULL
is	NULL
an	NULL
EBV-transformed	NULL
LCL	NULL
.	NULL

BJAB	NULL
is	NULL
an	NULL
EBV-negative	NULL
Burkitt	NULL
lymphoma	NULL
cell	NULL
line	NULL
.	NULL

293	NULL
is	NULL
a	NULL
human	NULL
embryonal	NULL
kidney	NULL
cell	NULL
line	NULL
.	NULL

An	NULL
LCL	NULL
transformed	NULL
by	NULL
recombinant	NULL
EBV	NULL
carrying	NULL
an	NULL
N-terminal	NULL
FLAG-tagged	NULL
LMP1	NULL
(	NULL
FLAG-LMP1	NULL
LCL	NULL
)	NULL
was	NULL
derived	NULL
by	NULL
transfecting	NULL
EcoRI-A	NULL
,	NULL
Sa/IEC	NULL
,	NULL
and	NULL
a	NULL
mutated	NULL
B230	NULL
cosmid	NULL
DNAs	NULL
into	NULL
P3HR-1	NULL
cells	NULL
.	NULL

B230	NULL
was	NULL
derived	NULL
by	NULL
replacing	NULL
codons	NULL
2	NULL
to	NULL
4	NULL
in	NULL
the	NULL
LMP1	NULL
gene	NULL
in	NULL
S-wt	NULL
(	NULL
18	NULL
)	NULL
with	NULL
a	NULL
double-stranded	NULL
oligonu-cleotide	NULL
that	NULL
encodes	NULL
the	NULL
FLAG	NULL
monoclonal	NULL
antibody	NULL
epitope	NULL
(	NULL
DYKDDDD	NULL
KV	NULL
)	NULL
.	NULL

A	NULL
NotI	NULL
site	NULL
was	NULL
then	NULL
inserted	NULL
at	NULL
a	NULL
HindIII	NULL
site	NULL
(	NULL
nucleotide	NULL
[	NULL
nt	NULL
]	NULL
166480	NULL
of	NULL
the	NULL
EBV	NULL
genome	NULL
sequence	NULL
)	NULL
in	NULL
the	NULL
FLAG-oligonucleotide-containing	NULL
DNA	NULL
frag-ment	NULL
,	NULL
and	NULL
a	NULL
Pact	NULL
site	NULL
was	NULL
inserted	NULL
into	NULL
a	NULL
Bg/II	NULL
site	NULL
(	NULL
nt	NULL
169032	NULL
)	NULL
,	NULL
resulting	NULL
in	NULL
clone	NULL
B220	NULL
.	NULL

Cosmid	NULL
B230	NULL
was	NULL
then	NULL
formed	NULL
from	NULL
the	NULL
EcoRI	NULL
(	NULL
nt	NULL
95239	NULL
)	NULL
to	NULL
NofI	NULL
(	NULL
nt	NULL
117614	NULL
)	NULL
fragment	NULL
from	NULL
EcoRI-B	NULL
,	NULL
the	NULL
Nof	NULL
]	NULL
(	NULL
nt	NULL
166480	NULL
)	NULL
to	NULL
SalI	NULL
(	NULL
nt	NULL
643	NULL
)	NULL
fragment	NULL
from	NULL
B220	NULL
,	NULL
the	NULL
Sell	NULL
(	NULL
ot	NULL
643	NULL
)	NULL
to	NULL
SneBI	NULL
(	NULL
13219	NULL
)	NULL
fragment	NULL
from	NULL
SnaBI	NULL
,	NULL
and	NULL
pDVcosPENBSP	NULL
vector	NULL
DNAs	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Cell	NULL
lines	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
(	NULL
B-cell	NULL
lines	NULL
)	NULL
or	NULL
Dulbecco	NULL
modified	NULL
Eagle	NULL
medium	NULL
(	NULL
293	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

Plasmids	NULL
.	NULL

pSGSTRAF1	NULL
was	NULL
constructed	NULL
by	NULL
inserting	NULL
the	NULL
TRAF	NULL
]	NULL
cDNA	NULL
(	NULL
EBI6	NULL
cDNA	NULL
)	NULL
(	NULL
31	NULL
)	NULL
into	NULL
the	NULL
EcoRI	NULL
site	NULL
of	NULL
pSGS	NULL
(	NULL
Stratagene	NULL
Corp.	NULL
)	NULL
.	NULL

pSGSFLAGTR	NULL
AF1	NULL
(	NULL
184-416	NULL
)	NULL
was	NULL
constructed	NULL
by	NULL
inserting	NULL
the	NULL
HindII-Bg/ll	NULL
fragment	NULL
of	NULL
pSGS	NULL
TRAF	NULL
]	NULL
into	NULL
the	NULL
Eco72I	NULL
site	NULL
of	NULL
pSGS	NULL
FLAG	NULL
(	NULL
10	NULL
)	NULL
.	NULL

pSGSFLAGTRAF3	NULL
(	NULL
345-568	NULL
)	NULL
contains	NULL
a	NULL
Bg/II	NULL
cDNA	NULL
fragment	NULL
encoding	NULL
TRAF3	NULL
aa	NULL
345	NULL
to	NULL
568	NULL
(	NULL
31	NULL
)	NULL
cloned	NULL
into	NULL
the	NULL
Hpal	NULL
site	NULL
of	NULL
pSGSFLAG	NULL
.	NULL

pSGSFLAG-LMP1	NULL
was	NULL
constructed	NULL
by	NULL
inserting	NULL
an	NULL
Mlul	NULL
fragment	NULL
that	NULL
contains	NULL
the	NULL
FLAG-LMP1	NULL
gene	NULL
fusion	NULL
from	NULL
B220	NULL
into	NULL
pSG5	NULL
.	NULL

pSGSFLAG-LMP1	NULL
(	NULL
1-231	NULL
)	NULL
contains	NULL
an	NULL
Xbel	NULL
linker	NULL
(	NULL
CTAGGTCTAGACTAG	NULL
)	NULL
(	NULL
New	NULL
England	NULL
Biolabs	NULL
)	NULL
inserted	NULL
at	NULL
an	NULL
Neel	NULL
!	NULL

site	NULL
(	NULL
nt	NULL
168627	NULL
)	NULL
(	NULL
21	NULL
)	NULL
and	NULL
encodes	NULL
a	NULL
FLAG	NULL
LMP1	NULL
to	NULL
residue	NULL
231	NULL
plus	NULL
an	NULL
additional	NULL
Leu-Val	NULL
before	NULL
termination	NULL
.	NULL

Plasmid	NULL
pSGSLMP1	NULL
(	NULL
1-231	NULL
)	NULL
was	NULL
constructed	NULL
by	NULL
PCR	NULL
amplification	NULL
of	NULL
the	NULL
cDNA	NULL
encoding	NULL
LMP1	NULL
aa	NULL
170	NULL
to	NULL
231	NULL
,	NULL
using	NULL
the	NULL
5	NULL
'	NULL
primer	NULL
170F	NULL
(	NULL
5	NULL
%	NULL
-GATCTCCTTTG	NULL
GCTCCTCCTG-3	NULL
'	NULL
)	NULL
and	NULL
the	NULL
3	NULL
'	NULL
primer	NULL
231R	NULL
(	NULL
5'-CCTAGGCATGCCATGGTT	NULL
AGGCTCCACTCACGAGCAGGT-3	NULL
'	NULL
)	NULL
.	NULL

The	NULL
downstream	NULL
primer	NULL
places	NULL
a	NULL
stop	NULL
codon	NULL
followed	NULL
by	NULL
a	NULL
Nco	NULL
!	NULL

site	NULL
after	NULL
Ala-231	NULL
.	NULL

The	NULL
amplified	NULL
fragment	NULL
was	NULL
digested	NULL
with	NULL
Neo	NULL
!	NULL

and	NULL
substituted	NULL
for	NULL
a	NULL
Nco	NULL
!	NULL

fragment	NULL
of	NULL
pBSLMP1	NULL
(	NULL
26	NULL
)	NULL
.	NULL

An	NULL
EcoRI	NULL
fragment	NULL
of	NULL
the	NULL
resulting	NULL
plasmid	NULL
was	NULL
then	NULL
subcloned	NULL
in	NULL
the	NULL
EcoRI	NULL
site	NULL
of	NULL
pSGS	NULL
to	NULL
generate	NULL
pSGSLMP1	NULL
(	NULL
1-231	NULL
)	NULL
.	NULL

pSGSLMP1	NULL
(	NULL
1-231	NULL
)	NULL
P204A	NULL
,	NULL
pSGSLMP1	NULL
(	NULL
1-231	NULL
)	NULL
Q206A	NULL
,	NULL
and	NULL
pSGSLMP1	NULL
(	NULL
P204A,0206A	NULL
)	NULL
were	NULL
constructed	NULL
in	NULL
a	NULL
similar	NULL
man-ner	NULL
,	NULL
using	NULL
PCR-mutated	NULL
Nco	NULL
!	NULL

fragments	NULL
.	NULL

The	NULL
outside	NULL
primers	NULL
used	NULL
were	NULL
170F	NULL
and	NULL
231R	NULL
for	NULL
the	NULL
P-204	NULL
to	NULL
A	NULL
or	NULL
Q-206	NULL
to	NULL
A	NULL
mutation	NULL
and	NULL
170F	NULL
and	NULL
L1-4	NULL
PCR	NULL
(	NULL
31	NULL
)	NULL
for	NULL
the	NULL
P-204	NULL
to	NULL
A	NULL
,	NULL
Q-206	NULL
to	NULL
A	NULL
mutation	NULL
;	NULL
the	NULL
inside	NULL
primers	NULL
were	NULL
5'-GGT	NULL
AGCTTGTTGAGCGTGCGGGAGGGAGTCATCGT-3	NULL
'	NULL
and	NULL
5'-TCCCTCCC	NULL
TNFR-ASSOCIATED	NULL
FACTORS	NULL
IN	NULL
LMP1-INDUCED	NULL
NF-	NULL
«	NULL
B	NULL
ACTIVATION	NULL
7099	NULL
GCACGCTCAACAAGCTACCGATGATTC-3	NULL
'	NULL
for	NULL
the	NULL
P-204	NULL
to	NULL
A	NULL
mutation	NULL
,	NULL
5-TCATCGGTAGCTGCITTGAGGGTGCGGGAGGGAGT-3	NULL
'	NULL
and	NULL
5'-CCGC	NULL
ACCCTCAAGCAGCTACCGATGATTCTGGCC-3	NULL
'	NULL
for	NULL
the	NULL
Q-206	NULL
to	NULL
A	NULL
mutation	NULL
,	NULL
and	NULL
5'-TCCCTCCCGCACGCTCAAGCAGCTACCGATGATTCTGGCC	NULL
-3	NULL
'	NULL
and	NULL
5-CTATCGGTAGCTGCITTGAGCGTGCGGGAGGGAGTCATCGT	NULL
-3	NULL
'	NULL
for	NULL
the	NULL
P-204	NULL
to	NULL
A	NULL
,	NULL
Q-206	NULL
to	NULL
A	NULL
mutation	NULL
.	NULL

pSGS	NULL
vectors	NULL
encoding	NULL
FLAG-LMP1	NULL
(	NULL
1-231	NULL
)	NULL
with	NULL
a	NULL
P-204	NULL
to	NULL
A	NULL
or	NULL
a	NULL
Q-206	NULL
to	NULL
A	NULL
mutation	NULL
,	NULL
or	NULL
FLAG-LMP1	NULL
with	NULL
P-204	NULL
to	NULL
A	NULL
and	NULL
Q-206	NULL
to	NULL
A	NULL
mutations	NULL
,	NULL
were	NULL
constructed	NULL
by	NULL
inserting	NULL
a	NULL
Mam1-Bpul102	NULL
I	NULL
fragment	NULL
of	NULL
pSGSLMP1	NULL
(	NULL
1-231	NULL
)	NULL
P204A	NULL
,	NULL
pSGSLMP1	NULL
(	NULL
1-231	NULL
)	NULL
0206A	NULL
,	NULL
or	NULL
pSGSLMP1	NULL
(	NULL
P204A,0206	NULL
)	NULL
between	NULL
the	NULL
MamI	NULL
and	NULL
Bpu1102	NULL
I	NULL
sites	NULL
of	NULL
pSGSFL	NULL
AG-LMPL	NULL
.	NULL

Plasmids	NULL
pGEXLMP1	NULL
(	NULL
187-386	NULL
)	NULL
,	NULL
pGEXLMP1	NULL
(	NULL
187-212	NULL
)	NULL
,	NULL
pGEXLM	NULL
P1	NULL
(	NULL
201-231	NULL
)	NULL
,	NULL
pGEXLMP1	NULL
(	NULL
240-386	NULL
)	NULL
,	NULL
pGEXLMP1	NULL
(	NULL
333-386	NULL
)	NULL
,	NULL
and	NULL
pGEXLMP1	NULL
(	NULL
240-386	NULL
)	NULL
were	NULL
constructed	NULL
by	NULL
PCR	NULL
amplification	NULL
of	NULL
the	NULL
corresponding	NULL
LMP1	NULL
cDNA	NULL
fragments	NULL
,	NULL
using	NULL
primers	NULL
having	NULL
a	NULL
5°	NULL
BamHI	NULL
site	NULL
to	NULL
facilitate	NULL
cloning	NULL
in	NULL
the	NULL
BamHI	NULL
site	NULL
of	NULL
the	NULL
pGEX-2TK	NULL
vector	NULL
.	NULL

Plasmids	NULL
expressing	NULL
wild-type	NULL
or	NULL
mutant	NULL
aa	NULL
199	NULL
to	NULL
214	NULL
or	NULL
aa	NULL
199	NULL
to	NULL
210	NULL
LMP1	NULL
domains	NULL
fused	NULL
to	NULL
glutathione	NULL
S-transferase	NULL
(	NULL
GST	NULL
)	NULL
were	NULL
made	NULL
by	NULL
inserting	NULL
synthetic	NULL
double-stranded	NULL
oligonu-cleotides	NULL
containing	NULL
a	NULL
5	NULL
'	NULL
BamHI	NULL
site	NULL
and	NULL
a	NULL
3	NULL
'	NULL
EcoRI	NULL
site	NULL
preceded	NULL
by	NULL
a	NULL
stop	NULL
codon	NULL
into	NULL
the	NULL
BamHI	NULL
and	NULL
EcoRI	NULL
sites	NULL
of	NULL
the	NULL
pGEX-2TK	NULL
vector	NULL
.	NULL

PCR-derived	NULL
Nco	NULL
!	NULL

fragments	NULL
encoding	NULL
wild-type	NULL
or	NULL
mutant	NULL
LMP1	NULL
(	NULL
187-231	NULL
)	NULL
were	NULL
also	NULL
inserted	NULL
in	NULL
the	NULL
Neo	NULL
!	NULL

site	NULL
of	NULL
pGEXLMP1	NULL
(	NULL
187-212	NULL
)	NULL
to	NULL
generate	NULL
the	NULL
pGEXLMP1	NULL
(	NULL
187-231	NULL
)	NULL
,	NULL
pGEXLMP1	NULL
(	NULL
187-231	NULL
)	NULL
P204A	NULL
,	NULL
and	NULL
pGEXLMP1	NULL
(	NULL
187-231	NULL
)	NULL
Q206A	NULL
plasmids	NULL
.	NULL

The	NULL
Gal4	NULL
DNA	NULL
binding	NULL
domain	NULL
fusions	NULL
of	NULL
LMP1	NULL
aa	NULL
187	NULL
to	NULL
212	NULL
(	NULL
G4DBD-LMP1	NULL
187-212	NULL
)	NULL
and	NULL
aa	NULL
201	NULL
to	NULL
231	NULL
(	NULL
G4DBD-LMP1	NULL
201-231	NULL
)	NULL
were	NULL
made	NULL
by	NULL
PCR	NULL
amplification	NULL
of	NULL
the	NULL
corresponding	NULL
LMP1	NULL
cDNA	NULL
fragments	NULL
,	NULL
using	NULL
primers	NULL
having	NULL
a	NULL
5	NULL
'	NULL
BamHI	NULL
site	NULL
,	NULL
followed	NULL
by	NULL
cloning	NULL
into	NULL
the	NULL
BamHI	NULL
site	NULL
of	NULL
the	NULL
yeast	NULL
vector	NULL
pAS2	NULL
(	NULL
31	NULL
)	NULL
.	NULL

G4TAD-TRAF2	NULL
was	NULL
constructed	NULL
by	NULL
fusing	NULL
FLAG-TRAF2	NULL
(	NULL
22	NULL
)	NULL
in	NULL
frame	NULL
to	NULL
the	NULL
transactivating	NULL
domain	NULL
of	NULL
Gal4	NULL
(	NULL
G4TAD	NULL
)	NULL
in	NULL
the	NULL
pACTII	NULL
vector	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Sequencing	NULL
of	NULL
G4TADLAP1	NULL
(	NULL
183-568	NULL
)	NULL
(	NULL
31	NULL
)	NULL
revealed	NULL
that	NULL
this	NULL
clone	NULL
has	NULL
codons	NULL
218	NULL
to	NULL
242	NULL
of	NULL
TRAF3	NULL
deleted	NULL
and	NULL
is	NULL
referred	NULL
to	NULL
in	NULL
this	NULL
paper	NULL
as	NULL
G4TAD-TRAF3	NULL
(	NULL
183-568	NULL
)	NULL
.	NULL

Vent	NULL
polymerase	NULL
was	NULL
used	NULL
in	NULL
most	NULL
PCRs	NULL
,	NULL
and	NULL
the	NULL
sequences	NULL
of	NULL
all	NULL
PCR-	NULL
or	NULL
oligonucleotide-derived	NULL
constructs	NULL
were	NULL
verified	NULL
by	NULL
DNA	NULL
sequencing	NULL
of	NULL
the	NULL
final	NULL
clone	NULL
(	NULL
Sequenase	NULL
;	NULL
Amersham	NULL
)	NULL
.	NULL

GST	NULL
fusion	NULL
protein	NULL
binding	NULL
assays	NULL
and	NULL
BJAB	NULL
transfections	NULL
.	NULL

In	NULL
vitro-translated	NULL
proteins	NULL
from	NULL
6	NULL
to	NULL
10	NULL
wl	NULL
of	NULL
reaction	NULL
mix	NULL
(	NULL
TNT	NULL
system	NULL
;	NULL
Promega	NULL
Corp.	NULL
)	NULL
were	NULL
diluted	NULL
in	NULL
0.3	NULL
ml	NULL
of	NULL
binding	NULL
buffer	NULL
(	NULL
50	NULL
mM	NULL
Tris	NULL
[	NULL
pH	NULL
7.4	NULL
]	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
0.1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
[	NULL
NP-40	NULL
]	NULL
,	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
1	NULL
mM	NULL
phenylmeth-ylsulfonyl	NULL
fluoride	NULL
[	NULL
PMSF	NULL
]	NULL
)	NULL
and	NULL
were	NULL
precleared	NULL
with	NULL
glutathione-Sepharose	NULL
beads	NULL
(	NULL
Pharmacia	NULL
)	NULL
for	NULL
1	NULL
h	NULL
at	NULL
4°C	NULL
.	NULL

GST	NULL
or	NULL
GST	NULL
fusion	NULL
proteins	NULL
bound	NULL
to	NULL
glutathione	NULL
beads	NULL
(	NULL
5	NULL
to	NULL
10	NULL
ug	NULL
)	NULL
(	NULL
40	NULL
)	NULL
were	NULL
then	NULL
incubated	NULL
with	NULL
in	NULL
vitro-translated	NULL
protein	NULL
for	NULL
1	NULL
to	NULL
2	NULL
h	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
beads	NULL
were	NULL
washed	NULL
5	NULL
times	NULL
with	NULL
1	NULL
ml	NULL
of	NULL
binding	NULL
buffer	NULL
.	NULL

Bound	NULL
proteins	NULL
were	NULL
recovered	NULL
by	NULL
boiling	NULL
in	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
sample	NULL
buffer	NULL
and	NULL
were	NULL
analyzed	NULL
by	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophore-sis	NULL
(	NULL
PAGE	NULL
)	NULL
.	NULL

Gels	NULL
were	NULL
stained	NULL
with	NULL
Coomassie	NULL
blue	NULL
to	NULL
verify	NULL
the	NULL
presence	NULL
of	NULL
equivalent	NULL
amounts	NULL
of	NULL
the	NULL
various	NULL
fusion	NULL
proteins	NULL
and	NULL
then	NULL
processed	NULL
for	NULL
autoradiography	NULL
and	NULL
PhosphorImager	NULL
analysis	NULL
.	NULL

For	NULL
GST	NULL
binding	NULL
assays	NULL
using	NULL
cell	NULL
extracts	NULL
,	NULL
10	NULL
``	NULL
BJAB	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
electroporation	NULL
at	NULL
210	NULL
V	NULL
and	NULL
960	NULL
uF	NULL
in	NULL
400	NULL
pl	NULL
of	NULL
RPMI	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

Eighteen	NULL
hours	NULL
after	NULL
transfection	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
and	NULL
lysed	NULL
for	NULL
30	NULL
min	NULL
on	NULL
ice	NULL
in	NULL
1	NULL
%	NULL
NP-40	NULL
lysis	NULL
buffer	NULL
(	NULL
1	NULL
%	NULL
NP-40	NULL
,	NULL
50	NULL
mM	NULL
Tris	NULL
[	NULL
pH	NULL
7.4	NULL
]	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
3	NULL
%	NULL
glycerol	NULL
,	NULL
1.5	NULL
mM	NULL
EDTA	NULL
)	NULL
containing	NULL
protease	NULL
inhibitors	NULL
(	NULL
1	NULL
mM	NULL
PMSF	NULL
,	NULL
1	NULL
mg	NULL
of	NULL
leupeptin	NULL
per	NULL
ml	NULL
,	NULL
and	NULL
1	NULL
mg	NULL
of	NULL
pepstatin	NULL
per	NULL
ml	NULL
)	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
centrifuged	NULL
at	NULL
14,000	NULL
x	NULL
g	NULL
for	NULL
15	NULL
min	NULL
at	NULL
4°C	NULL
and	NULL
precleared	NULL
with	NULL
glutathione	NULL
beads	NULL
for	NULL
1	NULL
h	NULL
at	NULL
4°C	NULL
.	NULL

Cleared	NULL
cell	NULL
lysates	NULL
were	NULL
then	NULL
incubated	NULL
for	NULL
2	NULL
h	NULL
at	NULL
4°C	NULL
with	NULL
approximately	NULL
5	NULL
pg	NULL
of	NULL
GST	NULL
control	NULL
or	NULL
GST	NULL
fusion	NULL
proteins	NULL
.	NULL

The	NULL
beads	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
1	NULL
ml	NULL
of	NULL
0.5	NULL
%	NULL
NP-40	NULL
lysis	NULL
buffer	NULL
,	NULL
and	NULL
precipitated	NULL
material	NULL
was	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
Western	NULL
immunoblotting	NULL
.	NULL

Alterna-tively	NULL
,	NULL
1	NULL
%	NULL
NP-40	NULL
extracts	NULL
from	NULL
2	NULL
X	NULL
10	NULL
``	NULL
cells	NULL
from	NULL
an	NULL
LCL	NULL
were	NULL
incubated	NULL
with	NULL
approximately	NULL
24	NULL
pg	NULL
of	NULL
GST	NULL
or	NULL
GST	NULL
fusion	NULL
proteins	NULL
and	NULL
processed	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Immunoprecipitation	NULL
and	NULL
immunoblotting	NULL
.	NULL

LCLs	NULL
or	NULL
transfected	NULL
BJAB	NULL
cells	NULL
obtained	NULL
18	NULL
h	NULL
posttransfection	NULL
were	NULL
washed	NULL
in	NULL
ice-cold	NULL
PBS	NULL
and	NULL
lysed	NULL
for	NULL
30	NULL
to	NULL
60	NULL
min	NULL
on	NULL
ice	NULL
in	NULL
0.5	NULL
%	NULL
NP-40	NULL
lysis	NULL
buffer	NULL
containing	NULL
protease	NULL
inhibitors	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
prepared	NULL
by	NULL
extensive	NULL
homogenization	NULL
by	NULL
Dounce	NULL
.	NULL

Lysates	NULL
were	NULL
centrifuged	NULL
for	NULL
15	NULL
min	NULL
at	NULL
14,000	NULL
x	NULL
g	NULL
and	NULL
precleared	NULL
with	NULL
protein	NULL
G-	NULL
or	NULL
protein	NULL
A-Sepharose	NULL
beads	NULL
(	NULL
Pharmacia	NULL
)	NULL
for	NULL
1	NULL
to	NULL
2	NULL
h.	NULL
Cleared	NULL
lysates	NULL
were	NULL
incubated	NULL
with	NULL
anti-FLAG	NULL
M2	NULL
affinity	NULL
gel	NULL
(	NULL
International	NULL
Biotechnologies	NULL
Inc.	NULL
)	NULL
for	NULL
2	NULL
h	NULL
at	NULL
4°C	NULL
or	NULL
with	NULL
rabbit	NULL
polyclonal	NULL
antibodies	NULL
recognizing	NULL
TRAF	NULL
]	NULL
or	NULL
TRAF3	NULL
(	NULL
TRAF1	NULL
N19	NULL
or	NULL
CRAF1	NULL
H20	NULL
;	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
for	NULL
2	NULL
h	NULL
at	NULL
4°C	NULL
followed	NULL
by	NULL
incubation	NULL
with	NULL
protein	NULL
A-Sepharose	NULL
beads	NULL
for	NULL
1	NULL
h	NULL
at	NULL
4°C	NULL
.	NULL

Beads	NULL
were	NULL
then	NULL
washed	NULL
five	NULL
times	NULL
with	NULL
1	NULL
ml	NULL
of	NULL
0.5	NULL
%	NULL
NP-40	NULL
lysis	NULL
buffer	NULL
,	NULL
and	NULL
bound	NULL
proteins	NULL
were	NULL
recovered	NULL
by	NULL
boiling	NULL
in	NULL
SDS	NULL
sample	NULL
buffer	NULL
or	NULL
by	NULL
elution	NULL
with	NULL
FLAG	NULL
peptide	NULL
.	NULL

For	NULL
peptide	NULL
elution	NULL
,	NULL
M2	NULL
beads	NULL
were	NULL
further	NULL
washed	NULL
with	NULL
1	NULL
ml	NULL
of	NULL
TBS	NULL
(	NULL
10	NULL
mM	NULL
Tris	NULL
[	NULL
pH	NULL
7.4	NULL
]	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
)	NULL
and	NULL
immunoprecipitated	NULL
proteins	NULL
were	NULL
eluted	NULL
twice	NULL
with	NULL
50	NULL
pl	NULL
of	NULL
FLAG	NULL
peptide	NULL
(	NULL
500	NULL
mM	NULL
in	NULL
TBS	NULL
)	NULL
.	NULL

Eluted	NULL
proteins	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
membranes	NULL
for	NULL
immunoblotting	NULL
.	NULL

TRAFs	NULL
were	NULL
detected	NULL
using	NULL
rabbit	NULL
polyclonal	NULL
antisera	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
recognizing	NULL
TRAF	NULL
(	NULL
TRAFL	NULL
$	NULL
19	NULL
)	NULL
,	NULL
TRAF2	NULL
(	NULL
TRAF2	NULL
C20	NULL
)	NULL
,	NULL
or	NULL
TRAF3	NULL
(	NULL
CRAF1	NULL
H20	NULL
and	NULL
CRAFL1	NULL
H122	NULL
)	NULL
or	NULL
both	NULL
TRAF1	NULL
and	NULL
TRAF3	NULL
(	NULL
CRAF1	NULL
C20	NULL
)	NULL
,	NULL
at	NULL
1	NULL
pg/ml	NULL
.	NULL

Binding	NULL
of	NULL
TRAF	NULL
antisera	NULL
was	NULL
detected	NULL
using	NULL
horseradish	NULL
peroxidase-conjugated	NULL
protein	NULL
A	NULL
(	NULL
1:7,500	NULL
dilution	NULL
)	NULL
and	NULL
ECL	NULL
reagents	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

LMP1	NULL
or	NULL
FLAG-tagged	NULL
LMP1	NULL
was	NULL
detected	NULL
by	NULL
using	NULL
$	NULL
12	NULL
anti-LMP1	NULL
(	NULL
27	NULL
)	NULL
or	NULL
MS	NULL
anti-FLAG	NULL
monoclonal	NULL
7100	NULL
DEVERGNE	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
C	NULL
``	NULL
B	NULL
s	NULL
$	NULL
y	NULL
¢	NULL
.s	NULL
As	NULL
A	NULL
&	NULL
O	NULL
an	NULL
&	NULL
S	NULL
``	NULL
gs	NULL
``	NULL
aP	NULL
v.55	NULL
!	NULL

P	NULL
3	NULL
$	NULL
&	NULL
``	NULL
&	NULL
633	NULL
43g	NULL
“	NULL
<	NULL
@	NULL
<	NULL
¢	NULL
S	NULL
*	NULL
aa	NULL
TRAF3	NULL
-	NULL
>	NULL
SXSW	NULL
hac	NULL
;	NULL
___	NULL
Pot	NULL
«	NULL
#	NULL
LMPL	NULL
-	NULL
>	NULL
«	NULL
aap	NULL
.	NULL

in	NULL
u	NULL
TRAF	NULL
-	NULL
>	NULL
TRAF	NULL
-	NULL
>	NULL
comme	NULL
CM	NULL
wae	NULL
.	NULL

y	NULL
@	NULL
TRAFZ	NULL
--	NULL
>	NULL
sum	NULL
F-LMP1	NULL
-	NULL
>	NULL
“	NULL
-	NULL
«	NULL
a	NULL
»	NULL
cae	NULL
ume	NULL
.	NULL

iii	NULL
TRAF3	NULL
-	NULL
>	NULL
s	NULL
«	NULL
ame	NULL
wane	NULL
some	NULL
,	NULL
5	NULL
%	NULL
lysate	NULL
M2	NULL
IP	NULL
1	NULL
20	NULL
3	NULL
4	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

In	NULL
vivo	NULL
association	NULL
of	NULL
TRAF1	NULL
,	NULL
TRAF2	NULL
,	NULL
and	NULL
TRAF3	NULL
with	NULL
LMP1	NULL
in	NULL
LCLs	NULL
.	NULL

(	NULL
A	NULL
)	NULL
NP-40	NULL
cell	NULL
extracts	NULL
from	NULL
40	NULL
X	NULL
10°	NULL
cells	NULL
of	NULL
a	NULL
recombinant	NULL
LCL	NULL
expressing	NULL
an	NULL
N-terminal	NULL
FLAG-tagged	NULL
LMP1	NULL
protein	NULL
(	NULL
F-LMP1	NULL
LCL	NULL
)	NULL
or	NULL
of	NULL
the	NULL
control	NULL
B4	NULL
LCL	NULL
(	NULL
WT	NULL
LCL	NULL
)	NULL
were	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
with	NULL
anti-FLAG	NULL
M2	NULL
affinity	NULL
gel	NULL
,	NULL
and	NULL
coimmunoprecipitated	NULL
proteins	NULL
were	NULL
eluted	NULL
by	NULL
competition	NULL
with	NULL
FLAG	NULL
peptide	NULL
.	NULL

Cell	NULL
lysates	NULL
(	NULL
5	NULL
%	NULL
of	NULL
the	NULL
total	NULL
before	NULL
immunopre-cipitation	NULL
)	NULL
and	NULL
the	NULL
eluted	NULL
proteins	NULL
were	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
on	NULL
an	NULL
8	NULL
%	NULL
gel	NULL
and	NULL
subjected	NULL
to	NULL
Western	NULL
blot	NULL
analysis	NULL
with	NULL
rabbit	NULL
polyclonal	NULL
antibodies	NULL
recognizing	NULL
both	NULL
TRAF	NULL
!	NULL

and	NULL
TRAF3	NULL
(	NULL
CRAF1	NULL
€20	NULL
)	NULL
or	NULL
TRAF2	NULL
(	NULL
TRAF2	NULL
C20	NULL
)	NULL
or	NULL
with	NULL
MS	NULL
anti-FLAG	NULL
monoclonal	NULL
antibody	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
the	NULL
TRAF1	NULL
doublet	NULL
and	NULL
of	NULL
TRAF2	NULL
,	NULL
TRAF3	NULL
,	NULL
and	NULL
FLAG-LMP1	NULL
are	NULL
indicated	NULL
.	NULL

(	NULL
B	NULL
)	NULL
NP-40	NULL
cell	NULL
extracts	NULL
from	NULL
the	NULL
1B4	NULL
LCL	NULL
(	NULL
5	NULL
x	NULL
10°	NULL
cells	NULL
per	NULL
lane	NULL
)	NULL
were	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
with	NULL
2	NULL
pg	NULL
of	NULL
rabbit	NULL
polyclonal	NULL
antibodies	NULL
recognizing	NULL
TRAF1	NULL
(	NULL
TRAF1	NULL
N19	NULL
)	NULL
or	NULL
TRAF3	NULL
(	NULL
CRAF1	NULL
H20	NULL
)	NULL
or	NULL
with	NULL
4	NULL
pg	NULL
of	NULL
normal	NULL
rabbit	NULL
serum	NULL
(	NULL
NRS	NULL
)	NULL
as	NULL
a	NULL
control	NULL
.	NULL

Of	NULL
the	NULL
total	NULL
cell	NULL
lysate	NULL
and	NULL
the	NULL
eluted	NULL
proteins	NULL
,	NULL
30	NULL
%	NULL
was	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
on	NULL
an	NULL
8	NULL
%	NULL
gel	NULL
and	NULL
subjected	NULL
to	NULL
Western	NULL
blot	NULL
analysis	NULL
with	NULL
$	NULL
12	NULL
anti-LMP1	NULL
monoclonal	NULL
antibody	NULL
or	NULL
with	NULL
rabbit	NULL
polyclonal	NULL
antibodies	NULL
recognizing	NULL
TRAF	NULL
]	NULL
(	NULL
TRAFL	NULL
$	NULL
19	NULL
)	NULL
,	NULL
TRAF2	NULL
(	NULL
TRAF2	NULL
C20	NULL
)	NULL
,	NULL
or	NULL
TRAF3	NULL
(	NULL
CRAF1	NULL
H122	NULL
)	NULL
.	NULL

At	NULL
a	NULL
higher	NULL
magnification	NULL
,	NULL
the	NULL
TRAF1	NULL
protein	NULL
(	NULL
arrow	NULL
)	NULL
is	NULL
detected	NULL
as	NULL
a	NULL
doublet	NULL
.	NULL

The	NULL
lower	NULL
TRAF	NULL
]	NULL
band	NULL
comigrates	NULL
with	NULL
the	NULL
immunoglobulin	NULL
heavy	NULL
chain	NULL
(	NULL
asterisk	NULL
)	NULL
in	NULL
the	NULL
TRAF	NULL
]	NULL
immunoprecipitate	NULL
,	NULL
while	NULL
the	NULL
upper	NULL
TRAF1	NULL
band	NULL
migrates	NULL
just	NULL
above	NULL
it	NULL
,	NULL
resulting	NULL
in	NULL
the	NULL
thicker	NULL
band	NULL
observed	NULL
.	NULL

antibody	NULL
(	NULL
IBI	NULL
)	NULL
,	NULL
respectively	NULL
,	NULL
followed	NULL
by	NULL
sheep	NULL
anti-mouse	NULL
antibodies	NULL
conjugated	NULL
to	NULL
horseradish	NULL
peroxidase	NULL
(	NULL
1:5,000	NULL
dilution	NULL
;	NULL
Amersham	NULL
}	NULL
.	NULL

NF-B-dependent	NULL
reporter	NULL
assays	NULL
in	NULL
293	NULL
cells	NULL
.	NULL

The	NULL
day	NULL
before	NULL
transfection	NULL
,	NULL
4	NULL
X	NULL
10°	NULL
293	NULL
cells	NULL
were	NULL
plated	NULL
in	NULL
35-mm-diameter	NULL
dishes	NULL
.	NULL

The	NULL
following	NULL
day	NULL
the	NULL
50	NULL
%	NULL
confluent	NULL
cells	NULL
were	NULL
fed	NULL
with	NULL
fresh	NULL
medium	NULL
and	NULL
were	NULL
transfected	NULL
using	NULL
the	NULL
calcium	NULL
phosphate	NULL
method	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Transfections	NULL
included	NULL
pGKBgal	NULL
(	NULL
10	NULL
)	NULL
,	NULL
a	NULL
phos-phoglucokinase	NULL
promoter-driven	NULL
-galactosidase	NULL
expression	NULL
plasmid	NULL
to	NULL
normalize	NULL
for	NULL
transfection	NULL
efficiency	NULL
,	NULL
together	NULL
with	NULL
a	NULL
reporter	NULL
plasmid	NULL
and	NULL
effector	NULL
expression	NULL
plasmids	NULL
.	NULL

Two	NULL
reporter	NULL
plasmids	NULL
were	NULL
used	NULL
,	NULL
the	NULL
3X-	NULL
«	NULL
B-L	NULL
plasmid	NULL
,	NULL
which	NULL
has	NULL
three	NULL
repeats	NULL
of	NULL
the	NULL
NF-kB	NULL
site	NULL
from	NULL
the	NULL
murine	NULL
major	NULL
histocompat-ibility	NULL
complex	NULL
class	NULL
I	NULL
promoter	NULL
upstream	NULL
of	NULL
a	NULL
minimal	NULL
fos	NULL
promoter	NULL
and	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
,	NULL
or	NULL
the	NULL
plasmid	NULL
3X-mut	NULL
«	NULL
-L	NULL
,	NULL
which	NULL
contains	NULL
mutated	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
(	NULL
30	NULL
)	NULL
.	NULL

After	NULL
14	NULL
to	NULL
16	NULL
h	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
rinsed	NULL
and	NULL
fresh	NULL
medium	NULL
was	NULL
added	NULL
.	NULL

After	NULL
an	NULL
additional	NULL
24	NULL
h	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
in	NULL
PBS	NULL
and	NULL
lysed	NULL
in	NULL
luciferase	NULL
lysis	NULL
buffer	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

The	NULL
lysates	NULL
were	NULL
assayed	NULL
for	NULL
luciferase	NULL
and	NULL
B-galactosidase	NULL
activities	NULL
using	NULL
an	NULL
OPTOCOMP	NULL
I	NULL
Luminometer	NULL
(	NULL
MGM	NULL
Instru-ments	NULL
)	NULL
.	NULL

ANOVA	NULL
(	NULL
13	NULL
)	NULL
was	NULL
used	NULL
for	NULL
statistical	NULL
analysis	NULL
.	NULL

RESULTS	NULL
TRAF1	NULL
,	NULL
TRAF2	NULL
,	NULL
and	NULL
TRAF3	NULL
associate	NULL
in	NULL
vivo	NULL
with	NULL
LMP1	NULL
in	NULL
LCLs	NULL
.	NULL

Although	NULL
TRAF1	NULL
,	NULL
TRAF2	NULL
,	NULL
or	NULL
TRAF3	NULL
can	NULL
associate	NULL
with	NULL
LMP1	NULL
when	NULL
a	NULL
TRAF	NULL
and	NULL
LMP1	NULL
are	NULL
transiently	NULL
overexpressed	NULL
by	NULL
gene	NULL
transfer	NULL
(	NULL
22	NULL
,	NULL
31	NULL
)	NULL
,	NULL
an	NULL
association	NULL
in	NULL
EBV	NULL
-transformed	NULL
B	NULL
lymphocytes	NULL
has	NULL
not	NULL
been	NULL
previously	NULL
investigated	NULL
.	NULL

Such	NULL
an	NULL
investigation	NULL
has	NULL
been	NULL
hindered	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
TRAFs	NULL
and	NULL
immunoprecipitating	NULL
antibodies	NULL
for	NULL
LMP1	NULL
both	NULL
bind	NULL
to	NULL
the	NULL
LMP1	NULL
CT.	NULL
We	NULL
therefore	NULL
first	NULL
derived	NULL
an	NULL
EBV	NULL
recombinant	NULL
encoding	NULL
a	NULL
FLAG-epitope	NULL
tag	NULL
in	NULL
the	NULL
LMP1	NULL
N-terminal	NULL
cytoplasmic	NULL
domain	NULL
,	NULL
a	NULL
domain	NULL
previously	NULL
shown	NULL
to	NULL
be	NULL
nonessential	NULL
for	NULL
transformation	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Most	NULL
of	NULL
the	NULL
soluble	NULL
FLAG-LMP1	NULL
was	NULL
immunoprecipitated	NULL
with	NULL
anti-FLAG	NULL
antibody	NULL
in	NULL
lysates	NULL
from	NULL
an	NULL
LCL	NULL
transformed	NULL
by	NULL
this	NULL
EBV	NULL
recombinant	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
;	NULL
compare	NULL
the	NULL
amount	NULL
of	NULL
FLAG-LMP1	NULL
in	NULL
lane	NULL
4	NULL
with	NULL
5	NULL
%	NULL
of	NULL
the	NULL
lysate	NULL
in	NULL
lane	NULL
2	NULL
with	NULL
the	NULL
negative	NULL
control	NULL
anti-FLAG	NULL
immunoprecipitate	NULL
from	NULL
a	NULL
[	NULL
non-FLAG	NULL
]	NULL
LMPI1	NULL
wild-type-expressing	NULL
LCL	NULL
in	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

Under	NULL
the	NULL
extraction	NULL
con	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

F-TRAF2	NULL
F-TRAF2	NULL
TRAFL	NULL
TRAFL	NULL
TRAF3	NULL
TZ	NULL
=I	NULL
Al	NULL
21	NULL
I	NULL
zl	NULL
£0	NULL
§	NULL
f	NULL
ee	NULL
A	NULL
1	NULL
8	NULL
-l	NULL
a	NULL
400	NULL
#	NULL
bog	NULL
hob	NULL
b	NULL
p	NULL
5	NULL
&	NULL
§	NULL
s	NULL
gi	NULL
ss	NULL
s	NULL
5	NULL
5	NULL
$	NULL
5	NULL
Site	NULL
<	NULL
-	NULL
F-TRAF2	NULL
am	NULL
||	NULL
me	NULL
<	NULL
-	NULL
TRAF3	NULL
€-	NULL
TRAF	NULL
]	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

In	NULL
vitro	NULL
binding	NULL
of	NULL
TRAF1	NULL
,	NULL
TRAF2	NULL
,	NULL
or	NULL
TRAF3	NULL
to	NULL
the	NULL
LMP1	NULL
CT.	NULL
TRAF	NULL
]	NULL
,	NULL
FLAG-tagged	NULL
TRAF2	NULL
(	NULL
F-TRAF2	NULL
)	NULL
(	NULL
21	NULL
)	NULL
,	NULL
or	NULL
TRAF3	NULL
(	NULL
29	NULL
)	NULL
was	NULL
translated	NULL
in	NULL
vitro	NULL
in	NULL
a	NULL
wheat	NULL
germ	NULL
extract	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
[	NULL
*°S	NULL
)	NULL
methionine	NULL
,	NULL
and	NULL
the	NULL
*5S-labeled	NULL
proteins	NULL
(	NULL
10-ul	NULL
reaction	NULL
mix	NULL
)	NULL
,	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
,	NULL
were	NULL
incubated	NULL
with	NULL
Sepharose	NULL
bead-bound	NULL
GST	NULL
or	NULL
GST-LMP1	NULL
CT	NULL
fusion	NULL
protein	NULL
.	NULL

Precipitated	NULL
proteins	NULL
were	NULL
analyzed	NULL
on	NULL
an	NULL
8	NULL
%	NULL
SDS-PAGE	NULL
,	NULL
followed	NULL
by	NULL
autoradiography	NULL
and	NULL
PhosphorImager	NULL
analysis	NULL
.	NULL

ditions	NULL
used	NULL
for	NULL
these	NULL
experiments	NULL
,	NULL
from	NULL
70	NULL
to	NULL
80	NULL
%	NULL
of	NULL
LMP1	NULL
and	NULL
more	NULL
than	NULL
90	NULL
%	NULL
of	NULL
TRAF1	NULL
,	NULL
TRAF2	NULL
,	NULL
and	NULL
TRAF3	NULL
are	NULL
in	NULL
the	NULL
soluble	NULL
fraction	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
amount	NULL
of	NULL
TRAF1	NULL
,	NULL
TRAF2	NULL
,	NULL
and	NULL
TRAF3	NULL
in	NULL
the	NULL
FLAG-LMP1	NULL
immunoprecipitate	NULL
with	NULL
the	NULL
amount	NULL
in	NULL
5	NULL
%	NULL
of	NULL
the	NULL
cell	NULL
extract	NULL
revealed	NULL
that	NULL
most	NULL
of	NULL
the	NULL
TRAF3	NULL
and	NULL
TRAF1	NULL
had	NULL
precipitated	NULL
with	NULL
FLAG-LMP1	NULL
,	NULL
while	NULL
only	NULL
5	NULL
%	NULL
of	NULL
the	NULL
TRAF2	NULL
had	NULL
precipitated	NULL
with	NULL
FLAG-LMP1I	NULL
.	NULL

The	NULL
extent	NULL
of	NULL
LMP1	NULL
association	NULL
with	NULL
TRAF1	NULL
or	NULL
TRAF3	NULL
was	NULL
also	NULL
investigated	NULL
by	NULL
immunoprecipitating	NULL
TRAF1	NULL
or	NULL
TRAF3	NULL
from	NULL
LCLs	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

An	NULL
immunoprecipitating	NULL
TRAF2	NULL
antibody	NULL
was	NULL
not	NULL
available	NULL
to	NULL
assess	NULL
the	NULL
extent	NULL
of	NULL
LMP1	NULL
association	NULL
with	NULL
TRAFZ	NULL
.	NULL

TRAF3	NULL
or	NULL
TRAF1	NULL
antibody	NULL
immunoprecipitated	NULL
most	NULL
of	NULL
the	NULL
TRAF3	NULL
or	NULL
TRAF1	NULL
from	NULL
the	NULL
lysate	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Approximately	NULL
30	NULL
%	NULL
of	NULL
the	NULL
LMP1	NULL
coimmunoprecipitated	NULL
with	NULL
TRAF3	NULL
or	NULL
TRAF1	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

No	NULL
significant	NULL
amount	NULL
of	NULL
TRAF1	NULL
or	NULL
TRAF2	NULL
was	NULL
present	NULL
in	NULL
the	NULL
TRAF3	NULL
immunoprecipitate	NULL
,	NULL
while	NULL
30	NULL
%	NULL
of	NULL
TRAF2	NULL
and	NULL
no	NULL
TRAF3	NULL
was	NULL
in	NULL
the	NULL
TRAF1	NULL
immunoprecipitate	NULL
(	NULL
TRAF1	NULL
antibody	NULL
was	NULL
verified	NULL
not	NULL
to	NULL
immunoprecipitate	NULL
TRAF2	NULL
[	NULL
data	NULL
not	NULL
shown	NULL
]	NULL
J	NULL
)	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
about	NULL
30	NULL
%	NULL
of	NULL
the	NULL
LMP1	NULL
is	NULL
associated	NULL
with	NULL
TRAF3	NULL
and	NULL
that	NULL
another	NULL
30	NULL
%	NULL
of	NULL
LMP1	NULL
is	NULL
associated	NULL
with	NULL
TRAF1	NULL
or	NULL
TRAFI-TRAF2	NULL
complexes	NULL
,	NULL
while	NULL
most	NULL
of	NULL
the	NULL
TRAF3	NULL
and	NULL
TRAF1	NULL
in	NULL
LCLs	NULL
is	NULL
bound	NULL
to	NULL
LMP1	NULL
.	NULL

In	NULL
vitro	NULL
binding	NULL
of	NULL
TRAF1	NULL
,	NULL
TRAF2	NULL
,	NULL
and	NULL
TRAF3	NULL
to	NULL
the	NULL
LMP1L	NULL
CT	NULL
.	NULL

Previous	NULL
experiments	NULL
performed	NULL
with	NULL
yeast	NULL
two-hybrid	NULL
liquid	NULL
-galactosidase	NULL
assays	NULL
demonstrated	NULL
that	NULL
TRAF3	NULL
(	NULL
aa	NULL
346	NULL
to	NULL
568	NULL
)	NULL
interacts	NULL
with	NULL
LMP1	NULL
CT	NULL
aa	NULL
187	NULL
to	NULL
386	NULL
or	NULL
187	NULL
to	NULL
231	NULL
,	NULL
while	NULL
no	NULL
interaction	NULL
between	NULL
TRAF1	NULL
(	NULL
aa	NULL
53	NULL
to	NULL
416	NULL
)	NULL
and	NULL
LMP1	NULL
CT	NULL
aa	NULL
187	NULL
to	NULL
386	NULL
could	NULL
be	NULL
evidenced	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Also	NULL
,	NULL
TRAF	NULL
does	NULL
not	NULL
interact	NULL
with	NULL
the	NULL
LMP1	NULL
CT	NULL
in	NULL
a	NULL
yeast	NULL
two-hybrid	NULL
assay	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
but	NULL
shows	NULL
specific	NULL
binding	NULL
to	NULL
a	NULL
GST-LMP1	NULL
CT	NULL
fusion	NULL
protein	NULL
when	NULL
translated	NULL
in	NULL
vitro	NULL
in	NULL
a	NULL
wheat	NULL
germ	NULL
extract	NULL
(	NULL
22	NULL
)	NULL
.	NULL

To	NULL
further	NULL
explore	NULL
the	NULL
potential	NULL
binding	NULL
of	NULL
TRAF1	NULL
to	NULL
the	NULL
LMP1	NULL
CT	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
animal	NULL
cell	NULL
TRAFs	NULL
,	NULL
TRAF1	NULL
,	NULL
TRAF2	NULL
,	NULL
or	NULL
TRAF3	NULL
was	NULL
translated	NULL
in	NULL
a	NULL
wheat	NULL
germ	NULL
extract	NULL
and	NULL
incubated	NULL
with	NULL
a	NULL
GST-LMP1	NULL
CT	NULL
fusion	NULL
protein	NULL
or	NULL
with	NULL
the	NULL
GST	NULL
control	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

TRAF1	NULL
and	NULL
TRAF2	NULL
bound	NULL
to	NULL
the	NULL
GST-LMP1	NULL
CT	NULL
with	NULL
similar	NULL
efficiency	NULL
,	NULL
the	NULL
average	NULL
efficiency	NULL
was	NULL
approximately	NULL
4-fold	NULL
less	NULL
than	NULL
TRAF3	NULL
and	NULL
more	NULL
than	NULL
100-fold	NULL
above	NULL
the	NULL
GST	NULL
background	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
and	NULL
replicate	NULL
experiments	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Mixing	NULL
in	NULL
vitro-translated	NULL
TRAF1	NULL
and	NULL
TRAFZ	NULL
did	NULL
not	NULL
increase	NULL
their	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
TRAF1	NULL
,	NULL
TRAF2	NULL
,	NULL
and	NULL
TRAF3	NULL
can	NULL
independently	NULL
bind	NULL
to	NULL
the	NULL
LMP1	NULL
CT	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
animal	NULL
cell	NULL
TRAFs	NULL
.	NULL

The	NULL
LMP1	NULL
CT	NULL
has	NULL
a	NULL
single	NULL
TRAF	NULL
binding	NULL
site	NULL
within	NULL
aa	NULL
201	NULL
to	NULL
210	NULL
.	NULL

Since	NULL
both	NULL
LMP1	NULL
CT	NULL
aa	NULL
187	NULL
to	NULL
231	NULL
and	NULL
aa	NULL
332	NULL
to	NULL
386	NULL
Vou	NULL
.	NULL

16	NULL
,	NULL
1996	NULL
A	NULL
§	NULL
a	NULL
&	NULL
Is	NULL
&	NULL
n	NULL
(	NULL
fl	NULL
)	NULL
5	NULL
&	NULL
&	NULL
gg	NULL
$	NULL
8	NULL
TRAFI	NULL
FTRAFPZ	NULL
TRAF3	NULL
-	NULL
a	NULL
a	NULL
in	NULL
&	NULL
n	NULL
mo	NULL
isr3se	NULL
CTITCT	NULL
OO	NULL
~~~	NULL
~	NULL
TT	NULL
C9	NULL
++	NULL
+	NULL
0	NULL
+++	NULL
3	NULL
]	NULL
+t	NULL
+++	NULL
is7212	NULL
OD	NULL
Np	NULL
ND	NULL
-	NULL
+++	NULL
201231	NULL
-	NULL
KCG	NULL
]	NULL
ND	NULL
ND	NULL
|	NULL
+++	NULL
1919214	NULL
_	NULL
(	NULL
Q	NULL
]	NULL
+	NULL
+00	NULL
+++	NULL
240-386	NULL
Co____	NULL
fP	NULL
J	NULL
=	NULL
a	NULL
e	NULL
333-386	NULL
C	NULL
--	NULL
-B	NULL
-	NULL
-	NULL
&	NULL
&	NULL
sb	NULL
PP	NULL
ss	NULL
de	NULL
,	NULL
V	NULL
ay	NULL
oF	NULL
5	NULL
B	NULL
__	NULL
@	NULL
@	NULL
«	NULL
``	NULL
s	NULL
@	NULL
Fs	NULL
«	NULL
-m	NULL
an	NULL
h	NULL
<	NULL
TRAF1	NULL
.	NULL

_	NULL
te	NULL
wan	NULL
<	NULL
-F-TRAFP2	NULL
10	NULL
2	NULL
%	NULL
3	NULL
4	NULL
50	NULL
6	NULL
7	NULL
é	NULL
&	NULL
>	NULL
«	NULL
p	NULL
8	NULL
.S	NULL
s	NULL
$	NULL
s	NULL
.	NULL

$	NULL
J	NULL
.	NULL

:	NULL
&	NULL
AP	NULL
as	NULL
``	NULL
ai	NULL
99	NULL
SECC	NULL
FES	NULL
FSE	NULL
with	NULL
-	NULL
wae	NULL
aas	NULL
wan	NULL
<	NULL
-TRAF3	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
17	NULL
8s	NULL
9	NULL
10	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Mapping	NULL
of	NULL
the	NULL
TRAF1	NULL
,	NULL
TRAF2	NULL
,	NULL
and	NULL
TRAF3	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
LMP1	NULL
CT.	NULL
(	NULL
A	NULL
)	NULL
Schematic	NULL
representation	NULL
of	NULL
the	NULL
LMP1	NULL
CT	NULL
deletion	NULL
mutant	NULL
GST	NULL
fusion	NULL
proteins	NULL
.	NULL

Domains	NULL
shown	NULL
to	NULL
mediate	NULL
NF-B	NULL
induction	NULL
(	NULL
30	NULL
)	NULL
are	NULL
identified	NULL
by	NULL
grey	NULL
boxes	NULL
,	NULL
and	NULL
domains	NULL
containing	NULL
a	NULL
PXQXT/S	NULL
motif	NULL
(	NULL
see	NULL
Discussion	NULL
)	NULL
by	NULL
black	NULL
boxes	NULL
.	NULL

Average	NULL
binding	NULL
of	NULL
total	NULL
input	NULL
in	NULL
vitro-translated	NULL
TRAFs	NULL
from	NULL
multiple	NULL
experiments	NULL
is	NULL
indicated	NULL
by	NULL
+++	NULL
(	NULL
>	NULL
20	NULL
%	NULL
)	NULL
,	NULL
++	NULL
(	NULL
5	NULL
to	NULL
15	NULL
%	NULL
)	NULL
,	NULL
+	NULL
(	NULL
1	NULL
%	NULL
)	NULL
,	NULL
and	NULL
-	NULL
(	NULL
no	NULL
binding	NULL
above	NULL
background	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Binding	NULL
of	NULL
in	NULL
vitro-translated	NULL
TRAF1	NULL
,	NULL
TRAF2	NULL
,	NULL
or	NULL
TRAF3	NULL
to	NULL
deletion	NULL
mutants	NULL
of	NULL
LMP1	NULL
CT	NULL
GST	NULL
fusion	NULL
proteins	NULL
.	NULL

Sepharose	NULL
beads	NULL
bound	NULL
to	NULL
GST	NULL
control	NULL
protein	NULL
or	NULL
GST	NULL
fusion	NULL
proteins	NULL
containing	NULL
the	NULL
full-length	NULL
LMP1	NULL
CT	NULL
or	NULL
various	NULL
deletion	NULL
mutants	NULL
were	NULL
incubated	NULL
in	NULL
vitro	NULL
with	NULL
*°S-labeled	NULL
TRAF1	NULL
,	NULL
FLAG-TRAF2	NULL
(	NULL
F-TRAF2	NULL
)	NULL
(	NULL
22	NULL
)	NULL
,	NULL
or	NULL
TRAF3	NULL
(	NULL
31	NULL
)	NULL
translated	NULL
in	NULL
vitro	NULL
in	NULL
rabbit	NULL
reticulocyte	NULL
lysate	NULL
.	NULL

Precipitated	NULL
proteins	NULL
were	NULL
analyzed	NULL
on	NULL
a	NULL
10	NULL
%	NULL
SDS-PAGE	NULL
followed	NULL
by	NULL
autoradiography	NULL
and	NULL
PhosphorImager	NULL
analysis	NULL
.	NULL

have	NULL
been	NULL
implicated	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
,	NULL
TRAF	NULL
binding	NULL
to	NULL
both	NULL
sites	NULL
was	NULL
further	NULL
investigated	NULL
in	NULL
yeast	NULL
two-hybrid	NULL
assays	NULL
and	NULL
in	NULL
in	NULL
vitro	NULL
GST	NULL
pull-down	NULL
experiments	NULL
.	NULL

As	NULL
previously	NULL
observed	NULL
,	NULL
in	NULL
yeast	NULL
two-hybrid	NULL
liquid	NULL
B-galactosidase	NULL
assays	NULL
,	NULL
a	NULL
Gal4	NULL
DNA	NULL
binding	NULL
domain	NULL
(	NULL
G4DBD	NULL
)	NULL
fusion	NULL
with	NULL
LMP1	NULL
aa	NULL
187	NULL
to	NULL
231	NULL
,	NULL
G4DBD-LMP1	NULL
(	NULL
187-231	NULL
)	NULL
,	NULL
interacted	NULL
strongly	NULL
with	NULL
G4TAD-TRAF3	NULL
(	NULL
183-568	NULL
)	NULL
(	NULL
31	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
G4DBD-LMP1	NULL
(	NULL
240-386	NULL
)	NULL
did	NULL
not	NULL
interact	NULL
with	NULL
G4TAD-TRAF3	NULL
(	NULL
183-568	NULL
)	NULL
either	NULL
in	NULL
liquid	NULL
or	NULL
in	NULL
more	NULL
sensitive	NULL
colony-based	NULL
-galactosidase	NULL
assays	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
G4DBD-LMP1	NULL
(	NULL
240-386	NULL
)	NULL
was	NULL
confirmed	NULL
by	NULL
LMP1	NULL
immunoblot	NULL
and	NULL
by	NULL
interaction	NULL
with	NULL
a	NULL
specific	NULL
G4TAD-cDNA	NULL
gene	NULL
fusion	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Further	NULL
,	NULL
TRAF3	NULL
,	NULL
translated	NULL
in	NULL
vitro	NULL
in	NULL
a	NULL
reticulocyte	NULL
lysate	NULL
,	NULL
did	NULL
not	NULL
bind	NULL
to	NULL
GST-LMP1	NULL
(	NULL
333-386	NULL
)	NULL
or	NULL
GST-LMP1	NULL
(	NULL
240-386	NULL
)	NULL
but	NULL
did	NULL
bind	NULL
strongly	NULL
to	NULL
GST-LMP1	NULL
(	NULL
187-386	NULL
)	NULL
or	NULL
GST-LMP1	NULL
(	NULL
187-231	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
TRAF3	NULL
binds	NULL
only	NULL
to	NULL
a	NULL
site	NULL
(	NULL
s	NULL
)	NULL
within	NULL
LMP1	NULL
CT	NULL
aa	NULL
187	NULL
to	NULL
231	NULL
.	NULL

Similarly	NULL
,	NULL
TRAF1	NULL
or	NULL
FLAG-TRAF2	NULL
,	NULL
translated	NULL
in	NULL
a	NULL
reticulocyte	NULL
lysate	NULL
,	NULL
did	NULL
not	NULL
bind	NULL
to	NULL
GST-LMP1	NULL
(	NULL
333-386	NULL
)	NULL
or	NULL
GST-LMP1	NULL
(	NULL
240-386	NULL
)	NULL
but	NULL
did	NULL
bind	NULL
to	NULL
GST-LMP1	NULL
(	NULL
187-386	NULL
)	NULL
or	NULL
GST-LMP1	NULL
(	NULL
187-231	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

FLAG-TRAF2	NULL
was	NULL
used	NULL
in	NULL
most	NULL
experiments	NULL
because	NULL
the	NULL
efficiency	NULL
of	NULL
in	NULL
vitro	NULL
translation	NULL
was	NULL
TNFR-ASSOCIATED	NULL
FACTORS	NULL
IN	NULL
LMP1-INDUCED	NULL
NF-	NULL
«	NULL
B	NULL
ACTIVATION	NULL
7101	NULL
higher	NULL
than	NULL
with	NULL
native	NULL
TRAFZ	NULL
.	NULL

Surprisingly	NULL
,	NULL
both	NULL
TRAF1	NULL
and	NULL
FLAG-TRAFZ	NULL
bound	NULL
better	NULL
to	NULL
GST-LMP1	NULL
(	NULL
187-231	NULL
)	NULL
than	NULL
to	NULL
GST-LMP1	NULL
(	NULL
187-386	NULL
)	NULL
.	NULL

On	NULL
average	NULL
,	NULL
more	NULL
than	NULL
50	NULL
%	NULL
of	NULL
TRAF1	NULL
,	NULL
10	NULL
%	NULL
of	NULL
FLAG-TRAF2	NULL
,	NULL
and	NULL
25	NULL
%	NULL
of	NULL
TRAF3	NULL
bound	NULL
to	NULL
GST-LMP1	NULL
(	NULL
187-231	NULL
)	NULL
,	NULL
while	NULL
15	NULL
%	NULL
of	NULL
TRAF1	NULL
,	NULL
1	NULL
%	NULL
of	NULL
FLAG-TRAF3	NULL
,	NULL
and	NULL
38	NULL
%	NULL
of	NULL
TRAF3	NULL
bound	NULL
to	NULL
GST-LMP1	NULL
(	NULL
187-386	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Since	NULL
TRAF1	NULL
and	NULL
FLAG-TRAF2	NULL
bound	NULL
more	NULL
strongly	NULL
to	NULL
GST-LMP1	NULL
(	NULL
187-231	NULL
)	NULL
than	NULL
to	NULL
GST-LMP1	NULL
(	NULL
187-386	NULL
)	NULL
,	NULL
G4TAD-TRAF2	NULL
or	NULL
G4TAD-TRAFI	NULL
(	NULL
53-416	NULL
)	NULL
was	NULL
tested	NULL
against	NULL
a	NULL
G4DBD-LMP1	NULL
(	NULL
187-231	NULL
)	NULL
in	NULL
a	NULL
yeast	NULL
two-hybrid	NULL
B-galactosidase	NULL
filter	NULL
assay	NULL
to	NULL
determine	NULL
whether	NULL
any	NULL
interaction	NULL
could	NULL
be	NULL
detected	NULL
in	NULL
this	NULL
assay	NULL
.	NULL

While	NULL
cells	NULL
with	NULL
G4DBD-LMP1	NULL
(	NULL
187-231	NULL
)	NULL
that	NULL
were	NULL
transfected	NULL
with	NULL
G4TAD-TRAF3	NULL
(	NULL
183-568	NULL
)	NULL
became	NULL
blue	NULL
in	NULL
30	NULL
min	NULL
,	NULL
the	NULL
same	NULL
cells	NULL
transfected	NULL
with	NULL
G4TAD-TRAF1	NULL
(	NULL
53-416	NULL
)	NULL
turned	NULL
blue	NULL
at	NULL
2	NULL
to	NULL
3	NULL
h	NULL
and	NULL
with	NULL
G4TAD-TRAF	NULL
or	NULL
G4TAD	NULL
failed	NULL
to	NULL
turn	NULL
blue	NULL
even	NULL
after	NULL
overnight	NULL
incubation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
as	NULL
observed	NULL
for	NULL
TRAF3	NULL
,	NULL
TRAF1	NULL
and	NULL
TRAF2	NULL
bind	NULL
only	NULL
to	NULL
a	NULL
site	NULL
(	NULL
s	NULL
)	NULL
within	NULL
LMP1	NULL
CT	NULL
aa	NULL
187	NULL
to	NULL
231	NULL
;	NULL
TRAF1	NULL
and	NULL
TRAF3	NULL
binding	NULL
to	NULL
this	NULL
site	NULL
can	NULL
be	NULL
detected	NULL
both	NULL
in	NULL
yeast	NULL
two-hybrid	NULL
assays	NULL
and	NULL
in	NULL
GST	NULL
fusion	NULL
protein	NULL
binding	NULL
assays	NULL
,	NULL
while	NULL
TRAF2	NULL
binding	NULL
,	NULL
which	NULL
is	NULL
weaker	NULL
than	NULL
TRAF	NULL
]	NULL
or	NULL
TRAF3	NULL
binding	NULL
,	NULL
can	NULL
only	NULL
be	NULL
detected	NULL
in	NULL
GST	NULL
fusion	NULL
protein	NULL
binding	NULL
assays	NULL
.	NULL

The	NULL
TRAF3	NULL
binding	NULL
site	NULL
within	NULL
LMP1	NULL
aa	NULL
187	NULL
to	NULL
231	NULL
was	NULL
further	NULL
defined	NULL
.	NULL

Both	NULL
G4DBD-LMP1	NULL
(	NULL
187-212	NULL
)	NULL
or	NULL
G4DBD-LMP1	NULL
(	NULL
201-231	NULL
)	NULL
interacted	NULL
with	NULL
G4TAD-TRAF3	NULL
(	NULL
183-568	NULL
)	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Also	NULL
,	NULL
in	NULL
vitro-translated	NULL
TRAF3	NULL
bound	NULL
nearly	NULL
as	NULL
well	NULL
to	NULL
GST-LMP1	NULL
(	NULL
187-212	NULL
)	NULL
or	NULL
GST-LMP1	NULL
(	NULL
201-231	NULL
)	NULL
as	NULL
to	NULL
GST-LMP1	NULL
(	NULL
187-231	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
TRAF3	NULL
binding	NULL
site	NULL
is	NULL
within	NULL
aa	NULL
201	NULL
to	NULL
212	NULL
(	NULL
or	NULL
there	NULL
are	NULL
two	NULL
separate	NULL
,	NULL
nonoverlapping	NULL
binding	NULL
sites	NULL
)	NULL
.	NULL

In	NULL
vitro-translated	NULL
TRAF3	NULL
bound	NULL
nearly	NULL
as	NULL
well	NULL
to	NULL
GST-LMP1	NULL
(	NULL
199-214	NULL
)	NULL
as	NULL
to	NULL
GST-LMP1	NULL
(	NULL
187-231	NULL
)	NULL
or	NULL
to	NULL
GST-LMP1	NULL
(	NULL
187-386	NULL
)	NULL
[	NULL
on	NULL
average	NULL
,	NULL
20	NULL
%	NULL
of	NULL
input	NULL
TRAF3	NULL
bound	NULL
to	NULL
GST-LMP1	NULL
(	NULL
199-214	NULL
)	NULL
versus	NULL
25	NULL
%	NULL
for	NULL
GST-LMP1	NULL
(	NULL
187-231	NULL
)	NULL
and	NULL
38	NULL
%	NULL
for	NULL
GST-LMP1	NULL
(	NULL
187-386	NULL
)	NULL
]	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
LMP1	NULL
aa	NULL
199	NULL
to	NULL
214	NULL
are	NULL
highly	NULL
competent	NULL
for	NULL
TRAF3	NULL
binding	NULL
,	NULL
and	NULL
the	NULL
binding	NULL
site	NULL
is	NULL
almost	NULL
certainly	NULL
within	NULL
aa	NULL
201	NULL
to	NULL
212	NULL
.	NULL

TRAF1	NULL
and	NULL
TRAF2Z	NULL
also	NULL
bound	NULL
to	NULL
the	NULL
LMP1	NULL
aa	NULL
199	NULL
to	NULL
214	NULL
site	NULL
.	NULL

In	NULL
vitro-translated	NULL
TRAF1	NULL
or	NULL
FLAG-TRAF2	NULL
bound	NULL
specifically	NULL
to	NULL
GST-LMP1	NULL
(	NULL
199-214	NULL
)	NULL
,	NULL
although	NULL
less	NULL
efficiently	NULL
than	NULL
TRAF3	NULL
(	NULL
average	NULL
binding	NULL
of	NULL
approximately	NULL
1	NULL
%	NULL
for	NULL
TRAF1	NULL
or	NULL
FLAG-TRAF2	NULL
versus	NULL
20	NULL
%	NULL
for	NULL
TRAF3	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
situation	NULL
with	NULL
TRAF3	NULL
,	NULL
both	NULL
TRAF1	NULL
and	NULL
FLAG-TRAF2	NULL
bound	NULL
less	NULL
efficiently	NULL
to	NULL
GST-LMP1	NULL
(	NULL
199-214	NULL
)	NULL
than	NULL
to	NULL
GST-LMP1	NULL
(	NULL
187-231	NULL
)	NULL
.	NULL

On	NULL
average	NULL
,	NULL
1	NULL
%	NULL
of	NULL
TRAF1	NULL
or	NULL
FLAG-TRAF2	NULL
bound	NULL
to	NULL
GST-LMP1	NULL
(	NULL
199-214	NULL
)	NULL
,	NULL
while	NULL
more	NULL
than	NULL
50	NULL
%	NULL
of	NULL
TRAF1	NULL
and	NULL
10	NULL
%	NULL
of	NULL
FLAG-TRAF2	NULL
bound	NULL
to	NULL
GST-LMP1	NULL
(	NULL
187-231	NULL
)	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
posttranslational	NULL
modifications	NULL
or	NULL
other	NULL
cellular	NULL
proteins	NULL
might	NULL
affect	NULL
the	NULL
TRAF	NULL
binding	NULL
to	NULL
the	NULL
LMP1	NULL
CT	NULL
,	NULL
GST-LMP1	NULL
CT	NULL
fusion	NULL
proteins	NULL
were	NULL
incubated	NULL
with	NULL
extracts	NULL
from	NULL
an	NULL
EBV-negative	NULL
Burkitt	NULL
lymphoma	NULL
cell	NULL
line	NULL
(	NULL
BJAB	NULL
)	NULL
transiently	NULL
overexpressing	NULL
TRAF1	NULL
,	NULL
FLAG-TRAF2	NULL
,	NULL
or	NULL
TRAF3	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

As	NULL
observed	NULL
with	NULL
in	NULL
vitro-translated	NULL
TRAFs	NULL
,	NULL
FLAG-TRAFZ	NULL
and	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
TRAF1	NULL
overexpressed	NULL
in	NULL
lymphoblasts	NULL
bound	NULL
to	NULL
GST-LMP1	NULL
(	NULL
187-231	NULL
)	NULL
better	NULL
than	NULL
to	NULL
GST-LMP1	NULL
(	NULL
187-386	NULL
)	NULL
or	NULL
to	NULL
GST-LMP1	NULL
(	NULL
199-214	NULL
)	NULL
and	NULL
TRAF3	NULL
bound	NULL
similarly	NULL
to	NULL
all	NULL
three	NULL
GST-LMP1	NULL
fusion	NULL
proteins	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
in	NULL
vivo-expressed	NULL
TRAF2	NULL
to	NULL
GST-LMP1	NULL
(	NULL
187-231	NULL
)	NULL
and	NULL
GST-LMP1	NULL
(	NULL
187-386	NULL
)	NULL
was	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
FLAG-TRAF2	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Also	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
lack	NULL
of	NULL
binding	NULL
of	NULL
in	NULL
vitro-translated	NULL
TRAFs	NULL
to	NULL
GST-LMP1	NULL
(	NULL
240-386	NULL
)	NULL
,	NULL
in	NULL
vivo-expressed	NULL
TRAF1	NULL
,	NULL
FLAG-TRAF2	NULL
,	NULL
or	NULL
TRAF3	NULL
did	NULL
not	NULL
bind	NULL
to	NULL
GST-LMP1	NULL
(	NULL
240-386	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
vitro-	NULL
and	NULL
in	NULL
vivo	NULL
7102	NULL
DEVERGNE	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
10	NULL
%	NULL
lysate	NULL
GST	NULL
187-386	NULL
187-231	NULL
199-214	NULL
240-386	NULL
59	NULL
.	NULL

*	NULL
--	NULL
@	NULL
UBeze	NULL
_	NULL
TRAF	NULL
]	NULL
hca	NULL
@	NULL
-	NULL
<	NULL
«	NULL
-F-TRAF2	NULL
50	NULL
-50-	NULL
1	NULL
;	NULL
z	NULL
g	NULL
§	NULL
0	NULL
L	NULL
e	NULL
a	NULL
a	NULL
®	NULL
A	NULL
&	NULL
-	NULL
q	NULL
®	NULL
8	NULL
f	NULL
k	NULL
d	NULL
#	NULL
foc	NULL
s	NULL
$	NULL
&	NULL
§	NULL
5	NULL
$	NULL
5	NULL
|	NULL
TRAF3	NULL
-	NULL
>	NULL
L	NULL
d	NULL
TEAFI	NULL
-	NULL
G	NULL
TRAF2	NULL
-	NULL
>	NULL
TRAF1/3	NULL
blot	NULL
TRAF2	NULL
blot	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

GST	NULL
binding	NULL
assay	NULL
using	NULL
cell	NULL
extracts	NULL
from	NULL
BJAB	NULL
cells	NULL
overexpressing	NULL
TRAF1	NULL
,	NULL
TRAF2	NULL
,	NULL
or	NULL
TRAF3	NULL
.	NULL

(	NULL
A	NULL
)	NULL
BJAB	NULL
cells	NULL
(	NULL
10	NULL
'	NULL
per	NULL
transfection	NULL
)	NULL
were	NULL
elec-troporated	NULL
with	NULL
30	NULL
g	NULL
of	NULL
pSGS	NULL
vector	NULL
expressing	NULL
TRAF1	NULL
,	NULL
FLAG-TRAF2	NULL
(	NULL
F-TRAF2	NULL
)	NULL
(	NULL
22	NULL
)	NULL
,	NULL
or	NULL
TRAF3	NULL
(	NULL
31	NULL
)	NULL
and	NULL
lysed	NULL
18	NULL
h	NULL
posttransfection	NULL
in	NULL
1	NULL
%	NULL
NP-40	NULL
lysis	NULL
buffer	NULL
.	NULL

Cleared	NULL
lysates	NULL
(	NULL
2	NULL
X	NULL
10°	NULL
cells	NULL
per	NULL
pull	NULL
down	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
Sepharose	NULL
beads	NULL
bound	NULL
to	NULL
GST	NULL
control	NULL
or	NULL
GST	NULL
fusion	NULL
proteins	NULL
containing	NULL
various	NULL
deletion	NULL
mutants	NULL
of	NULL
LMP1	NULL
CT	NULL
.	NULL

Cell	NULL
lysates	NULL
(	NULL
10	NULL
%	NULL
obtained	NULL
before	NULL
the	NULL
GST	NULL
binding	NULL
assay	NULL
)	NULL
and	NULL
coprecipitated	NULL
material	NULL
were	NULL
separated	NULL
by	NULL
8	NULL
%	NULL
SDS-PAGE	NULL
,	NULL
.	NULL

Coprecipitating	NULL
TRAF	NULL
proteins	NULL
were	NULL
detected	NULL
by	NULL
immunoblot	NULL
analysis	NULL
using	NULL
rabbit	NULL
polyclonal	NULL
antisera	NULL
recognizing	NULL
both	NULL
TRAF1	NULL
and	NULL
TRAF3	NULL
(	NULL
CRAF1	NULL
C20	NULL
)	NULL
or	NULL
TRAF2	NULL
(	NULL
TRAF2	NULL
C20	NULL
)	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
prestained	NULL
molecular	NULL
markers	NULL
(	NULL
in	NULL
kilodaltons	NULL
)	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
left	NULL
.	NULL

(	NULL
B	NULL
)	NULL
GST	NULL
binding	NULL
assay	NULL
using	NULL
LCL	NULL
extracts	NULL
.	NULL

NP-40	NULL
extracts	NULL
from	NULL
[	NULL
B4	NULL
cells	NULL
(	NULL
20	NULL
X	NULL
10°	NULL
cells	NULL
per	NULL
pull	NULL
down	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
Sepharose	NULL
bead-bound	NULL
GST	NULL
or	NULL
GST-LMP1	NULL
CT	NULL
deletion	NULL
mutant	NULL
fusion	NULL
proteins	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
endogenous	NULL
TRAFs	NULL
was	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
Western	NULL
blotting	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

expressed	NULL
TRAFs	NULL
are	NULL
similar	NULL
in	NULL
their	NULL
binding	NULL
to	NULL
GST-LMP1	NULL
CT	NULL
fusion	NULL
proteins	NULL
.	NULL

Endogenous	NULL
TRAF1	NULL
,	NULL
TRAF2	NULL
,	NULL
and	NULL
TRAF3	NULL
from	NULL
an	NULL
EBV-transformed	NULL
LCL	NULL
and	NULL
overexpressed	NULL
TRAFs	NULL
bound	NULL
similarly	NULL
to	NULL
GST-LMP1	NULL
fusion	NULL
proteins	NULL
except	NULL
that	NULL
endogenous	NULL
TRAF3	NULL
did	NULL
not	NULL
bind	NULL
to	NULL
GST-LMP1	NULL
(	NULL
187-231	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
,	NULL
although	NULL
it	NULL
was	NULL
readily	NULL
detected	NULL
in	NULL
the	NULL
lysate	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
LCLs	NULL
there	NULL
appears	NULL
to	NULL
be	NULL
very	NULL
little	NULL
free	NULL
TRAF3	NULL
;	NULL
TRAF3	NULL
is	NULL
probably	NULL
stably	NULL
associated	NULL
with	NULL
LMP1	NULL
and	NULL
other	NULL
proteins	NULL
.	NULL

A	NULL
core	NULL
TRAF	NULL
binding	NULL
motif	NULL
.	NULL

A	NULL
point	NULL
mutation	NULL
that	NULL
changes	NULL
Thr-234	NULL
to	NULL
Ala	NULL
in	NULL
the	NULL
CD40	NULL
cytoplasmic	NULL
tail	NULL
prevents	NULL
TRAF3	NULL
binding	NULL
to	NULL
CD40	NULL
and	NULL
results	NULL
in	NULL
a	NULL
signaling-defective	NULL
phenotype	NULL
(	NULL
15	NULL
,	NULL
17	NULL
)	NULL
.	NULL

Alignment	NULL
of	NULL
the	NULL
CD40	NULL
site	NULL
around	NULL
Thr-234	NULL
with	NULL
the	NULL
LMP1	NULL
aa	NULL
199	NULL
to	NULL
214	NULL
TRAF	NULL
binding	NULL
site	NULL
reveals	NULL
a	NULL
common	NULL
PXQXT	NULL
sequence	NULL
and	NULL
little	NULL
other	NULL
similarity	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

To	NULL
test	NULL
the	NULL
significance	NULL
of	NULL
this	NULL
similarity	NULL
,	NULL
LMP1	NULL
aa	NULL
199	NULL
to	NULL
210	NULL
were	NULL
systematically	NULL
mutated	NULL
to	NULL
alanine	NULL
and	NULL
the	NULL
effects	NULL
on	NULL
TRAF	NULL
binding	NULL
were	NULL
evaluated	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

TRAF3	NULL
bound	NULL
as	NULL
well	NULL
to	NULL
GST-LMP1	NULL
(	NULL
199-210	NULL
)	NULL
with	NULL
D-199	NULL
or	NULL
$	NULL
-200	NULL
mutated	NULL
to	NULL
A	NULL
as	NULL
to	NULL
GST-LMP1	NULL
(	NULL
199-214	NULL
)	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
LMP1	NULL
aa	NULL
199	NULL
to	NULL
210	NULL
act	NULL
as	NULL
a	NULL
sufficient	NULL
TRAF3	NULL
binding	NULL
site	NULL
and	NULL
that	NULL
D-199	NULL
and	NULL
$	NULL
-200	NULL
are	NULL
not	NULL
critical	NULL
in	NULL
this	NULL
minimal	NULL
binding	NULL
site	NULL
.	NULL

Mutation	NULL
of	NULL
L-201	NULL
reduced	NULL
TRAF3	NULL
binding	NULL
by	NULL
94	NULL
%	NULL
,	NULL
while	NULL
mutation	NULL
of	NULL
P-202	NULL
or	NULL
H-203	NULL
decreased	NULL
TRAF3	NULL
binding	NULL
by	NULL
40	NULL
and	NULL
84	NULL
%	NULL
,	NULL
respectively	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
mutation	NULL
of	NULL
P-204	NULL
,	NULL
Q-205	NULL
,	NULL
or	NULL
Q-206	NULL
to	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

alanine	NULL
decreased	NULL
TRAF3	NULL
binding	NULL
by	NULL
more	NULL
than	NULL
99	NULL
%	NULL
and	NULL
mutation	NULL
of	NULL
T-208	NULL
decreased	NULL
TRAF3	NULL
binding	NULL
more	NULL
than	NULL
95	NULL
%	NULL
.	NULL

Mutation	NULL
of	NULL
D-209	NULL
resulted	NULL
in	NULL
only	NULL
a	NULL
40	NULL
%	NULL
decrease	NULL
in	NULL
TRAF3	NULL
binding	NULL
,	NULL
but	NULL
simultaneous	NULL
mutation	NULL
of	NULL
D-209	NULL
and	NULL
D-210	NULL
resulted	NULL
in	NULL
a	NULL
95	NULL
%	NULL
decrease	NULL
in	NULL
TRAF3	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Thus	NULL
L-201	NULL
,	NULL
P-204	NULL
,	NULL
Q-205	NULL
,	NULL
Q-206	NULL
,	NULL
T-208	NULL
and	NULL
DD	NULL
(	NULL
209,210	NULL
)	NULL
appear	NULL
to	NULL
be	NULL
important	NULL
in	NULL
binding	NULL
TRAF3	NULL
,	NULL
while	NULL
P-202	NULL
and	NULL
H-203	NULL
may	NULL
be	NULL
less	NULL
important	NULL
and	NULL
A-207	NULL
has	NULL
not	NULL
been	NULL
evaluated	NULL
because	NULL
of	NULL
the	NULL
nature	NULL
of	NULL
the	NULL
test	NULL
.	NULL

TRAF1	NULL
and	NULL
TRAF2	NULL
binding	NULL
to	NULL
the	NULL
set	NULL
of	NULL
LMP1	NULL
mutants	NULL
paralleled	NULL
TRAF3	NULL
binding	NULL
.	NULL

P-204	NULL
,	NULL
Q-206	NULL
,	NULL
T-208	NULL
,	NULL
and	NULL
DD	NULL
(	NULL
209,210	NULL
)	NULL
mutations	NULL
abolished	NULL
most	NULL
of	NULL
the	NULL
TRAF1	NULL
or	NULL
TRAF2	NULL
binding	NULL
,	NULL
while	NULL
the	NULL
D-209	NULL
mutation	NULL
had	NULL
little	NULL
effect	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

These	NULL
data	NULL
are	NULL
further	NULL
evidence	NULL
that	NULL
TRAF1	NULL
,	NULL
TRAF2	NULL
,	NULL
and	NULL
TRAF3	NULL
recognize	NULL
the	NULL
same	NULL
core	NULL
site	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
most	NULL
disruptive	NULL
mutations	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
P-204	NULL
to	NULL
A	NULL
or	NULL
Q-206	NULL
to	NULL
A	NULL
,	NULL
in	NULL
the	NULL
context	NULL
of	NULL
GST-LMP1	NULL
(	NULL
187-231	NULL
)	NULL
confirmed	NULL
the	NULL
role	NULL
of	NULL
these	NULL
residues	NULL
in	NULL
TRAF	NULL
binding	NULL
and	NULL
revealed	NULL
a	NULL
significant	NULL
role	NULL
for	NULL
surrounding	NULL
residues	NULL
.	NULL

TRAF	NULL
binding	NULL
was	NULL
almost	NULL
completely	NULL
abrogated	NULL
by	NULL
either	NULL
mutation	NULL
,	NULL
and	NULL
TRAF1	NULL
binding	NULL
was	NULL
decreased	NULL
more	NULL
than	NULL
60	NULL
%	NULL
by	NULL
the	NULL
P-204	NULL
to	NULL
A	NULL
or	NULL
the	NULL
Q-206	NULL
to	NULL
A	NULL
mutation	NULL
.	NULL

Surprisingly	NULL
,	NULL
TRAF3	NULL
binding	NULL
was	NULL
largely	NULL
unaffected	NULL
by	NULL
either	NULL
mutation	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
surrounding	NULL
residues	NULL
in	NULL
the	NULL
LMP1	NULL
CT	NULL
can	NULL
support	NULL
high-level	NULL
interaction	NULL
of	NULL
a	NULL
significantly	NULL
mutated	NULL
core	NULL
site	NULL
with	NULL
TRAF3	NULL
and	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
with	NULL
TRAF1	NULL
.	NULL

To	NULL
further	NULL
evaluate	NULL
the	NULL
importance	NULL
of	NULL
the	NULL
core	NULL
binding	NULL
site	NULL
in	NULL
TRAF1	NULL
,	NULL
TRAF2	NULL
,	NULL
and	NULL
TRAF3	NULL
association	NULL
with	NULL
LMP1	NULL
in	NULL
vivo	NULL
,	NULL
a	NULL
FLAG-tagged	NULL
LMP1	NULL
mutant	NULL
consisting	NULL
of	NULL
aa	NULL
1	NULL
to	NULL
231	NULL
[	NULL
FLAG-LMP1	NULL
(	NULL
1-231	NULL
)	NULL
]	NULL
,	NULL
either	NULL
wild-type	NULL
or	NULL
with	NULL
a	NULL
P-204	NULL
to	NULL
A	NULL
or	NULL
Q-206	NULL
to	NULL
A	NULL
mutation	NULL
,	NULL
was	NULL
expressed	NULL
in	NULL
BJAB	NULL
cells	NULL
and	NULL
the	NULL
binding	NULL
of	NULL
endogenous	NULL
TRAFs	NULL
was	NULL
assessed	NULL
in	NULL
communopre-cipitation	NULL
experiments	NULL
.	NULL

As	NULL
expected	NULL
from	NULL
the	NULL
GST	NULL
binding	NULL
data	NULL
,	NULL
FLAG-LMP1	NULL
(	NULL
1-231	NULL
)	NULL
bound	NULL
efficiently	NULL
TRAF1	NULL
,	NULL
-2	NULL
,	NULL
and	NULL
-3	NULL
,	NULL
while	NULL
FLAG-LMP1	NULL
(	NULL
1-231	NULL
)	NULL
with	NULL
P-204	NULL
to	NULL
A	NULL
or	NULL
Q-206	NULL
to	NULL
A	NULL
mutations	NULL
retained	NULL
substantial	NULL
TRAF3	NULL
binding	NULL
but	NULL
was	NULL
reduced	NULL
in	NULL
TRAF1	NULL
binding	NULL
and	NULL
did	NULL
not	NULL
bind	NULL
TRAF2	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
full-length	NULL
FLAG-LMP1	NULL
with	NULL
both	NULL
P-204	NULL
and	NULL
Q-206	NULL
mutated	NULL
to	NULL
A	NULL
did	NULL
not	NULL
bind	NULL
TRAF1	NULL
or	NULL
TRAF2	NULL
and	NULL
showed	NULL
minimal	NULL
or	NULL
no	NULL
TRAF3	NULL
binding	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
LMP1	NULL
residues	NULL
around	NULL
the	NULL
core	NULL
TRAF	NULL
binding	NULL
site	NULL
can	NULL
support	NULL
continued	NULL
interaction	NULL
with	NULL
TRAF3	NULL
in	NULL
the	NULL
face	NULL
of	NULL
the	NULL
mutation	NULL
of	NULL
one	NULL
key	NULL
residue	NULL
but	NULL
not	NULL
with	NULL
two	NULL
mutations	NULL
.	NULL

These	NULL
data	NULL
confirm	NULL
the	NULL
importance	NULL
of	NULL
the	NULL
PXQXT	NULL
motif	NULL
for	NULL
TRAF1	NULL
,	NULL
TRAF2	NULL
,	NULL
and	NULL
TRAF3	NULL
binding	NULL
and	NULL
further	NULL
indicate	NULL
that	NULL
there	NULL
is	NULL
no	NULL
other	NULL
TRAF1	NULL
,	NULL
TRAF2	NULL
,	NULL
or	NULL
TRAF3	NULL
binding	NULL
site	NULL
in	NULL
LMP1	NULL
.	NULL

Mutation	NULL
of	NULL
LMP1	NULL
(	NULL
1-231	NULL
)	NULL
P-204	NULL
or	NULL
Q-206	NULL
to	NULL
A	NULL
affects	NULL
NF-B	NULL
activation	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
the	NULL
core	NULL
TRAF	NULL
binding	NULL
site	NULL
mutations	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
was	NULL
assessed	NULL
by	NULL
transfection	NULL
of	NULL
293	NULL
cells	NULL
with	NULL
a	NULL
wild-type	NULL
or	NULL
mutant	NULL
FLAG-LMP1	NULL
(	NULL
1-231	NULL
)	NULL
expression	NULL
vector	NULL
and	NULL
a	NULL
NF-kB-dependent	NULL
promoter	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
.	NULL

FLAG-LMP1	NULL
(	NULL
1-231	NULL
)	NULL
induced	NULL
greater	NULL
than	NULL
20-fold	NULL
higher	NULL
luciferase	NULL
activity	NULL
than	NULL
reporter	NULL
plasmid	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
,	NULL
and	NULL
the	NULL
effect	NULL
was	NULL
dependent	NULL
on	NULL
the	NULL
NF-KB	NULL
sites	NULL
in	NULL
the	NULL
reporter	NULL
plasmid	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

FLAG-LMP1	NULL
(	NULL
1-231	NULL
)	NULL
with	NULL
P-204	NULL
mutated	NULL
to	NULL
A	NULL
had	NULL
10	NULL
%	NULL
of	NULL
the	NULL
wild-type	NULL
activity	NULL
and	NULL
was	NULL
expressed	NULL
at	NULL
a	NULL
level	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
wild-type	NULL
LMP1	NULL
(	NULL
1-231	NULL
)	NULL
as	NULL
assessed	NULL
by	NULL
immunoblotting	NULL
.	NULL

FLAG-LMP1	NULL
(	NULL
1-231	NULL
)	NULL
with	NULL
Q-206	NULL
mutated	NULL
to	NULL
A	NULL
had	NULL
from	NULL
15	NULL
to	NULL
49	NULL
%	NULL
of	NULL
the	NULL
wild-type	NULL
activity	NULL
when	NULL
expressed	NULL
at	NULL
similar	NULL
levels	NULL
to	NULL
at	NULL
least	NULL
twofold	NULL
higher	NULL
levels	NULL
than	NULL
wild	NULL
type	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
link	NULL
TRAF	NULL
binding	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
LMP1	NULL
(	NULL
1-231	NULL
)	NULL
,	NULL
favoring	NULL
a	NULL
role	NULL
for	NULL
TRAF1	NULL
or	NULL
TRAF2	NULL
since	NULL
TRAF3	NULL
binding	NULL
was	NULL
only	NULL
slightly	NULL
affected	NULL
by	NULL
the	NULL
P-204	NULL
or	NULL
Q-206	NULL
mutation	NULL
.	NULL

TRAF3	NULL
binds	NULL
to	NULL
LMP1	NULL
and	NULL
represses	NULL
LMP1	NULL
(	NULL
1-231	NULL
)	NULL
-mediated	NULL
NF-B	NULL
activation	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
role	NULL
of	NULL
TRAF3	NULL
in	NULL
Vou	NULL
.	NULL

16	NULL
,	NULL
1996	NULL
TNFR-ASSOCIATED	NULL
FACTORS	NULL
IN	NULL
LMP1-INDUCED	NULL
NF-	NULL
«	NULL
B	NULL
ACTIVATION	NULL
__	NULL
7103	NULL
as	NULL
A	NULL
CD40	NULL
221-239	NULL
SNTAAPVOQETLHGCQP	NULL
LMP1	NULL
199-214	NULL
DSLPHPQQATDDSGHE	NULL
0	NULL
hy	NULL
5	NULL
o	NULL
PP	NULL
$	NULL
3339	NULL
“	NULL
,	NULL
P	NULL
«	NULL
P	NULL
.J	NULL
«	NULL
t	NULL
«	NULL
P5	NULL
AYP	NULL
A	NULL
$	NULL
s	NULL
-_	NULL
s	NULL
-	NULL
SECS	NULL
»	NULL
.g	NULL
AF	NULL
$	NULL
48	NULL
48	NULL
aP	NULL
AP	NULL
aP	NULL
$	NULL
#	NULL
dt	NULL
&	NULL
9	NULL
9	NULL
9	NULL
9	NULL
a	NULL
9	NULL
$	NULL
``	NULL
Cee	NULL
uci	NULL
ic	NULL
ici	NULL
$	NULL
``	NULL
VSA	NULL
S	NULL
S	NULL
S	NULL
5	NULL
y	NULL
G	NULL
Q	NULL
\	NULL
J	NULL
D	NULL
P	NULL
Ap	NULL
@	NULL
-	NULL
am	NULL
»	NULL
-a	NULL
~-	NULL
a	NULL
»	NULL
a	NULL
ae	NULL
-_	NULL
<	NULL
-	NULL
TRAF3	NULL
=s	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
«	NULL
rm	NULL
»	NULL
«	NULL
-	NULL
<	NULL
-	NULL
TRAF1	NULL
.	NULL

-=	NULL
«	NULL
--	NULL
<	NULL
-	NULL
F-TRAF2	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
16	NULL
17	NULL
B	NULL
200	NULL
C	NULL
8	NULL
,	NULL
-	NULL
LMPL187-231	NULL
a	NULL
See	NULL
&	NULL
=	NULL
is	NULL
a	NULL
8	NULL
EB	NULL
S	NULL
§	NULL
a	NULL
with	NULL
_	NULL
aam	NULL
<	NULL
TRAFL	NULL
LOT	NULL
:	NULL
100	NULL
pal	NULL
E	NULL
wae	NULL
_	NULL
am	NULL
<	NULL
F-TRAF2	NULL
6	NULL
at	NULL
°	NULL
wan	NULL
_	NULL
we	NULL
amai	NULL
<	NULL
-	NULL
TRAF3	NULL
D	NULL
S	NULL
L	NULL
P	NULL
H	NULL
P	NULL
Q	NULL
Q	NULL
A	NULL
T	NULL
D	NULL
DD	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

Mutagenesis	NULL
analysis	NULL
of	NULL
the	NULL
minimal	NULL
TRAF	NULL
binding	NULL
site	NULL
on	NULL
the	NULL
LMP1	NULL
CT.	NULL
(	NULL
A	NULL
)	NULL
GST	NULL
binding	NULL
assay	NULL
with	NULL
GST	NULL
fusion	NULL
proteins	NULL
containing	NULL
point	NULL
mutations	NULL
in	NULL
the	NULL
TRAF	NULL
binding	NULL
site	NULL
.	NULL

Sequence	NULL
alignment	NULL
between	NULL
the	NULL
CD40	NULL
and	NULL
LMP1	NULL
CT	NULL
TRAF	NULL
binding	NULL
sites	NULL
is	NULL
shown	NULL
at	NULL
the	NULL
top	NULL
.	NULL

The	NULL
conserved	NULL
PXQXT	NULL
motif	NULL
is	NULL
identified	NULL
by	NULL
grey	NULL
boxes	NULL
.	NULL

CD40	NULL
Thr-234	NULL
shown	NULL
to	NULL
be	NULL
critical	NULL
for	NULL
TRAF3	NULL
binding	NULL
and	NULL
for	NULL
signaling	NULL
is	NULL
indicated	NULL
by	NULL
an	NULL
asterisk	NULL
(	NULL
15	NULL
,	NULL
17	NULL
)	NULL
.	NULL

The	NULL
LMP1	NULL
amino	NULL
acids	NULL
which	NULL
have	NULL
been	NULL
tested	NULL
by	NULL
alanine	NULL
mutagenesis	NULL
are	NULL
in	NULL
bold	NULL
characters	NULL
.	NULL

The	NULL
core	NULL
sequence	NULL
for	NULL
TRAF	NULL
binding	NULL
to	NULL
LMP1	NULL
is	NULL
underlined	NULL
.	NULL

*°S-labeled	NULL
TRAF1	NULL
,	NULL
FLAG-TRAF2	NULL
(	NULL
F-TRAF2	NULL
)	NULL
(	NULL
22	NULL
)	NULL
,	NULL
or	NULL
TRAF3	NULL
(	NULL
31	NULL
)	NULL
translated	NULL
in	NULL
vitro	NULL
in	NULL
rabbit	NULL
reticulocyte	NULL
lysate	NULL
was	NULL
incubated	NULL
with	NULL
Sepharose	NULL
bead-bound	NULL
GST	NULL
or	NULL
GST-LMP1	NULL
(	NULL
199-214	NULL
)	NULL
or	NULL
-	NULL
(	NULL
199-210	NULL
)	NULL
with	NULL
specific	NULL
amino	NULL
acids	NULL
(	NULL
identified	NULL
by	NULL
sequence	NULL
number	NULL
)	NULL
mutated	NULL
to	NULL
alanine	NULL
.	NULL

Precipitated	NULL
material	NULL
was	NULL
analyzed	NULL
by	NULL
10	NULL
%	NULL
SDS-PAGE	NULL
followed	NULL
by	NULL
autoradiography	NULL
and	NULL
PhosphorImager	NULL
analysis	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Histogram	NULL
analysis	NULL
of	NULL
TRAF3	NULL
binding	NULL
to	NULL
LMP1	NULL
mutant	NULL
peptides	NULL
.	NULL

The	NULL
average	NULL
(	NULL
mean	NULL
+	NULL
standard	NULL
deviation	NULL
)	NULL
of	NULL
TRAF3	NULL
binding	NULL
to	NULL
the	NULL
mutant	NULL
relative	NULL
to	NULL
wild-type	NULL
LMP1	NULL
aa	NULL
199	NULL
to	NULL
214	NULL
from	NULL
replicate	NULL
experiments	NULL
is	NULL
represented	NULL
.	NULL

The	NULL
amino	NULL
acids	NULL
which	NULL
were	NULL
mutated	NULL
to	NULL
alanine	NULL
are	NULL
in	NULL
bold	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Binding	NULL
of	NULL
TRAF1	NULL
,	NULL
TRAF2	NULL
,	NULL
and	NULL
TRAF3	NULL
to	NULL
GST	NULL
LMP1	NULL
187	NULL
to	NULL
231	NULL
fusion	NULL
proteins	NULL
with	NULL
a	NULL
P-204	NULL
to	NULL
A	NULL
or	NULL
Q-206	NULL
to	NULL
A	NULL
mutation	NULL
.	NULL

Sepharose	NULL
bead-bound	NULL
GST	NULL
or	NULL
GST-LMP1	NULL
(	NULL
187-231	NULL
)	NULL
,	NULL
either	NULL
wild-type	NULL
(	NULL
WT	NULL
)	NULL
or	NULL
with	NULL
a	NULL
P-204	NULL
to	NULL
A	NULL
or	NULL
Q-206	NULL
to	NULL
A	NULL
mutation	NULL
,	NULL
was	NULL
incubated	NULL
in	NULL
vitro	NULL
with	NULL
*°S-labeled	NULL
TRAF1	NULL
,	NULL
FLAG-TRAF2	NULL
(	NULL
F-TRAF2	NULL
)	NULL
(	NULL
22	NULL
)	NULL
,	NULL
or	NULL
TRAF3	NULL
(	NULL
31	NULL
)	NULL
translated	NULL
in	NULL
vitro	NULL
in	NULL
rabbit	NULL
reticulocyte	NULL
lysate	NULL
.	NULL

Precipitated	NULL
material	NULL
was	NULL
analyzed	NULL
by	NULL
10	NULL
%	NULL
SDS-PAGE	NULL
followed	NULL
by	NULL
autoradiography	NULL
and	NULL
PhosphorImager	NULL
analysis	NULL
.	NULL

LMP1	NULL
(	NULL
1-231	NULL
)	NULL
-mediated	NULL
NF-kB	NULL
activation	NULL
,	NULL
293	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
a	NULL
TRAF3	NULL
expression	NULL
vector	NULL
,	NULL
a	NULL
FLAG-LMP1	NULL
(	NULL
1-231	NULL
)	NULL
expression	NULL
vector	NULL
,	NULL
and	NULL
an	NULL
NF-kB-dependent	NULL
promoter	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
.	NULL

Cotransfection	NULL
of	NULL
TRAF3	NULL
expression	NULL
vector	NULL
(	NULL
1	NULL
or	NULL
4	NULL
ug	NULL
)	NULL
resulted	NULL
in	NULL
a	NULL
substantial	NULL
decrease	NULL
of	NULL
the	NULL
LMP1	NULL
(	NULL
1-231	NULL
)	NULL
-mediated	NULL
NF-KB	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
)	NULL
.	NULL

The	NULL
effect	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
was	NULL
not	NULL
due	NULL
to	NULL
an	NULL
effect	NULL
of	NULL
TRAF3	NULL
on	NULL
LMP1	NULL
(	NULL
1-231	NULL
)	NULL
expression	NULL
.	NULL

Although	NULL
TRAF3	NULL
overexpression	NULL
caused	NULL
a	NULL
decrease	NULL
in	NULL
some	NULL
experiments	NULL
,	NULL
the	NULL
decrease	NULL
was	NULL
minor	NULL
(	NULL
no	NULL
more	NULL
than	NULL
twofold	NULL
)	NULL
and	NULL
did	NULL
not	NULL
correlate	NULL
with	NULL
the	NULL
decrease	NULL
in	NULL
NF-KB	NULL
activation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

A	NULL
similar	NULL
negative	NULL
effect	NULL
of	NULL
TRAF3	NULL
overexpression	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
has	NULL
been	NULL
observed	NULL
with	NULL
CD40	NULL
or	NULL
p80	NULL
TNFR	NULL
overexpression	NULL
in	NULL
293	NULL
cells	NULL
(	NULL
36	NULL
)	NULL
.	NULL

The	NULL
TRAF	NULL
domain	NULL
of	NULL
TRAF3	NULL
(	NULL
aa	NULL
345	NULL
to	NULL
568	NULL
)	NULL
,	NULL
which	NULL
has	NULL
high	NULL
affinity	NULL
for	NULL
the	NULL
LMP1	NULL
CT	NULL
in	NULL
the	NULL
yeast	NULL
two-hybrid	NULL
assay	NULL
(	NULL
31	NULL
)	NULL
,	NULL
also	NULL
significantly	NULL
decreased	NULL
LMP1	NULL
(	NULL
1-231	NULL
)	NULL
-mediated	NULL
activation	NULL
without	NULL
affecting	NULL
LMP1	NULL
(	NULL
1-231	NULL
)	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

These	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
effect	NULL
being	NULL
due	NULL
to	NULL
TRAF3	NULL
occupancy	NULL
of	NULL
the	NULL
LMP1	NULL
TRAF	NULL
binding	NULL
site	NULL
and	NULL
displacement	NULL
of	NULL
other	NULL
NF-kB	NULL
activating	NULL
TRAFs	NULL
.	NULL

As	NULL
expected	NULL
from	NULL
the	NULL
lack	NULL
of	NULL
TRAF3	NULL
binding	NULL
to	NULL
the	NULL
LMP1	NULL
CT	NULL
outside	NULL
of	NULL
the	NULL
aa	NULL
187	NULL
to	NULL
231	NULL
binding	NULL
site	NULL
,	NULL
TRAF3	NULL
coexpression	NULL
had	NULL
no	NULL
significant	NULL
effects	NULL
on	NULL
NF-kB	NULL
induction	NULL
mediated	NULL
by	NULL
LMPA188-331	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
directly	NULL
evaluate	NULL
whether	NULL
TRAF3	NULL
overexpression	NULL
displaced	NULL
other	NULL
TRAFs	NULL
from	NULL
LMP1	NULL
,	NULL
FLAG-tagged	NULL
LMP1	NULL
or	NULL
a	NULL
FLAG-tagged	NULL
control	NULL
protein	NULL
(	NULL
FLAG-tagged	NULL
EBI3	NULL
)	NULL
(	NULL
4	NULL
)	NULL
was	NULL
7104	NULL
DEVERGNE	NULL
ET	NULL
AL	NULL
.	NULL

30	NULL
20	NULL
4	NULL
Fold	NULL
-	NULL
activation	NULL
10	NULL
4	NULL
C	NULL
3X-xB-L	NULL
{	NULL
11g	NULL
)	NULL
+	NULL
+	NULL
+	NULL
+	NULL
F-LMP231	NULL
(	NULL
0.6ug	NULL
)	NULL
+	NULL
F-LMP231PA	NULL
(	NULL
lug	NULL
»	NULL
+	NULL
F-LMPZ31QA	NULL
(	NULL
1ug	NULL
)	NULL
+	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

Effect	NULL
of	NULL
the	NULL
P-204	NULL
to	NULL
A	NULL
and	NULL
Q-206	NULL
to	NULL
A	NULL
mutations	NULL
on	NULL
LMP1	NULL
(	NULL
1-231	NULL
)	NULL
-mediated	NULL
NF-xB	NULL
induction	NULL
.	NULL

293	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
a	NULL
reporter	NULL
gene	NULL
containing	NULL
three	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
(	NULL
3X-	NULL
«	NULL
B-L	NULL
)	NULL
,	NULL
0.5	NULL
pg	NULL
of	NULL
pGKBgal	NULL
,	NULL
and	NULL
the	NULL
indicated	NULL
amount	NULL
(	NULL
in	NULL
micrograms	NULL
)	NULL
of	NULL
pSGS	NULL
vector	NULL
expressing	NULL
wild-type	NULL
FLAG-LMP1	NULL
(	NULL
1-231	NULL
)	NULL
(	NULL
F-LMP231	NULL
)	NULL
or	NULL
FLAG-LMP1	NULL
(	NULL
1-231	NULL
)	NULL
with	NULL
a	NULL
P-204	NULL
to	NULL
A	NULL
(	NULL
F-LMP231PA	NULL
)	NULL
or	NULL
Q-206	NULL
to	NULL
A	NULL
(	NULL
F-LMP231QA	NULL
)	NULL
mutation	NULL
.	NULL

Reporter	NULL
luciferase	NULL
values	NULL
were	NULL
normalized	NULL
for	NULL
transfection	NULL
efficiency	NULL
as	NULL
determined	NULL
by	NULL
B-galactosidase	NULL
expression	NULL
under	NULL
control	NULL
of	NULL
a	NULL
constitutive	NULL
promoter	NULL
in	NULL
a	NULL
cotransfected	NULL
plasmid	NULL
.	NULL

The	NULL
results	NULL
of	NULL
one	NULL
experiment	NULL
are	NULL
shown	NULL
of	NULL
two	NULL
in	NULL
which	NULL
each	NULL
transfection	NULL
was	NULL
performed	NULL
in	NULL
duplicate	NULL
or	NULL
triplicate	NULL
.	NULL

Values	NULL
are	NULL
shown	NULL
as	NULL
the	NULL
mean	NULL
(	NULL
+	NULL
standard	NULL
deviation	NULL
)	NULL
of	NULL
relative	NULL
luciferase	NULL
activity	NULL
.	NULL

In	NULL
this	NULL
experiment	NULL
,	NULL
mutant	NULL
LMP1	NULL
(	NULL
1-231	NULL
)	NULL
proteins	NULL
were	NULL
expressed	NULL
at	NULL
levels	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
the	NULL
wild	NULL
type	NULL
,	NULL
as	NULL
assessed	NULL
by	NULL
immunoblotting	NULL
with	NULL
anti-FLAG	NULL
antibody	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

expressed	NULL
in	NULL
a	NULL
non-EBV-infected	NULL
Burkitt	NULL
lymphoma	NULL
cell	NULL
line	NULL
(	NULL
BJAB	NULL
)	NULL
along	NULL
with	NULL
TRAF3	NULL
or	NULL
TRAF1	NULL
or	NULL
an	NULL
unrelated	NULL
protein	NULL
and	NULL
the	NULL
effect	NULL
on	NULL
the	NULL
association	NULL
of	NULL
endogenous	NULL
heterologous	NULL
TRAFs	NULL
with	NULL
LMP1	NULL
was	NULL
evaluated	NULL
.	NULL

Immunoblots	NULL
of	NULL
cell	NULL
lysates	NULL
indicated	NULL
that	NULL
TRAF1	NULL
levels	NULL
are	NULL
low	NULL
in	NULL
BJAB	NULL
cells	NULL
and	NULL
increased	NULL
with	NULL
LMP1	NULL
expression	NULL
,	NULL
while	NULL
TRAF2	NULL
and	NULL
TRAF3	NULL
are	NULL
constitutively	NULL
expressed	NULL
in	NULL
BJAB	NULL
cells	NULL
.	NULL

In	NULL
each	NULL
instance	NULL
,	NULL
the	NULL
A	NULL
``	NULL
7	NULL
B	NULL
*	NULL
c	NULL
20	NULL
-	NULL
204	NULL
.g	NULL
hs	NULL
.2	NULL
F	NULL
&	NULL
G	NULL
104	NULL
im	NULL
u_	NULL
o	NULL
o	NULL
|	NULL
3X-	NULL
«	NULL
B-L	NULL
(	NULL
Iug	NULL
)	NULL
+	NULL
+o	NULL
+	NULL
+	NULL
Fook	NULL
o	NULL
o+	NULL
+	NULL
F-LMP231	NULL
(	NULL
0.61g	NULL
)	NULL
+o	NULL
+	NULL
+	NULL
+o	NULL
+	NULL
+	NULL
F-TRAF3	NULL
(	NULL
ng	NULL
)	NULL
1004	NULL
F-TRAF3	NULL
(	NULL
345-568	NULL
)	NULL
(	NULL
ug	NULL
)	NULL
20	NULL
4	NULL
FIG	NULL
.	NULL

8	NULL
.	NULL

TRAF3	NULL
or	NULL
TRAF3	NULL
(	NULL
345-568	NULL
)	NULL
repress	NULL
LMP1	NULL
(	NULL
1-231	NULL
)	NULL
-mediated	NULL
NF-kB	NULL
induction	NULL
.	NULL

293	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
1	NULL
pg	NULL
of	NULL
3X-xB-L	NULL
reporter	NULL
plasmid	NULL
,	NULL
0.5	NULL
pg	NULL
of	NULL
pGKBgal	NULL
,	NULL
and	NULL
the	NULL
indicated	NULL
amount	NULL
of	NULL
pSG5	NULL
vector	NULL
expressing	NULL
FLAG-LMP1	NULL
(	NULL
1-231	NULL
)	NULL
(	NULL
F-LMP231	NULL
)	NULL
,	NULL
FLAG-TRAF3	NULL
(	NULL
A	NULL
)	NULL
,	NULL
or	NULL
FLAG-TRAF3	NULL
(	NULL
345-568	NULL
)	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Values	NULL
are	NULL
shown	NULL
as	NULL
the	NULL
mean	NULL
+	NULL
standard	NULL
deviation	NULL
of	NULL
relative	NULL
luciferase	NULL
activity	NULL
from	NULL
one	NULL
representative	NULL
experiment	NULL
of	NULL
three	NULL
,	NULL
in	NULL
which	NULL
the	NULL
transfections	NULL
were	NULL
performed	NULL
in	NULL
triplicate	NULL
or	NULL
duplicate	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

I	NULL
I	NULL
I	NULL
p	NULL
O	NULL
I	NULL
TRAFI	NULL
TRAF3	NULL
-	NULL
-	NULL
-	NULL
-	NULL
40	NULL
EBI3-F	NULL
19	NULL
-	NULL
:	NULL
=	NULL
o=	NULL
F-LMP1	NULL
66	NULL
I	NULL
I	NULL
tn	NULL
in	NULL
in	NULL
€	NULL
--	NULL
TRAF2	NULL
45	NULL
66	NULL
45	NULL
_	NULL
«	NULL
ome	NULL
.	NULL

€-	NULL
TRAFI	NULL
66	NULL
as	NULL
--	NULL
-C	NULL
+-	NULL
TRAF3	NULL
e	NULL
``	NULL
``	NULL
acs	NULL
45	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
FIG	NULL
.	NULL

9	NULL
.	NULL

In	NULL
vivo	NULL
competition	NULL
between	NULL
overexpressed	NULL
TRAF1	NULL
or	NULL
TRAF3	NULL
and	NULL
endogenous	NULL
TRAFs	NULL
for	NULL
binding	NULL
to	NULL
LMP1	NULL
.	NULL

BJAB	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
indicated	NULL
amount	NULL
(	NULL
in	NULL
micrograms	NULL
)	NULL
of	NULL
pSGS	NULL
FLAG-LMP1	NULL
or	NULL
FLAG-EBI3	NULL
(	NULL
4	NULL
)	NULL
together	NULL
with	NULL
TRAF1	NULL
or	NULL
TRAF3	NULL
or	NULL
an	NULL
unrelated	NULL
protein	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Eighteen	NULL
hours	NULL
posttransfection	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
0.5	NULL
%	NULL
NP-40	NULL
lysis	NULL
buffer	NULL
and	NULL
cleared	NULL
lysates	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
M2	NULL
anti-FLAG	NULL
affinity	NULL
gel	NULL
.	NULL

Coprecipitating	NULL
TRAF	NULL
proteins	NULL
were	NULL
detected	NULL
with	NULL
rabbit	NULL
anti-TRAF	NULL
polyclonal	NULL
antibodies	NULL
.	NULL

Blotting	NULL
with	NULL
M5	NULL
anti-FLAG	NULL
antibody	NULL
showed	NULL
that	NULL
a	NULL
similar	NULL
amount	NULL
of	NULL
FLAG-LMP1	NULL
was	NULL
precipitated	NULL
in	NULL
each	NULL
lane	NULL
.	NULL

The	NULL
lower	NULL
amount	NULL
of	NULL
TRAF3	NULL
coprecipitated	NULL
with	NULL
FLAG-LMP1	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
overexpressed	NULL
TRAF1	NULL
was	NULL
not	NULL
observed	NULL
in	NULL
other	NULL
experiments	NULL
.	NULL

The	NULL
band	NULL
present	NULL
just	NULL
below	NULL
TRAF2	NULL
in	NULL
the	NULL
TRAF2	NULL
blot	NULL
corresponds	NULL
to	NULL
immunoglobulins	NULL
which	NULL
cross-react	NULL
with	NULL
TRAF2	NULL
antibody	NULL
.	NULL

levels	NULL
of	NULL
endogenous	NULL
TRAFs	NULL
were	NULL
unaffected	NULL
by	NULL
expression	NULL
of	NULL
a	NULL
heterologous	NULL
TRAF	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Endogenous	NULL
TRAF1	NULL
,	NULL
TRAF2	NULL
,	NULL
and	NULL
TRAF3	NULL
coprecipitated	NULL
with	NULL
FLAG-LMP1	NULL
but	NULL
not	NULL
with	NULL
control	NULL
FLAG-tagged	NULL
EBI3	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

TRAF3	NULL
overexpression	NULL
resulted	NULL
in	NULL
more	NULL
TRAF3	NULL
and	NULL
less	NULL
TRAF1	NULL
or	NULL
TRAF2	NULL
associated	NULL
with	NULL
LMP1	NULL
,	NULL
while	NULL
TRAF1	NULL
overexpression	NULL
resulted	NULL
in	NULL
more	NULL
TRAF1	NULL
and	NULL
less	NULL
TRAF2	NULL
associated	NULL
with	NULL
LMP1	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

In	NULL
most	NULL
experiments	NULL
TRAF3	NULL
association	NULL
with	NULL
LMP1	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
TRAF1	NULL
overexpression	NULL
.	NULL

This	NULL
is	NULL
compatible	NULL
with	NULL
the	NULL
TRAFs	NULL
competing	NULL
for	NULL
the	NULL
same	NULL
site	NULL
and	NULL
with	NULL
a	NULL
binding	NULL
affinity	NULL
of	NULL
TRAF3	NULL
>	NULL
TRAF1	NULL
>	NULL
TRAF2	NULL
,	NULL
as	NULL
was	NULL
indicated	NULL
by	NULL
the	NULL
GST-LMP1	NULL
(	NULL
187-386	NULL
)	NULL
binding	NULL
data	NULL
.	NULL

The	NULL
negative	NULL
effect	NULL
of	NULL
overexpression	NULL
of	NULL
TRAF3	NULL
on	NULL
LMP1	NULL
(	NULL
1-231	NULL
)	NULL
-mediated	NULL
NF-kB	NULL
activation	NULL
is	NULL
therefore	NULL
likely	NULL
due	NULL
to	NULL
TRAF3	NULL
displacement	NULL
of	NULL
endogenous	NULL
TRAF2	NULL
and/or	NULL
TRAF1	NULL
.	NULL

Competition	NULL
experiments	NULL
with	NULL
TRAF2	NULL
overexpression	NULL
are	NULL
not	NULL
reported	NULL
because	NULL
high-level	NULL
TRAF2	NULL
overexpression	NULL
in	NULL
BJAB	NULL
cells	NULL
resulted	NULL
in	NULL
a	NULL
marked	NULL
decrease	NULL
in	NULL
LMP1	NULL
expression	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

TRAF1	NULL
(	NULL
not	NULL
TRAF2	NULL
)	NULL
augments	NULL
LMP1	NULL
(	NULL
1-231	NULL
)	NULL
-mediated	NULL
NF-B	NULL
activation	NULL
;	NULL
RING	NULL
finger-deleted	NULL
TRAF2	NULL
blocks	NULL
NF-B	NULL
activation	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
TRAF1	NULL
.	NULL

Since	NULL
TRAF1	NULL
is	NULL
highly	NULL
associated	NULL
with	NULL
the	NULL
LMP1	NULL
CT	NULL
in	NULL
LCLs	NULL
,	NULL
we	NULL
considered	NULL
the	NULL
possibility	NULL
that	NULL
TRAF1	NULL
might	NULL
have	NULL
a	NULL
role	NULL
in	NULL
LMP1-mediated	NULL
NF-kB	NULL
activation	NULL
.	NULL

Transfection	NULL
of	NULL
293	NULL
cells	NULL
with	NULL
a	NULL
TRAF1	NULL
expression	NULL
vector	NULL
(	NULL
0.25	NULL
or	NULL
1	NULL
ug	NULL
)	NULL
and	NULL
increasing	NULL
amounts	NULL
of	NULL
FLAG-LMP1	NULL
(	NULL
1-231	NULL
)	NULL
expression	NULL
vector	NULL
(	NULL
0.3	NULL
to	NULL
3	NULL
g	NULL
)	NULL
resulted	NULL
in	NULL
at	NULL
least	NULL
a	NULL
threefold	NULL
synergistic	NULL
effect	NULL
on	NULL
NF-KB	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

Vou	NULL
.	NULL

16	NULL
,	NULL
1996	NULL
140	NULL
100	NULL
fold	NULL
activation	NULL
|	NULL
-	NULL
»	NULL
-	NULL
F-LMP231+	NULL
»	NULL
25ugTRAF1	NULL
ao	NULL
|	NULL
|	NULL
-o-	NULL
F-LMPR3T+10gT	NULL
RAFA	NULL
i	NULL
-a-	NULL
F-LMP231	NULL
0	NULL
05	NULL
1	NULL
1.5	NULL
2	NULL
25	NULL
3	NULL
ug	NULL
of	NULL
F-LMP231	NULL
FIG	NULL
.	NULL

10	NULL
.	NULL

TRAF	NULL
]	NULL
acts	NULL
synergistically	NULL
with	NULL
LMP1	NULL
(	NULL
1-231	NULL
)	NULL
to	NULL
augment	NULL
NF-	NULL
«	NULL
B	NULL
transactivation	NULL
.	NULL

293	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
1	NULL
mg	NULL
of	NULL
3X-	NULL
«	NULL
B-L	NULL
reporter	NULL
plasmid	NULL
,	NULL
0.5	NULL
ug	NULL
of	NULL
pGKBgal	NULL
,	NULL
and	NULL
increasing	NULL
concentrations	NULL
(	NULL
0.3	NULL
to	NULL
3	NULL
ug	NULL
)	NULL
of	NULL
pSGS	NULL
FLAG-LMP1	NULL
(	NULL
1-231	NULL
)	NULL
(	NULL
F-LMP231	NULL
)	NULL
,	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
0.25	NULL
or	NULL
1	NULL
ug	NULL
of	NULL
pSGS	NULL
TRAFL	NULL
.	NULL

Values	NULL
shown	NULL
represent	NULL
the	NULL
mean	NULL
+	NULL
standard	NULL
deviation	NULL
of	NULL
relative	NULL
luciferase	NULL
activity	NULL
from	NULL
one	NULL
representative	NULL
experiment	NULL
of	NULL
five	NULL
,	NULL
in	NULL
which	NULL
each	NULL
transfection	NULL
was	NULL
performed	NULL
in	NULL
duplicate	NULL
or	NULL
triplicate	NULL
.	NULL

10	NULL
)	NULL
.	NULL

The	NULL
effect	NULL
was	NULL
dependent	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
,	NULL
and	NULL
TRAF1	NULL
overexpression	NULL
did	NULL
not	NULL
activate	NULL
NF-kB	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
FLAG-LMP1	NULL
(	NULL
1-231	NULL
)	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

TRAF1	NULL
had	NULL
no	NULL
significant	NULL
effect	NULL
on	NULL
NF-kB	NULL
induction	NULL
by	NULL
LMPA188-331	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Although	NULL
TRAF1	NULL
coexpression	NULL
was	NULL
accompanied	NULL
by	NULL
an	NULL
increase	NULL
in	NULL
LMP1	NULL
levels	NULL
in	NULL
some	NULL
experiments	NULL
,	NULL
TRAF1	NULL
synergy	NULL
with	NULL
FLAG-LMP1	NULL
(	NULL
1-231	NULL
)	NULL
can	NULL
only	NULL
be	NULL
due	NULL
in	NULL
small	NULL
measure	NULL
to	NULL
an	NULL
effect	NULL
of	NULL
TRAF1	NULL
on	NULL
FLAG-LMP1	NULL
(	NULL
1-231	NULL
)	NULL
expression	NULL
.	NULL

Cotransfection	NULL
of	NULL
0.6	NULL
or	NULL
1.5	NULL
ug	NULL
of	NULL
FLAG-LMP1	NULL
(	NULL
1-231	NULL
)	NULL
expression	NULL
vector	NULL
together	NULL
with	NULL
TRAF1	NULL
expression	NULL
vector	NULL
resulted	NULL
in	NULL
FLAG-LMP1	NULL
(	NULL
1-231	NULL
)	NULL
levels	NULL
that	NULL
were	NULL
lower	NULL
than	NULL
those	NULL
with	NULL
1.5	NULL
or	NULL
3	NULL
ug	NULL
of	NULL
FLAG-LMP1	NULL
(	NULL
1-231	NULL
)	NULL
expression	NULL
vector	NULL
,	NULL
respectively	NULL
.	NULL

TRAF1	NULL
coexpression	NULL
always	NULL
increased	NULL
NF-xB	NULL
activation	NULL
severalfold	NULL
,	NULL
while	NULL
levels	NULL
of	NULL
LMP1	NULL
(	NULL
1-231	NULL
)	NULL
expression	NULL
above	NULL
that	NULL
achieved	NULL
with	NULL
0.6	NULL
or	NULL
1.5	NULL
ug	NULL
of	NULL
LMP1	NULL
(	NULL
1-231	NULL
)	NULL
expression	NULL
vector	NULL
alone	NULL
resulted	NULL
in	NULL
little	NULL
or	NULL
no	NULL
increase	NULL
in	NULL
NF-kB	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

10	NULL
)	NULL
.	NULL

TRAF1	NULL
coactivation	NULL
required	NULL
the	NULL
TRAF1	NULL
N-terminal	NULL
putative	NULL
Zn	NULL
finger	NULL
domain	NULL
.	NULL

Although	NULL
TRAF1	NULL
with	NULL
aa	NULL
2	NULL
to	NULL
183	NULL
deleted	NULL
[	NULL
TRAF1	NULL
(	NULL
184-416	NULL
)	NULL
]	NULL
is	NULL
similar	NULL
to	NULL
TRAF1	NULL
in	NULL
binding	NULL
to	NULL
GST-LMP1	NULL
(	NULL
187-231	NULL
)	NULL
,	NULL
TRAF1	NULL
(	NULL
184-416	NULL
)	NULL
expression	NULL
did	NULL
not	NULL
enhance	NULL
and	NULL
in	NULL
fact	NULL
decreased	NULL
LMP1	NULL
(	NULL
1-231	NULL
)	NULL
-mediated	NULL
NF-kB	NULL
activation	NULL
(	NULL
P	NULL
=	NULL
0.0026	NULL
;	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
deletion	NULL
may	NULL
affect	NULL
TRAF1	NULL
interaction	NULL
with	NULL
TRAF2	NULL
or	NULL
with	NULL
another	NULL
protein	NULL
in	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
pathway	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
that	NULL
with	NULL
TRAF1	NULL
,	NULL
TRAF	NULL
overexpression	NULL
had	NULL
almost	NULL
no	NULL
effect	NULL
on	NULL
LMP1	NULL
(	NULL
1-231	NULL
)	NULL
-mediated	NULL
NF-B	NULL
activation	NULL
.	NULL

Expression	NULL
of	NULL
TRAF2	NULL
over	NULL
a	NULL
broad	NULL
range	NULL
under	NULL
the	NULL
control	NULL
of	NULL
a	NULL
simian	NULL
virus	NULL
40	NULL
or	NULL
cytomegalovirus	NULL
promoter	NULL
did	NULL
not	NULL
result	NULL
in	NULL
increased	NULL
LMP1	NULL
(	NULL
1-231	NULL
)	NULL
-mediated	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

11A	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

FLAG-LMP1	NULL
(	NULL
1-231	NULL
)	NULL
levels	NULL
were	NULL
not	NULL
reduced	NULL
by	NULL
TRAF2	NULL
expression	NULL
as	NULL
assessed	NULL
by	NULL
Western	NULL
blotting	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
TRAF2	NULL
does	NULL
not	NULL
coactivate	NULL
NF-kB	NULL
with	NULL
LMP1	NULL
(	NULL
1-231	NULL
)	NULL
in	NULL
293	NULL
cells	NULL
.	NULL

Despite	NULL
the	NULL
lack	NULL
of	NULL
synergy	NULL
of	NULL
TRAF2	NULL
with	NULL
LMP1	NULL
(	NULL
1-231	NULL
)	NULL
in	NULL
NF-kB	NULL
activation	NULL
,	NULL
TRAF2	NULL
could	NULL
still	NULL
be	NULL
a	NULL
mediator	NULL
of	NULL
LMP1	NULL
(	NULL
1-231	NULL
)	NULL
activation	NULL
of	NULL
NF-kB	NULL
since	NULL
TRAF2	NULL
is	NULL
constitutively	NULL
expressed	NULL
in	NULL
cells	NULL
,	NULL
can	NULL
bind	NULL
weakly	NULL
to	NULL
the	NULL
LMP1	NULL
TRAF	NULL
binding	NULL
site	NULL
,	NULL
can	NULL
heterodimerize	NULL
with	NULL
TRAF1	NULL
which	NULL
is	NULL
highly	NULL
associated	NULL
with	NULL
LMP1	NULL
,	NULL
and	NULL
can	NULL
activate	NULL
NF-kB	NULL
(	NULL
36	NULL
)	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
TNFR-ASSOCIATED	NULL
FACTORS	NULL
IN	NULL
LMP1-INDUCED	NULL
NF-	NULL
«	NULL
B	NULL
ACTIVATION	NULL
7105	NULL
A	NULL
20	NULL
3	NULL
B	NULL
10	NULL
&	NULL
€	NULL
E	NULL
a	NULL
3X	NULL
4	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
FLMPZ31	NULL
(	NULL
0.6pg	NULL
)	NULL
4	NULL
+	NULL
4	NULL
.	NULL

TRAFZ	NULL
(	NULL
ng	NULL
)	NULL
02s	NULL
-	NULL
0.258	NULL
0.5	NULL
0.5	NULL
pCDNA3	NULL
(	NULL
0.519	NULL
)	NULL
400	NULL
5	NULL
100	NULL
E	NULL
&	NULL
H	NULL
a	NULL
200	NULL
3	NULL
a	NULL
&	NULL
100	NULL
0	NULL
LMPA3T	NULL
(	NULL
Iq	NULL
)	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
pCDNA3	NULL
(	NULL
Ipg	NULL
)	NULL
+	NULL
+	NULL
FIG	NULL
.	NULL

11	NULL
.	NULL

(	NULL
A	NULL
)	NULL
TRAF2	NULL
overexpression	NULL
has	NULL
no	NULL
effect	NULL
on	NULL
LMP1	NULL
(	NULL
1-231	NULL
)	NULL
-mediated	NULL
NF-	NULL
«	NULL
B	NULL
induction	NULL
.	NULL

293	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
3X-	NULL
«	NULL
B-L	NULL
reporter	NULL
plasmid	NULL
,	NULL
0.5	NULL
ug	NULL
of	NULL
pGKBgal	NULL
,	NULL
and	NULL
the	NULL
indicated	NULL
amount	NULL
of	NULL
pSGS	NULL
FLAG-LMP1	NULL
(	NULL
1-231	NULL
)	NULL
(	NULL
F-LMP231	NULL
)	NULL
,	NULL
peDNA3	NULL
TRAF2	NULL
(	NULL
22	NULL
)	NULL
,	NULL
or	NULL
peDNA3	NULL
vector	NULL
control	NULL
.	NULL

FLAG-LMP1	NULL
(	NULL
1-231	NULL
)	NULL
expression	NULL
was	NULL
slightly	NULL
increased	NULL
when	NULL
TRAF2	NULL
was	NULL
coexpressed	NULL
,	NULL
as	NULL
assessed	NULL
by	NULL
Western	NULL
blotting	NULL
with	NULL
anti-FLAG	NULL
antibody	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Values	NULL
are	NULL
shown	NULL
as	NULL
the	NULL
mean	NULL
+	NULL
standard	NULL
deviation	NULL
of	NULL
relative	NULL
luciferase	NULL
activity	NULL
from	NULL
one	NULL
experiment	NULL
of	NULL
two	NULL
,	NULL
in	NULL
which	NULL
each	NULL
transfection	NULL
was	NULL
performed	NULL
in	NULL
triplicate	NULL
.	NULL

(	NULL
B	NULL
)	NULL
RING	NULL
finger-deleted	NULL
TRAF2	NULL
(	NULL
TRAF2A6-86	NULL
)	NULL
blocks	NULL
TRAF1	NULL
coactivation	NULL
of	NULL
LMP1	NULL
(	NULL
1-231	NULL
)	NULL
-mediated	NULL
NF-	NULL
«	NULL
B	NULL
induction	NULL
.	NULL

293	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
3X-	NULL
«	NULL
B-L	NULL
reporter	NULL
plasmid	NULL
,	NULL
1	NULL
mg	NULL
of	NULL
pGKBgal	NULL
,	NULL
and	NULL
the	NULL
indicated	NULL
amount	NULL
of	NULL
pSGS	NULL
LMP1	NULL
(	NULL
1-231	NULL
)	NULL
or	NULL
TRAF1	NULL
or	NULL
of	NULL
peDNA3	NULL
TRAF2A6-86	NULL
(	NULL
22	NULL
)	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
peDNA3	NULL
plasmid	NULL
was	NULL
kept	NULL
constant	NULL
in	NULL
each	NULL
transfection	NULL
.	NULL

Values	NULL
shown	NULL
represent	NULL
the	NULL
mean	NULL
+	NULL
standard	NULL
deviation	NULL
of	NULL
relative	NULL
luciferase	NULL
activity	NULL
from	NULL
three	NULL
experiments	NULL
,	NULL
in	NULL
which	NULL
each	NULL
transfection	NULL
was	NULL
performed	NULL
in	NULL
triplicate	NULL
.	NULL

expression	NULL
of	NULL
the	NULL
dominant-negative	NULL
RING	NULL
finger	NULL
deletion	NULL
mutant	NULL
of	NULL
TRAF2	NULL
which	NULL
was	NULL
previously	NULL
shown	NULL
to	NULL
inhibit	NULL
p80	NULL
TNFR-	NULL
,	NULL
p60	NULL
TNFR-	NULL
,	NULL
and	NULL
CD4O0-mediated	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
(	NULL
14	NULL
,	NULL
36	NULL
)	NULL
strongly	NULL
blocked	NULL
LMP1	NULL
(	NULL
1-231	NULL
)	NULL
-mediated	NULL
NF-KB	NULL
activation	NULL
(	NULL
22	NULL
)	NULL
as	NULL
well	NULL
as	NULL
the	NULL
TRAF1	NULL
synergistic	NULL
effect	NULL
on	NULL
LMP1	NULL
(	NULL
1-231	NULL
)	NULL
-mediated	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

11B	NULL
)	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
the	NULL
RING	NULL
finger-deleted	NULL
TRAF2	NULL
could	NULL
be	NULL
due	NULL
to	NULL
occupancy	NULL
of	NULL
the	NULL
LMP1	NULL
TRAF	NULL
binding	NULL
site	NULL
and	NULL
displacement	NULL
of	NULL
TRAF1	NULL
from	NULL
LMP1	NULL
since	NULL
high-level	NULL
overexpression	NULL
of	NULL
RING	NULL
finger-deleted	NULL
TRAFZ	NULL
in	NULL
BJAB	NULL
cells	NULL
resulted	NULL
in	NULL
decreased	NULL
TRAF2	NULL
and	NULL
also	NULL
TRAF1	NULL
binding	NULL
to	NULL
the	NULL
LMP1	NULL
CT	NULL
in	NULL
experiments	NULL
similar	NULL
to	NULL
those	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

8	NULL
(	NULL
reference	NULL
22	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

DISCUSSION	NULL
These	NULL
data	NULL
on	NULL
the	NULL
biochemical	NULL
interactions	NULL
of	NULL
the	NULL
LMP1	NULL
CT	NULL
with	NULL
each	NULL
of	NULL
the	NULL
known	NULL
TRAFs	NULL
and	NULL
on	NULL
the	NULL
role	NULL
of	NULL
these	NULL
interactions	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
confirm	NULL
and	NULL
extend	NULL
previous	NULL
evidence	NULL
that	NULL
LMP1	NULL
is	NULL
a	NULL
constitutively	NULL
activated	NULL
receptor	NULL
of	NULL
the	NULL
TNFR	NULL
family	NULL
.	NULL

In	NULL
EBV-transformed	NULL
LCLs	NULL
,	NULL
most	NULL
of	NULL
LMPI1	NULL
is	NULL
associated	NULL
with	NULL
TRAF3	NULL
or	NULL
TRAF1	NULL
,	NULL
TRAF3	NULL
and	NULL
TRAF1	NULL
are	NULL
each	NULL
extensively	NULL
complexed	NULL
with	NULL
LMP1	NULL
,	NULL
and	NULL
at	NULL
least	NULL
5	NULL
%	NULL
of	NULL
TRAFZ	NULL
is	NULL
associated	NULL
with	NULL
LMP1	NULL
.	NULL

TRAF1I	NULL
,	NULL
TRAF2	NULL
,	NULL
and	NULL
7106	NULL
DEVERGNE	NULL
ET	NULL
AL	NULL
.	NULL

TRAF3	NULL
,	NULL
together	NULL
,	NULL
constitutively	NULL
occupy	NULL
a	NULL
single	NULL
site	NULL
in	NULL
the	NULL
aa	NULL
187	NULL
to	NULL
231	NULL
domain	NULL
of	NULL
the	NULL
LMP1	NULL
CT	NULL
.	NULL

This	NULL
domain	NULL
is	NULL
sufficient	NULL
for	NULL
transformation	NULL
when	NULL
expressed	NULL
from	NULL
the	NULL
EBV	NULL
genome	NULL
in	NULL
the	NULL
natural	NULL
context	NULL
of	NULL
the	NULL
six	NULL
hydrophobic	NULL
transmembrane	NULL
domains	NULL
of	NULL
the	NULL
LMP1	NULL
which	NULL
enable	NULL
constitutive	NULL
aggregation	NULL
in	NULL
the	NULL
plasma	NULL
membrane	NULL
(	NULL
23	NULL
)	NULL
.	NULL

The	NULL
association	NULL
of	NULL
TRAF1l	NULL
,	NULL
TRAF2	NULL
,	NULL
and	NULL
TRAF3	NULL
with	NULL
an	NULL
NF-	NULL
«	NULL
B-activating	NULL
and	NULL
-trans-forming	NULL
domain	NULL
of	NULL
LMP1	NULL
in	NULL
EBV	NULL
-transformed	NULL
B	NULL
lymphocytes	NULL
implicates	NULL
constitutive	NULL
TRAF	NULL
aggregation	NULL
in	NULL
activation	NULL
and	NULL
transformation	NULL
by	NULL
LMP1	NULL
.	NULL

In	NULL
the	NULL
broad	NULL
context	NULL
of	NULL
TNFR	NULL
signaling	NULL
,	NULL
the	NULL
constitutive	NULL
high-level	NULL
association	NULL
of	NULL
TRAFs	NULL
with	NULL
aggregated	NULL
LMP1	NULL
in	NULL
LCLs	NULL
and	NULL
the	NULL
continuous	NULL
effects	NULL
of	NULL
LMP1	NULL
on	NULL
cell	NULL
growth	NULL
and	NULL
NF-kB	NULL
activation	NULL
are	NULL
compatible	NULL
with	NULL
the	NULL
notion	NULL
that	NULL
the	NULL
TRAFs	NULL
associate	NULL
with	NULL
and	NULL
signal	NULL
from	NULL
aggregated	NULL
TNFRs	NULL
.	NULL

The	NULL
finding	NULL
that	NULL
high-level	NULL
TRAF2	NULL
overexpression	NULL
can	NULL
independently	NULL
activate	NULL
NF-KB	NULL
is	NULL
also	NULL
consistent	NULL
with	NULL
signaling	NULL
being	NULL
dependent	NULL
on	NULL
TRAF	NULL
aggregation	NULL
since	NULL
TRAF2	NULL
can	NULL
homoag-gregate	NULL
(	NULL
36	NULL
,	NULL
37	NULL
)	NULL
.	NULL

TNFRs	NULL
differ	NULL
from	NULL
LMP1	NULL
in	NULL
that	NULL
aggregation	NULL
and	NULL
signaling	NULL
from	NULL
TNFRs	NULL
are	NULL
ligand	NULL
dependent	NULL
.	NULL

An	NULL
expectation	NULL
from	NULL
these	NULL
findings	NULL
is	NULL
that	NULL
TRAFs	NULL
or	NULL
a	NULL
TRAF-interacting	NULL
downstream	NULL
effector	NULL
protein	NULL
will	NULL
associate	NULL
with	NULL
and	NULL
signal	NULL
from	NULL
TNFRs	NULL
only	NULL
in	NULL
response	NULL
to	NULL
ligand	NULL
.	NULL

These	NULL
data	NULL
also	NULL
significantly	NULL
extend	NULL
our	NULL
understanding	NULL
of	NULL
a	NULL
core	NULL
TRAF-interacting	NULL
site	NULL
and	NULL
of	NULL
its	NULL
ability	NULL
to	NULL
directly	NULL
interact	NULL
with	NULL
TRAF1	NULL
,	NULL
TRAF2	NULL
,	NULL
and	NULL
TRAF3	NULL
.	NULL

Previous	NULL
evidence	NULL
indicated	NULL
that	NULL
the	NULL
CD40	NULL
cytoplasmic	NULL
domain	NULL
directly	NULL
interacts	NULL
with	NULL
TRAF3	NULL
and	NULL
TRAF2	NULL
,	NULL
the	NULL
p80	NULL
TNFR	NULL
with	NULL
TRAF2	NULL
and	NULL
through	NULL
TRAF2	NULL
with	NULL
TRAF1	NULL
,	NULL
the	NULL
p60	NULL
TNFR	NULL
with	NULL
TRADD	NULL
and	NULL
through	NULL
TRADD	NULL
with	NULL
TRAF2	NULL
and	NULL
TRAF1	NULL
,	NULL
and	NULL
the	NULL
LMP1	NULL
CT	NULL
aa	NULL
187	NULL
to	NULL
231	NULL
with	NULL
TRAF3	NULL
(	NULL
3	NULL
,	NULL
14	NULL
,	NULL
15	NULL
,	NULL
31	NULL
,	NULL
36	NULL
,	NULL
37	NULL
,	NULL
39	NULL
)	NULL
.	NULL

While	NULL
this	NULL
report	NULL
was	NULL
in	NULL
preparation	NULL
,	NULL
the	NULL
CD30	NULL
cytoplasmic	NULL
domain	NULL
was	NULL
shown	NULL
to	NULL
interact	NULL
with	NULL
TRAF1	NULL
,	NULL
TRAF2	NULL
,	NULL
and	NULL
TRAF3	NULL
(	NULL
7	NULL
,	NULL
25	NULL
)	NULL
,	NULL
providing	NULL
the	NULL
first	NULL
evidence	NULL
that	NULL
all	NULL
three	NULL
TRAFs	NULL
can	NULL
directly	NULL
interact	NULL
with	NULL
a	NULL
TNFR	NULL
.	NULL

We	NULL
have	NULL
now	NULL
demonstrated	NULL
an	NULL
interaction	NULL
between	NULL
the	NULL
LMP1	NULL
CT	NULL
aa	NULL
187	NULL
to	NULL
231	NULL
and	NULL
TRAF3	NULL
or	NULL
TRAF	NULL
]	NULL
in	NULL
the	NULL
yeast	NULL
two-hybrid	NULL
assay	NULL
and	NULL
between	NULL
GST-LMP1	NULL
CT	NULL
and	NULL
TRAF1	NULL
,	NULL
TRAF2	NULL
,	NULL
or	NULL
TRAF3	NULL
translated	NULL
in	NULL
wheat	NULL
germ	NULL
extracts	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
LMP1	NULL
CT	NULL
aa	NULL
187	NULL
to	NULL
231	NULL
site	NULL
resembles	NULL
the	NULL
CD30	NULL
cytoplasmic	NULL
domain	NULL
in	NULL
interacting	NULL
directly	NULL
with	NULL
TRAF1	NULL
,	NULL
TRAF2	NULL
,	NULL
and	NULL
TRAF3	NULL
.	NULL

A	NULL
core	NULL
motif	NULL
through	NULL
which	NULL
several	NULL
TNFRs	NULL
engage	NULL
TRAFs	NULL
had	NULL
not	NULL
been	NULL
previously	NULL
defined	NULL
.	NULL

LMP1	NULL
aa	NULL
199	NULL
to	NULL
214	NULL
are	NULL
sufficient	NULL
for	NULL
high-level	NULL
TRAF3	NULL
binding	NULL
and	NULL
for	NULL
specific	NULL
TRAF1	NULL
and	NULL
TRAF2	NULL
binding	NULL
.	NULL

Mutagenesis	NULL
analyses	NULL
indicate	NULL
that	NULL
10	NULL
aa	NULL
,	NULL
LPHPQQATDD	NULL
,	NULL
are	NULL
a	NULL
sufficient	NULL
core	NULL
TRAF3	NULL
binding	NULL
site	NULL
.	NULL

Several	NULL
similar	NULL
sites	NULL
in	NULL
the	NULL
LMP1s	NULL
of	NULL
the	NULL
rhesus	NULL
and	NULL
baboon	NULL
lymphycryptoviruses	NULL
bind	NULL
TRAF3	NULL
.	NULL

The	NULL
minimal	NULL
consensus	NULL
binding	NULL
site	NULL
that	NULL
emerges	NULL
from	NULL
comparison	NULL
of	NULL
the	NULL
EBV	NULL
and	NULL
other	NULL
lymphycryptovirus	NULL
LMP1	NULL
TRAF	NULL
binding	NULL
sites	NULL
is	NULL
PXQXT/S	NULL
(	NULL
7	NULL
)	NULL
.	NULL

CD40	NULL
has	NULL
a	NULL
similar	NULL
sequence	NULL
,	NULL
TAAPVQET	NULL
LHGC	NULL
,	NULL
and	NULL
the	NULL
boldface	NULL
T	NULL
is	NULL
critical	NULL
for	NULL
TRAF3	NULL
binding	NULL
and	NULL
NF-KB	NULL
activation	NULL
(	NULL
15	NULL
,	NULL
39	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
a	NULL
17-aa	NULL
sequence	NULL
containing	NULL
the	NULL
PVQET	NULL
motif	NULL
has	NULL
been	NULL
defined	NULL
as	NULL
the	NULL
minimum	NULL
TRAF1	NULL
and	NULL
TRAF2	NULL
binding	NULL
site	NULL
in	NULL
CD40	NULL
(	NULL
2	NULL
)	NULL
.	NULL

CD30	NULL
also	NULL
has	NULL
a	NULL
similar	NULL
sequence	NULL
,	NULL
ADHTPHPEQETEPPLG	NULL
,	NULL
which	NULL
can	NULL
mediate	NULL
high-level	NULL
TRAF3	NULL
binding	NULL
(	NULL
7	NULL
)	NULL
.	NULL

A	NULL
yeast	NULL
two-hybrid	NULL
screen	NULL
with	NULL
a	NULL
G4DBD-TRAF3	NULL
gene	NULL
fusion	NULL
as	NULL
bait	NULL
has	NULL
identified	NULL
a	NULL
number	NULL
of	NULL
cDNAs	NULL
that	NULL
encode	NULL
novel	NULL
proteins	NULL
that	NULL
have	NULL
PXQXT/S	NULL
motifs	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Among	NULL
these	NULL
proteins	NULL
was	NULL
TANK	NULL
,	NULL
a	NULL
novel	NULL
protein	NULL
which	NULL
was	NULL
shown	NULL
to	NULL
interact	NULL
with	NULL
TRAF2	NULL
and	NULL
TRAF3	NULL
through	NULL
a	NULL
21-aa	NULL
peptide	NULL
centered	NULL
around	NULL
a	NULL
PIQCT	NULL
motif	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
PXQXT/S	NULL
appears	NULL
to	NULL
be	NULL
a	NULL
frequent	NULL
core	NULL
TRAF	NULL
binding	NULL
site	NULL
.	NULL

PXQXT/S	NULL
is	NULL
not	NULL
the	NULL
only	NULL
sequence	NULL
that	NULL
can	NULL
engage	NULL
TRAF	NULL
proteins	NULL
,	NULL
since	NULL
the	NULL
p80	NULL
TNFR	NULL
cytoplasmic	NULL
domain	NULL
does	NULL
not	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

have	NULL
a	NULL
PXQXT/S	NULL
motif	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
surrounding	NULL
context	NULL
is	NULL
important	NULL
for	NULL
the	NULL
binding	NULL
of	NULL
TRAFs	NULL
to	NULL
the	NULL
core	NULL
residues	NULL
as	NULL
is	NULL
evidenced	NULL
by	NULL
the	NULL
finding	NULL
that	NULL
several	NULL
PXQXT/S	NULL
sites	NULL
in	NULL
the	NULL
rhesus	NULL
,	NULL
baboon	NULL
,	NULL
or	NULL
human	NULL
LMP1	NULL
do	NULL
not	NULL
bind	NULL
TRAF3	NULL
(	NULL
reference	NULL
7	NULL
and	NULL
this	NULL
study	NULL
)	NULL
and	NULL
by	NULL
the	NULL
alanine	NULL
mutagenesis	NULL
results	NULL
that	NULL
indicate	NULL
that	NULL
residues	NULL
N	NULL
terminal	NULL
and	NULL
CT	NULL
to	NULL
the	NULL
core	NULL
motif	NULL
are	NULL
important	NULL
for	NULL
high-level	NULL
TRAF	NULL
interaction	NULL
.	NULL

Moreover	NULL
,	NULL
differences	NULL
in	NULL
the	NULL
extent	NULL
of	NULL
binding	NULL
of	NULL
TRAF1	NULL
,	NULL
-2	NULL
,	NULL
or	NULL
-3	NULL
to	NULL
the	NULL
core	NULL
site	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
LMP1	NULL
CT	NULL
aa	NULL
199	NULL
to	NULL
214	NULL
versus	NULL
the	NULL
LMP1	NULL
CT	NULL
aa	NULL
187	NULL
to	NULL
231	NULL
or	NULL
the	NULL
whole	NULL
LMP1	NULL
CT	NULL
illustrate	NULL
the	NULL
effects	NULL
of	NULL
broader	NULL
sequence	NULL
contexts	NULL
on	NULL
TRAF	NULL
interaction	NULL
.	NULL

A	NULL
surprising	NULL
aspect	NULL
of	NULL
these	NULL
data	NULL
is	NULL
that	NULL
TRAF1	NULL
and	NULL
TRAF2	NULL
are	NULL
both	NULL
implicated	NULL
in	NULL
LMP1	NULL
(	NULL
1-231	NULL
)	NULL
-induced	NULL
NF-kB	NULL
activation	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
core	NULL
TRAF	NULL
binding	NULL
site	NULL
in	NULL
LMP1	NULL
(	NULL
1-231	NULL
)	NULL
substantially	NULL
reduces	NULL
TRAF1	NULL
and	NULL
TRAF2	NULL
binding	NULL
and	NULL
NF-kB	NULL
activation	NULL
,	NULL
thereby	NULL
linking	NULL
the	NULL
binding	NULL
and	NULL
aggregation	NULL
of	NULL
TRAF1	NULL
or	NULL
TRAF2	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

TRAF1	NULL
is	NULL
induced	NULL
by	NULL
LMP1	NULL
and	NULL
extensively	NULL
associates	NULL
with	NULL
LMP1	NULL
in	NULL
LCLs	NULL
,	NULL
while	NULL
TRAF2	NULL
is	NULL
constitutively	NULL
expressed	NULL
and	NULL
is	NULL
less	NULL
extensively	NULL
associated	NULL
with	NULL
LMP1	NULL
.	NULL

Most	NULL
importantly	NULL
,	NULL
TRAF1	NULL
substantially	NULL
co-activates	NULL
NF-kB	NULL
when	NULL
expressed	NULL
in	NULL
cells	NULL
along	NULL
with	NULL
LMP1	NULL
(	NULL
1-231	NULL
)	NULL
and	NULL
TRAF2	NULL
does	NULL
not	NULL
.	NULL

The	NULL
failure	NULL
of	NULL
TRAF2	NULL
to	NULL
coactivate	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
not	NULL
evidence	NULL
against	NULL
a	NULL
role	NULL
for	NULL
TRAF2	NULL
,	NULL
since	NULL
TRAF2	NULL
is	NULL
constitutively	NULL
expressed	NULL
and	NULL
may	NULL
be	NULL
already	NULL
in	NULL
excess	NULL
.	NULL

How-ever	NULL
,	NULL
the	NULL
unique	NULL
coactivating	NULL
effects	NULL
of	NULL
TRAF1	NULL
are	NULL
evident	NULL
despite	NULL
the	NULL
putative	NULL
TRAF2	NULL
excess	NULL
.	NULL

Thus	NULL
,	NULL
TRAF1	NULL
has	NULL
a	NULL
role	NULL
in	NULL
LMP1-mediated	NULL
NF-kB	NULL
activation	NULL
which	NULL
can	NULL
not	NULL
be	NULL
filled	NULL
by	NULL
TRAFZ	NULL
.	NULL

Further	NULL
,	NULL
TRAF1	NULL
and	NULL
TRAF2	NULL
can	NULL
heterodimerize	NULL
in	NULL
the	NULL
yeast	NULL
two-hybrid	NULL
assay	NULL
(	NULL
36	NULL
,	NULL
37	NULL
)	NULL
,	NULL
and	NULL
we	NULL
have	NULL
now	NULL
demonstrated	NULL
that	NULL
TRAF1	NULL
and	NULL
TRAFZ2	NULL
complexes	NULL
exist	NULL
in	NULL
vivo	NULL
in	NULL
LCLs	NULL
.	NULL

Moreover	NULL
,	NULL
a	NULL
dominant-negative	NULL
RING	NULL
finger	NULL
deletion	NULL
mutant	NULL
of	NULL
TRAF2	NULL
can	NULL
block	NULL
LMP1	NULL
(	NULL
1-231	NULL
)	NULL
-mediated	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
(	NULL
22	NULL
)	NULL
and	NULL
TRAF1	NULL
coactivation	NULL
.	NULL

The	NULL
simplest	NULL
model	NULL
to	NULL
explain	NULL
these	NULL
effects	NULL
is	NULL
that	NULL
TRAF1	NULL
binds	NULL
preferentially	NULL
to	NULL
the	NULL
LMP1	NULL
CT	NULL
and	NULL
recruits	NULL
TRAF2	NULL
which	NULL
in	NULL
turn	NULL
mediates	NULL
NF-kB	NULL
activation	NULL
.	NULL

TRAF1	NULL
may	NULL
have	NULL
a	NULL
similar	NULL
role	NULL
in	NULL
activation	NULL
by	NULL
other	NULL
TNFRs	NULL
,	NULL
to	NULL
which	NULL
it	NULL
binds	NULL
with	NULL
higher	NULL
affinity	NULL
than	NULL
TRAF2	NULL
.	NULL

TRAF3	NULL
is	NULL
extensively	NULL
associated	NULL
with	NULL
the	NULL
LMP1	NULL
TRAF	NULL
binding	NULL
site	NULL
in	NULL
LCLs	NULL
,	NULL
binds	NULL
strongly	NULL
to	NULL
the	NULL
site	NULL
,	NULL
and	NULL
in	NULL
gene	NULL
transfer-mediated	NULL
overexpression	NULL
downregulates	NULL
NF-	NULL
«	NULL
kB	NULL
activation	NULL
from	NULL
LMP1	NULL
(	NULL
1-231	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
high	NULL
level	NULL
of	NULL
TRAF3	NULL
binding	NULL
to	NULL
LMP1	NULL
may	NULL
dampen	NULL
activation	NULL
by	NULL
LMP1	NULL
in	NULL
EBV-transformed	NULL
LCLs	NULL
.	NULL

TRAF1	NULL
,	NULL
TRAF2	NULL
,	NULL
and	NULL
TRAF3	NULL
did	NULL
not	NULL
bind	NULL
to	NULL
the	NULL
LMP1	NULL
CT	NULL
aa	NULL
333	NULL
to	NULL
386	NULL
domain	NULL
which	NULL
has	NULL
a	NULL
strong	NULL
NF-kB	NULL
activating	NULL
effect	NULL
and	NULL
did	NULL
not	NULL
significantly	NULL
affect	NULL
NF-kB	NULL
induction	NULL
by	NULL
this	NULL
domain	NULL
.	NULL

Further	NULL
,	NULL
the	NULL
dominant-negative	NULL
RING	NULL
finger	NULL
TRAF2	NULL
has	NULL
a	NULL
much	NULL
smaller	NULL
inhibiting	NULL
effect	NULL
on	NULL
LMPA188-331-mediated	NULL
activation	NULL
than	NULL
on	NULL
LMP1	NULL
(	NULL
1-231	NULL
)	NULL
-mediated	NULL
NF-kB	NULL
activation	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
data	NULL
indicate	NULL
that	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
the	NULL
LMP1	NULL
CT	NULL
aa	NULL
332	NULL
to	NULL
386	NULL
domain	NULL
is	NULL
not	NULL
mediated	NULL
by	NULL
direct	NULL
interaction	NULL
with	NULL
TRAF1	NULL
,	NULL
TRAF2	NULL
,	NULL
or	NULL
TRAF3	NULL
.	NULL

The	NULL
extensive	NULL
association	NULL
of	NULL
LMP1	NULL
with	NULL
TRAF3	NULL
and	NULL
TRAF1	NULL
rather	NULL
than	NULL
with	NULL
TRAF2	NULL
in	NULL
LCLs	NULL
is	NULL
consistent	NULL
with	NULL
a	NULL
model	NULL
in	NULL
which	NULL
TRAF3	NULL
and	NULL
TRAF1	NULL
dominate	NULL
over	NULL
TRAF2	NULL
for	NULL
direct	NULL
occupancy	NULL
of	NULL
the	NULL
LMP1	NULL
CT	NULL
TRAF	NULL
binding	NULL
site	NULL
.	NULL

The	NULL
differential	NULL
association	NULL
of	NULL
TRAFs	NULL
with	NULL
the	NULL
LMP1	NULL
CT	NULL
in	NULL
LCLs	NULL
may	NULL
also	NULL
be	NULL
affected	NULL
by	NULL
their	NULL
differential	NULL
affinity	NULL
for	NULL
other	NULL
proteins	NULL
,	NULL
including	NULL
TNFRs	NULL
.	NULL

Several	NULL
TNFRs	NULL
are	NULL
abundantly	NULL
expressed	NULL
in	NULL
LCLs	NULL
and	NULL
in	NULL
other	NULL
cells	NULL
in	NULL
which	NULL
LMP1	NULL
is	NULL
expressed	NULL
,	NULL
including	NULL
Hodgkin	NULL
's	NULL
disease	NULL
Reed	NULL
Sternberg	NULL
cells	NULL
and	NULL
nasopharyngeal	NULL
carcinoma	NULL
cells	NULL
.	NULL

CD40	NULL
can	NULL
bind	NULL
TRAF3	NULL
and	NULL
TRAF2	NULL
,	NULL
p80	NULL
TNFR	NULL
can	NULL
bind	NULL
TRAF2	NULL
,	NULL
TRAF3	NULL
,	NULL
and	NULL
TRAF1/TRAF2	NULL
het-erodimers	NULL
,	NULL
LTBR	NULL
can	NULL
bind	NULL
TRAF3	NULL
,	NULL
and	NULL
CD30	NULL
can	NULL
bind	NULL
TRAF1	NULL
,	NULL
TRAF2	NULL
,	NULL
and	NULL
TRAF3	NULL
.	NULL

Different	NULL
TRAF	NULL
complexes	NULL
Vou	NULL
.	NULL

16	NULL
,	NULL
1996	NULL
forming	NULL
at	NULL
aggregated	NULL
TNFR	NULL
cytoplasmic	NULL
tails	NULL
may	NULL
be	NULL
the	NULL
basis	NULL
for	NULL
signaling	NULL
specificity	NULL
from	NULL
these	NULL
receptors	NULL
.	NULL

Continued	NULL
signaling	NULL
through	NULL
p80	NULL
TNFR	NULL
appears	NULL
to	NULL
contribute	NULL
to	NULL
the	NULL
growth	NULL
of	NULL
EBV-transformed	NULL
B	NULL
lymphocytes	NULL
(	NULL
5	NULL
,	NULL
8	NULL
)	NULL
and	NULL
may	NULL
affect	NULL
LMP1	NULL
signaling	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
differential	NULL
association	NULL
of	NULL
TRAFs	NULL
with	NULL
TNFRs	NULL
in	NULL
LCLs	NULL
may	NULL
affect	NULL
their	NULL
individual	NULL
association	NULL
with	NULL
the	NULL
LMP1	NULL
CT	NULL
,	NULL
and	NULL
the	NULL
extensive	NULL
association	NULL
of	NULL
TRAF1	NULL
and	NULL
TRAF3	NULL
with	NULL
the	NULL
LMP1	NULL
CT	NULL
almost	NULL
certainly	NULL
affects	NULL
their	NULL
availability	NULL
for	NULL
signaling	NULL
from	NULL
TNFRs	NULL
.	NULL

NF-xB	NULL
activation	NULL
through	NULL
the	NULL
TRAF	NULL
binding	NULL
site	NULL
is	NULL
probably	NULL
only	NULL
important	NULL
in	NULL
primary	NULL
B-lymphocyte	NULL
transformation	NULL
by	NULL
the	NULL
LMP1	NULL
(	NULL
1-231	NULL
)	NULL
recombinant	NULL
EBV	NULL
since	NULL
this	NULL
recombinant	NULL
lacks	NULL
the	NULL
LMP1	NULL
CT	NULL
332	NULL
to	NULL
386	NULL
domain	NULL
that	NULL
independently	NULL
conveys	NULL
70	NULL
to	NULL
80	NULL
%	NULL
of	NULL
the	NULL
NF-KB	NULL
activity	NULL
.	NULL

However	NULL
this	NULL
domain	NULL
must	NULL
be	NULL
important	NULL
in	NULL
mediating	NULL
other	NULL
LMP1	NULL
effects	NULL
,	NULL
including	NULL
lymphocyte	NULL
activation	NULL
,	NULL
adhesion	NULL
,	NULL
growth	NULL
,	NULL
or	NULL
survival	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
LMP1	NULL
with	NULL
the	NULL
TRAF	NULL
binding	NULL
site	NULL
deleted	NULL
induces	NULL
near	NULL
wild-type	NULL
NF-kB	NULL
activation	NULL
,	NULL
but	NULL
recombinant	NULL
EBV	NULL
genomes	NULL
with	NULL
this	NULL
deletion	NULL
are	NULL
unable	NULL
to	NULL
transform	NULL
primary	NULL
B	NULL
lymphocytes	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Together	NULL
with	NULL
the	NULL
previous	NULL
data	NULL
that	NULL
LMP1	NULL
(	NULL
1-231	NULL
)	NULL
is	NULL
sufficient	NULL
for	NULL
primary	NULL
B-lymphocyte	NULL
growth	NULL
transformation	NULL
(	NULL
21	NULL
)	NULL
,	NULL
these	NULL
data	NULL
indicate	NULL
that	NULL
the	NULL
TRAF	NULL
binding	NULL
domain	NULL
has	NULL
essential	NULL
transforming	NULL
role	NULL
(	NULL
s	NULL
)	NULL
distinct	NULL
from	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

TRAF3	NULL
,	NULL
TRAF1	NULL
,	NULL
and	NULL
TRAF2	NULL
are	NULL
the	NULL
only	NULL
proteins	NULL
that	NULL
have	NULL
been	NULL
identified	NULL
to	NULL
interact	NULL
with	NULL
the	NULL
transformation-sufficient	NULL
aa	NULL
187	NULL
to	NULL
231	NULL
domain	NULL
.	NULL

Thus	NULL
,	NULL
TRAF3	NULL
,	NULL
TRAF1	NULL
,	NULL
and	NULL
TRAF1/TRAF2	NULL
heteroaggregates	NULL
almost	NULL
certainly	NULL
mediate	NULL
LMP1	NULL
activation	NULL
,	NULL
adhesion	NULL
,	NULL
growth-enhancing	NULL
,	NULL
and	NULL
survival	NULL
effects	NULL
in	NULL
addition	NULL
to	NULL
low-level	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

TRAF3	NULL
,	NULL
TRAF1I	NULL
,	NULL
or	NULL
TRAFI/	NULL
TRAFZ	NULL
heteroaggregates	NULL
are	NULL
likely	NULL
to	NULL
mediate	NULL
similar	NULL
effects	NULL
from	NULL
activated	NULL
TNFRs	NULL
.	NULL

One	NULL
potentially	NULL
unique	NULL
effect	NULL
of	NULL
TRAF1/TRAF2	NULL
heteroaggregates	NULL
is	NULL
in	NULL
recruiting	NULL
inhibitor	NULL
of	NULL
apoptosis	NULL
proteins	NULL
(	NULL
35	NULL
)	NULL
which	NULL
may	NULL
enhance	NULL
cell	NULL
survival	NULL
under	NULL
conditions	NULL
that	NULL
would	NULL
otherwise	NULL
result	NULL
in	NULL
apoptosis	NULL
(	NULL
28	NULL
)	NULL
.	NULL

The	NULL
mechanisms	NULL
of	NULL
these	NULL
and	NULL
other	NULL
cell	NULL
growth	NULL
and	NULL
survival	NULL
effects	NULL
remain	NULL
to	NULL
be	NULL
elucidated	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
Genhong	NULL
Cheng	NULL
,	NULL
David	NULL
Baltimore	NULL
,	NULL
Michael	NULL
Franken	NULL
,	NULL
and	NULL
Fred	NULL
Wang	NULL
shared	NULL
their	NULL
results	NULL
prior	NULL
to	NULL
publication	NULL
.	NULL

Thomas	NULL
Mitchell	NULL
and	NULL
Bill	NULL
Sugden	NULL
contributed	NULL
the	NULL
3X-	NULL
«	NULL
B-L	NULL
,	NULL
and	NULL
SV2LMPA188-331	NULL
constructs	NULL
.	NULL

X.	NULL
Qian	NULL
Miso	NULL
,	NULL
Lisa	NULL
Vara	NULL
,	NULL
Josephine	NULL
Harada	NULL
,	NULL
and	NULL
Heather	NULL
Atkins	NULL
provided	NULL
technical	NULL
assistance	NULL
,	NULL
and	NULL
Alejandro	NULL
Chevaile	NULL
provided	NULL
assistance	NULL
with	NULL
statistical	NULL
analysis	NULL
.	NULL

EH	NULL
.	NULL

made	NULL
a	NULL
major	NULL
contribution	NULL
in	NULL
doing	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
experiments	NULL
.	NULL

The	NULL
LCL	NULL
transformed	NULL
by	NULL
an	NULL
EBV	NULL
recombinant	NULL
with	NULL
a	NULL
FLAG-epitope	NULL
gene	NULL
fusion	NULL
in	NULL
the	NULL
LMP1	NULL
N-terminal	NULL
cytoplasmic	NULL
domain	NULL
was	NULL
made	NULL
by	NULL
K.M.L	NULL
.	NULL

This	NULL
research	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
CA47006	NULL
(	NULL
E.K	NULL
.	NULL
)	NULL

,	NULL
CA67380-02	NULL
(	NULL
K.M.K	NULL
.	NULL
)	NULL

and	NULL
CA01568-04	NULL
(	NULL
K.M.K	NULL
.	NULL
)	NULL

from	NULL
the	NULL
National	NULL
Cancer	NULL
Institute	NULL
of	NULL
the	NULL
USPHS	NULL
.	NULL

G.M	NULL
.	NULL

is	NULL
a	NULL
postdoctoral	NULL
fellow	NULL
of	NULL
the	NULL
Leukemia	NULL
Society	NULL
of	NULL
America	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Banchereau	NULL
,	NULL
J.	NULL
,	NULL
F.	NULL
Bazan	NULL
,	NULL
D.	NULL
Blanchard	NULL
,	NULL
F.	NULL
Briere	NULL
,	NULL
J.	NULL
P.	NULL
Galizzi	NULL
,	NULL
C.	NULL
van	NULL
Kooten	NULL
,	NULL
Y.	NULL
J.	NULL
Liu	NULL
,	NULL
F.	NULL
Rousset	NULL
,	NULL
and	NULL
S.	NULL
Saeland	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
CD40	NULL
antigen	NULL
and	NULL
its	NULL
ligand	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12:881-922	NULL
.	NULL

2	NULL
.	NULL

Cheng	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1996	NULL
.	NULL

TANK	NULL
,	NULL
a	NULL
co-inducer	NULL
with	NULL
TRAF2	NULL
of	NULL
TNF-	NULL
and	NULL
CD40L-mediated	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

10:963-973	NULL
.	NULL

3	NULL
.	NULL

Cheng	NULL
,	NULL
G.	NULL
,	NULL
A.	NULL
M.	NULL
Cleary	NULL
,	NULL
Z.	NULL
S.	NULL
Ye	NULL
,	NULL
D.	NULL
I.	NULL
Hong	NULL
,	NULL
S.	NULL
Lederman	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1995	NULL
.	NULL

Involvement	NULL
of	NULL
CRAF1	NULL
,	NULL
a	NULL
relative	NULL
of	NULL
TRAF	NULL
,	NULL
in	NULL
CD40	NULL
signaling	NULL
.	NULL

Science	NULL
267:1494-1497	NULL
.	NULL

4	NULL
.	NULL

Devergne	NULL
,	NULL
O.	NULL
,	NULL
M.	NULL
Hummel	NULL
,	NULL
H.	NULL
Koeppen	NULL
,	NULL
M.	NULL
Le	NULL
Beau	NULL
,	NULL
E.	NULL
C.	NULL
Nathanson	NULL
,	NULL
E.	NULL
Kieff	NULL
,	NULL
and	NULL
M.	NULL
Birkenbach	NULL
.	NULL

1996	NULL
.	NULL

A	NULL
novel	NULL
interleukin-12	NULL
p40	NULL
related	NULL
protein	NULL
induced	NULL
by	NULL
latent	NULL
Epstein-Barr	NULL
virus	NULL
infection	NULL
in	NULL
B	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

70:1143-1153	NULL
.	NULL

5	NULL
.	NULL

Estrov	NULL
,	NULL
Z.	NULL
,	NULL
R.	NULL
Kurzrock	NULL
,	NULL
E.	NULL
Pocsik	NULL
,	NULL
S.	NULL
Pathak	NULL
,	NULL
H.	NULL
M.	NULL
Kantarjian	NULL
,	NULL
T.	NULL
F.	NULL
Zipf	NULL
,	NULL
D.	NULL
Harris	NULL
,	NULL
M.	NULL
Talpaz	NULL
,	NULL
and	NULL
B	NULL
.	NULL

B.	NULL
Aggarwal	NULL
.	NULL

1993	NULL
.	NULL

Lymphotoxin	NULL
is	NULL
an	NULL
autocrine	NULL
growth	NULL
factor	NULL
for	NULL
Epstein-Barr	NULL
virus-infected	NULL
cell	NULL
lines	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

177	NULL
:	NULL
763-774	NULL
.	NULL

6	NULL
.	NULL

Fennewald	NULL
,	NULL
S.	NULL
,	NULL
V.	NULL
van	NULL
Santen	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

1984	NULL
.	NULL

Nucleotide	NULL
sequence	NULL
of	NULL
an	NULL
TNFR-ASSOCIATED	NULL
FACTORS	NULL
IN	NULL
LMP1-INDUCED	NULL
NF-	NULL
«	NULL
B	NULL
ACTIVATION	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

7107	NULL
mRNA	NULL
transcribed	NULL
in	NULL
latent	NULL
growth-transforming	NULL
virus	NULL
infection	NULL
indicates	NULL
it	NULL
may	NULL
encode	NULL
a	NULL
membrane	NULL
protein	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

51:411-419.	NULL
.	NULL

Franken	NULL
,	NULL
M.	NULL
,	NULL
O.	NULL
Devergne	NULL
,	NULL
M.	NULL
Rosenzweig	NULL
,	NULL
B.	NULL
Annis	NULL
,	NULL
E.	NULL
Kieff	NULL
,	NULL
and	NULL
F.	NULL
Wang	NULL
.	NULL

1996	NULL
.	NULL

Comparative	NULL
analysis	NULL
identifies	NULL
conserved	NULL
tumor	NULL
necrosis	NULL
factor	NULL
recep-tor-associated	NULL
factor	NULL
3	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
human	NULL
and	NULL
simian	NULL
Epstein-Barr	NULL
virus	NULL
oncogene	NULL
LMP1	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

70:7819-7826.	NULL
.	NULL

Gibbons	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
M.	NULL
Rowe	NULL
,	NULL
A.	NULL
P.	NULL
Pope	NULL
,	NULL
M.	NULL
Feldmann	NULL
,	NULL
and	NULL
F.	NULL
M.	NULL
Brennan	NULL
.	NULL

1994	NULL
.	NULL

Lymphotoxin	NULL
acts	NULL
as	NULL
an	NULL
autocrine	NULL
growth	NULL
factor	NULL
for	NULL
Epstein-Barr	NULL
virus	NULL
transformed	NULL
B	NULL
cells	NULL
and	NULL
differentiated	NULL
Burkitt	NULL
lymphoma	NULL
cell	NULL
lines	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

24:1879-1885.	NULL
.	NULL

Graham	NULL
,	NULL
F.	NULL
L.	NULL
,	NULL
and	NULL
A.	NULL
J	NULL
.	NULL

Van	NULL
Der	NULL
Eb	NULL
.	NULL

1973	NULL
.	NULL

A	NULL
new	NULL
technique	NULL
for	NULL
the	NULL
assay	NULL
of	NULL
infectivity	NULL
of	NULL
human	NULL
adenovirus	NULL
5	NULL
DNA	NULL
.	NULL

Virology	NULL
52:456-467	NULL
.	NULL

Hatzivassiliou	NULL
,	NULL
E.	NULL
,	NULL
P.	NULL
Cardot	NULL
,	NULL
V.	NULL
Zannis	NULL
,	NULL
and	NULL
A.	NULL
Mitsialis	NULL
.	NULL

Usp-a	NULL
Drosoph-ila	NULL
RXRa	NULL
homolog	NULL
can	NULL
mobilize	NULL
the	NULL
human	NULL
thyroid	NULL
hormone	NULL
receptor	NULL
to	NULL
transactivate	NULL
the	NULL
human	NULL
apolipoprotein	NULL
A-II	NULL
promoter	NULL
.	NULL

Submitted	NULL
for	NULL
publication	NULL
.	NULL

Henderson	NULL
,	NULL
S.	NULL
,	NULL
M.	NULL
Rowe	NULL
,	NULL
C.	NULL
Gregory	NULL
,	NULL
D.	NULL
Croom-Carter	NULL
,	NULL
F.	NULL
Wang	NULL
,	NULL
R.	NULL
Long-necker	NULL
,	NULL
E.	NULL
Kieff	NULL
,	NULL
and	NULL
A.	NULL
Rickinson	NULL
.	NULL

1991	NULL
.	NULL

Induction	NULL
of	NULL
bel-2	NULL
expression	NULL
by	NULL
Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein	NULL
1	NULL
protects	NULL
infected	NULL
B	NULL
cells	NULL
from	NULL
programmed	NULL
cell	NULL
death	NULL
.	NULL

Cell	NULL
65:1107-1115	NULL
.	NULL

Hennessy	NULL
,	NULL
K.	NULL
,	NULL
S.	NULL
Fennewald	NULL
,	NULL
M.	NULL
Hummel	NULL
,	NULL
T.	NULL
Cole	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

1984	NULL
.	NULL

A	NULL
membrane	NULL
protein	NULL
encoded	NULL
by	NULL
Epstein-Barr	NULL
virus	NULL
in	NULL
latent	NULL
growth-transforming	NULL
infection	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
81:7201-7211	NULL
.	NULL

Hiutson	NULL
,	NULL
A	NULL
.	NULL

1980	NULL
.	NULL

The	NULL
analysis	NULL
of	NULL
variance	NULL
:	NULL
a	NULL
basic	NULL
course	NULL
.	NULL

Charles	NULL
Griffin	NULL
and	NULL
Co.	NULL
,	NULL
London	NULL
.	NULL

Hsu	NULL
,	NULL
H.	NULL
,	NULL
H.	NULL
B.	NULL
Shu	NULL
,	NULL
M.	NULL
G.	NULL
Pan	NULL
,	NULL
and	NULL
D.	NULL
Goeddel	NULL
.	NULL

1996	NULL
.	NULL

TRADD-TRAF2	NULL
and	NULL
TRADD-FADD	NULL
interactions	NULL
define	NULL
two	NULL
distinct	NULL
TNF	NULL
receptor	NULL
1	NULL
signal	NULL
transduction	NULL
pathways	NULL
.	NULL

Cell	NULL
84:299-308	NULL
.	NULL

Hu	NULL
,	NULL
H.	NULL
,	NULL
K.	NULL
O'Rourke	NULL
,	NULL
M.	NULL
S.	NULL
Boguski	NULL
,	NULL
and	NULL
V.	NULL
M.	NULL
Dixit	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
novel	NULL
RING	NULL
finger	NULL
protein	NULL
interacts	NULL
with	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
CD40	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:30069-30072	NULL
.	NULL

Huen	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
S.	NULL
A.	NULL
Henderson	NULL
,	NULL
D.	NULL
Croom-Carter	NULL
,	NULL
and	NULL
M.	NULL
Rowe	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein-1	NULL
(	NULL
LMP1	NULL
)	NULL
mediates	NULL
activation	NULL
of	NULL
NF-xB	NULL
and	NULL
cell	NULL
surface	NULL
phenotype	NULL
via	NULL
two	NULL
effector	NULL
regions	NULL
in	NULL
its	NULL
carboxy-terminal	NULL
cytoplasmic	NULL
domain	NULL
.	NULL

Oncogene	NULL
10:549-560	NULL
.	NULL

Inui	NULL
,	NULL
S.	NULL
,	NULL
T.	NULL
Kaisho	NULL
,	NULL
H.	NULL
Kikutani	NULL
,	NULL
I.	NULL
Stamenkovic	NULL
,	NULL
B	NULL
.	NULL

Seed	NULL
,	NULL
E.	NULL
A.	NULL
Clark	NULL
,	NULL
and	NULL
T.	NULL
Kishimoto	NULL
.	NULL

1990	NULL
.	NULL

Identification	NULL
of	NULL
the	NULL
intracytoplasmic	NULL
region	NULL
essential	NULL
for	NULL
signal	NULL
transduction	NULL
through	NULL
a	NULL
B	NULL
cell	NULL
activation	NULL
molecule	NULL
,	NULL
CD40	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

20:1747-1753.	NULL
.	NULL

Izumi	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
K.	NULL
M.	NULL
Kaye	NULL
,	NULL
and	NULL
E.	NULL
Kief	NULL
.	NULL

1994	NULL
.	NULL

Epstcin-Barr	NULL
virus	NULL
recombinant	NULL
molecular	NULL
genetic	NULL
analysis	NULL
of	NULL
the	NULL
LMP1	NULL
amino-terminal	NULL
cytoplasmic	NULL
domain	NULL
reveals	NULL
a	NULL
probable	NULL
structural	NULL
role	NULL
,	NULL
with	NULL
no	NULL
component	NULL
essential	NULL
for	NULL
primary	NULL
B-lymphocyte	NULL
growth	NULL
transformation	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

68:4369-4376	NULL
.	NULL

Izumi	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
K.	NULL
M.	NULL
Kaye	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

Kaye	NULL
,	NULL
K.	NULL
,	NULL
K.	NULL
Izumi	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

1993	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein	NULL
1	NULL
is	NULL
essential	NULL
for	NULL
B	NULL
lymphocyte	NULL
transformation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:9150-9154	NULL
.	NULL

Kaye	NULL
,	NULL
K.	NULL
,	NULL
K.	NULL
M.	NULL
Izumi	NULL
,	NULL
G.	NULL
Mosialos	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
Epstein-Barr	NULL
virus	NULL
LMP1	NULL
cytoplasmic	NULL
carboxy	NULL
terminus	NULL
is	NULL
essential	NULL
for	NULL
B	NULL
lymphocyte	NULL
transformation	NULL
;	NULL
fibroblast	NULL
cocultivation	NULL
complements	NULL
a	NULL
critical	NULL
function	NULL
within	NULL
the	NULL
terminal	NULL
155	NULL
residues	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:675-683	NULL
.	NULL

Kaye	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
O.	NULL
Devergne	NULL
,	NULL
J.	NULL
N.	NULL
Harada	NULL
,	NULL
K.	NULL
M.	NULL
Izumi	NULL
,	NULL
R.	NULL
Yalamanchili	NULL
,	NULL
E.	NULL
Kieff	NULL
,	NULL
and	NULL
G.	NULL
Mosialos	NULL
.	NULL

1996	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
receptor	NULL
associated	NULL
factor	NULL
2	NULL
is	NULL
a	NULL
mediator	NULL
of	NULL
NF-kB	NULL
activation	NULL
by	NULL
latent	NULL
infection	NULL
membrane	NULL
protein	NULL
1	NULL
,	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
transforming	NULL
protein	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93:11085-11090	NULL
.	NULL

Kaye	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
K.	NULL
M.	NULL
Izumi	NULL
,	NULL
E.	NULL
Johannsen	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

Kieff	NULL
,	NULL
E.	NULL
1996	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
and	NULL
its	NULL
replication	NULL
,	NULL
p.	NULL
2343-2396	NULL
.	NULL

In	NULL
B.	NULL
N.	NULL
Fields	NULL
,	NULL
D.	NULL
M.	NULL
Knipe	NULL
,	NULL
P.	NULL
M.	NULL
Howley	NULL
,	NULL
et	NULL
al	NULL
.	NULL

(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Virology	NULL
,	NULL
3rd	NULL
ed	NULL
.	NULL

Raven	NULL
Press	NULL
,	NULL
Ltd.	NULL
,	NULL
Philadelphia	NULL
.	NULL

.	NULL

Lee	NULL
,	NULL
S.	NULL
Y.	NULL
,	NULL
C.	NULL
G.	NULL
Park	NULL
,	NULL
and	NULL
Y.	NULL
Choi	NULL
.	NULL

1996	NULL
.	NULL

T	NULL
cell	NULL
receptor	NULL
dependent	NULL
cell	NULL
death	NULL
of	NULL
T	NULL
cell	NULL
hybridomas	NULL
mediated	NULL
by	NULL
the	NULL
CD30	NULL
cytoplasmic	NULL
domain	NULL
in	NULL
association	NULL
with	NULL
tumor	NULL
necrosis	NULL
factor-associated	NULL
factors	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

183	NULL
:	NULL
669-674	NULL
.	NULL

Liebowitz	NULL
,	NULL
D.	NULL
,	NULL
J.	NULL
Mannick	NULL
,	NULL
K.	NULL
Takada	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

1992	NULL
.	NULL

Phenotypes	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
LMP1	NULL
mutants	NULL
indicate	NULL
transmembrane	NULL
and	NULL
amino-terminal	NULL
cytoplasmic	NULL
domains	NULL
necessary	NULL
for	NULL
effects	NULL
in	NULL
B-lymphoma	NULL
cells	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:4612-4616	NULL
.	NULL

Liebowitz	NULL
,	NULL
D.	NULL
,	NULL
D.	NULL
Wang	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

1986	NULL
.	NULL

Orientation	NULL
and	NULL
patching	NULL
of	NULL
the	NULL
latent	NULL
infection	NULL
membrane	NULL
protein	NULL
encoded	NULL
by	NULL
Epstein-Barr	NULL
virus	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

58:233-337	NULL
.	NULL

Liston	NULL
,	NULL
P.	NULL
,	NULL
N.	NULL
Roy	NULL
,	NULL
K.	NULL
Tamai	NULL
,	NULL
C.	NULL
Lefebvre	NULL
,	NULL
S.	NULL
Baird	NULL
,	NULL
G.	NULL
Cherton-Horvat	NULL
,	NULL
R.	NULL
Farahani	NULL
,	NULL
M.	NULL
McLean	NULL
,	NULL
J.	NULL
E.	NULL
Ikeda	NULL
,	NULL
A.	NULL
MacKenzie	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Korneluck	NULL
.	NULL

1996	NULL
.	NULL

Suppression	NULL
of	NULL
apoptosis	NULL
in	NULL
mammalian	NULL
cells	NULL
by	NULL
NAIP	NULL
and	NULL
a	NULL
related	NULL
family	NULL
of	NULL
IAP	NULL
genes	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
379:349-353	NULL
.	NULL

Mann	NULL
,	NULL
K.	NULL
P.	NULL
,	NULL
D.	NULL
Staunton	NULL
,	NULL
and	NULL
D.	NULL
Thorley-Lawson	NULL
.	NULL

1985	NULL
.	NULL

Epstein-Barr	NULL
virus-encoded	NULL
protein	NULL
found	NULL
in	NULL
plasma	NULL
membranes	NULL
of	NULL
transformed	NULL
cells	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

55:710-720	NULL
.	NULL

Mitchell	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
B.	NULL
Sugden	NULL
.	NULL

1995	NULL
.	NULL

Stimulation	NULL
of	NULL
NF-	NULL
«	NULL
B-mediated	NULL
transcription	NULL
by	NULL
mutant	NULL
derivatives	NULL
of	NULL
the	NULL
latent	NULL
membrane	NULL
protein	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:2968-2976	NULL
.	NULL

Mosialos	NULL
,	NULL
G.	NULL
,	NULL
M.	NULL
Birkenbach	NULL
,	NULL
R.	NULL
Yalamanchili	NULL
,	NULL
T.	NULL
VanArsdale	NULL
,	NULL
C.	NULL
Ware	NULL
,	NULL
and	NULL
7108	NULL
32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

DEVERGNE	NULL
ET	NULL
AL	NULL
.	NULL

E.	NULL
Kief	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
Epstein-Barr	NULL
virus	NULL
transforming	NULL
protein	NULL
LMP1	NULL
engages	NULL
signaling	NULL
proteins	NULL
for	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor	NULL
family	NULL
.	NULL

Cell	NULL
80:389-399	NULL
.	NULL

Mosialos	NULL
,	NULL
G.	NULL
,	NULL
R.	NULL
Yalamanchili	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

Rickinson	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
E.	NULL
Kief	NULL
.	NULL

1996	NULL
.	NULL

Epstcin-Barr	NULL
virus	NULL
,	NULL
p.	NULL
2397-2446	NULL
.	NULL

In	NULL
B.	NULL
N.	NULL
Fields	NULL
,	NULL
D.	NULL
M.	NULL
Knipe	NULL
,	NULL
P.	NULL
M.	NULL
Howley	NULL
et	NULL
al	NULL
.	NULL

(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Virology	NULL
,	NULL
3rd	NULL
ed	NULL
.	NULL

Raven	NULL
Press	NULL
,	NULL
Ltd.	NULL
,	NULL
Philadelphia	NULL
.	NULL

Robertson	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
E.	NULL
Kief	NULL
.	NULL

1995	NULL
.	NULL

Reducing	NULL
the	NULL
complexity	NULL
of	NULL
the	NULL
transforming	NULL
Epstein-Barr	NULL
virus	NULL
genome	NULL
to	NULL
64	NULL
kilobase	NULL
pairs	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:983-993	NULL
.	NULL

Rothe	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
G.	NULL
Pan	NULL
,	NULL
W.	NULL
J.	NULL
Henzel	NULL
,	NULL
T.	NULL
M.	NULL
Ayres	NULL
,	NULL
and	NULL
D.	NULL
V.	NULL
Goeddel	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
TNFR2-TRAF	NULL
signaling	NULL
complex	NULL
contains	NULL
two	NULL
novel	NULL
proteins	NULL
related	NULL
to	NULL
baculoviral	NULL
inhibitor	NULL
of	NULL
apoptosis	NULL
proteins	NULL
.	NULL

Cell	NULL
83:1243-1252	NULL
.	NULL

Rothe	NULL
,	NULL
M.	NULL
,	NULL
V.	NULL
Sarma	NULL
,	NULL
V.	NULL
M.	NULL
Dixit	NULL
,	NULL
and	NULL
D.	NULL
V.	NULL
Goeddel	NULL
.	NULL

1995	NULL
.	NULL

TRAF2-medi-ated	NULL
activation	NULL
of	NULL
NF-kB	NULL
by	NULL
TNF	NULL
receptor	NULL
2	NULL
and	NULL
CD40	NULL
.	NULL

Science	NULL
269:1424-1427	NULL
.	NULL

Rothe	NULL
,	NULL
M.	NULL
,	NULL
S.	NULL
C.	NULL
Wong	NULL
,	NULL
W.	NULL
J.	NULL
Henzel	NULL
,	NULL
and	NULL
D.	NULL
V.	NULL
Goeddel	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
novel	NULL
family	NULL
of	NULL
putative	NULL
signal	NULL
transducers	NULL
associate	NULL
with	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
the	NULL
75	NULL
kDa	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor	NULL
.	NULL

Cell	NULL
78:681-692	NULL
.	NULL

Sarma	NULL
,	NULL
V.	NULL
,	NULL
Z.	NULL
Lin	NULL
,	NULL
L.	NULL
Clark	NULL
,	NULL
B.	NULL
M.	NULL
Rust	NULL
,	NULL
M.	NULL
Tewari	NULL
,	NULL
R.	NULL
J.	NULL
Noelle	NULL
,	NULL
and	NULL
V.	NULL
M.	NULL
39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

Dixit	NULL
.	NULL

1995	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
B-cell	NULL
surface	NULL
receptor	NULL
CD40	NULL
induces	NULL
A20	NULL
,	NULL
a	NULL
novel	NULL
zinc	NULL
finger	NULL
protein	NULL
that	NULL
inhibits	NULL
apoptosis	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:12343-12346	NULL
.	NULL

Sato	NULL
,	NULL
T.	NULL
,	NULL
S.	NULL
Irie	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Reed	NULL
.	NULL

1995	NULL
.	NULL

A	NULL
novel	NULL
member	NULL
of	NULL
the	NULL
TRAF	NULL
family	NULL
of	NULL
putative	NULL
signal	NULL
transducing	NULL
proteins	NULL
binds	NULL
to	NULL
the	NULL
cytosolic	NULL
domain	NULL
of	NULL
CD40	NULL
.	NULL

FEBS	NULL
Lett	NULL
.	NULL

358:113-118	NULL
.	NULL

Smith	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
and	NULL
K.	NULL
S.	NULL
Johnson	NULL
.	NULL

1988	NULL
.	NULL

Single-step	NULL
purification	NULL
of	NULL
polypep-tides	NULL
expressed	NULL
in	NULL
Escherichia	NULL
coli	NULL
as	NULL
fusion	NULL
proteins	NULL
with	NULL
glutathione	NULL
S-transferase	NULL
.	NULL

Gene	NULL
67:31-40	NULL
.	NULL

Wang	NULL
,	NULL
D.	NULL
,	NULL
D.	NULL
Liebowitz	NULL
,	NULL
F.	NULL
Wang	NULL
,	NULL
C.	NULL
Gregory	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
Rickinson	NULL
,	NULL
R.	NULL
Larson	NULL
,	NULL
T.	NULL
Springer	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

1988	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
latent	NULL
infection	NULL
membrane	NULL
protein	NULL
alters	NULL
the	NULL
human	NULL
B-lymphocyte	NULL
phenotype	NULL
:	NULL
deletion	NULL
of	NULL
the	NULL
amino	NULL
terminus	NULL
abolishes	NULL
activity	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

62:4173-4184	NULL
.	NULL

Wang	NULL
,	NULL
F.	NULL
,	NULL
C.	NULL
Gregory	NULL
,	NULL
J	NULL
.	NULL

Sample	NULL
,	NULL
M.	NULL
Rowe	NULL
,	NULL
D.	NULL
Liebowitz	NULL
,	NULL
R.	NULL
Murray	NULL
,	NULL
A.	NULL
Rickinson	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

1990	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein	NULL
(	NULL
LMP1	NULL
)	NULL
and	NULL
nuclear	NULL
proteins	NULL
2	NULL
and	NULL
3C	NULL
are	NULL
effectors	NULL
of	NULL
phenotypic	NULL
changes	NULL
in	NULL
B	NULL
lymphocytes	NULL
:	NULL
EBNA-2	NULL
and	NULL
LMP1	NULL
cooperatively	NULL
induce	NULL
CD23	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:2309-2318	NULL
.	NULL

